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Abstract
The incidence of head lice, 'Pediculus humanus capitis^  in the West is increasing, with 
insecticide resistance the likely cause. Previous studies have explored the utility of essential 
oils, and some of their constituent monoterpenoids, in the treatment of head lice. This 
investigation examines the relative short-term toxicity of a range of different 
monoterpenoid structures on adult clothing lice, Pediculus humanus corporis, and their eggs; a 
structure-activity series was generated for the adults, and partially for eggs. The most 
effective monoterpenoid against adult Hce was (+)-terpinen-4-ol, with monocyclic 
compounds containing a single O-atom having the highest activities. Furthermore, there 
appear to be important differences between the relative potencies of monoterpenoids on 
lice and eggs, as nerolidol was particularly effective against eggs but completely ineffective 
against adult lice.
To investigate the insecticidal mechanism of action of monterpenoids, various pediculicidal 
structures were screened for activity on an insect ionotropic GABA receptor, composed of 
the Drosophila melanogaster svhumt RDL^ ,^ expressed in Xenopus oocytes. Thymol, eugenol 
and carvacrol potentiated GABA responses at this receptor, and possessed agonist activity 
at high concentrations. This is the first documentation of monoterpenoid bioactivity at an 
isolated insect receptor known to be representative of an in vivo insecticidal target.
Thymol also had potentiating and agonist effects on human al|33Y2s GABA^ receptors 
expressed in Xenopus oocytes, and 50 p,M thymol induced a leftwards shift of the GABA 
dose-response curve. Further work on this receptor examined the interaction of thymol 
with previously characterised modulator binding sites. The results of functional studies 
suggest that thymol does not share a binding site with benzodiazepines, barbiturates, 
steroids, propofol, (3-carbolines or loreclezole.
The direct involvement of insect GABA receptors in monoterpenoid insecticidal activity 
remains to be confirmed, as does the location of the thymol binding site on insect and 
mammalian ionotropic GABA receptors.
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Chapter1 
introduction
1.1 concepts of head louse control
Lice have been known to parasitise humans for thousands of years. Remains of lice have 
even been found on Egyptian mummies approximately 5000 years old [11]. Historically,
Hce were associated with disease and dirt, no doubt because the clothing louse of man was 
responsible for the spread of terrible illnesses such as typhus and trench fever. This 
association paraUels the infamy of the black rat in being a plague-carrier. In the same way 
that the reputation of the brown rat, which is not a plague vector, was harmed by its 
association with the black rat, so the reputation of the head louse was harmed by 
association with its close relative, the clothing louse.
Social attitudes to head Hce infection vary greatly between societies, and even within 
different segments of a community. Westerners are generaUy embarrassed to admit they 
have Hce whereas in poorer parts of the world they have always been viewed as a fact of Hfe 
[81]. In the 20*^  Century, the gradual introduction of pedicuHcides (agents lethal to Hce) and 
concomitant gradual decrease in tolerance of Hce led to falHng infestation rates in Western 
societies. In the U.K., the incidence of head Hce was probably at its lowest in the late 1980s 
and early 1990s, but since then resistance has destroyed the usefulness of the majority of 
approved pharmaceutical interventions.
Unfortunately, Western OTC (over the counter) and POM (prescription only medicine) 
pedicuHcides are expensive. The cost of treating head Hce was estimated at 367 milHon 
doUars per annum in the USA in the early 1990s [69]. In developing countries, where the 
extent of the problem is far greater, such treatments are either unavailable or prohibitively 
expensive [81]. Cures for pediculosis (an infestation of human Hce) continue to centre 
around social grooming and ancient remedies, many of which are based on natural 
products. However, Httle would be known of the efficacy, selectivity and side-effects of 
such remedies.
Since around 1991, there has been increasing anecdotal evidence from health professionals 
and parents aHke supporting a recrudescence of head Hce in the West [51]. The sudden
widespread occurrence and the desperation experienced by parents in the face of treatment 
failures have perhaps precipitated the dissipation of the taboo surrounding the discussion 
of lice, resulting in a large number of media articles on louse control.
There are a great many plants with reputed anti-lice activity [128] and therefore the 
scientific evaluation of natural products, perhaps from popular remedies of the developing 
world, could provide new avenues in louse control.
1.2 The taxonomy and anatomy of human lice and their interreiationship
Lice are said to be the most fully parasitic of aU insects, as every stage of their Hfe-cycle is 
intimately associated with the host. As a result of the permanent ectoparasitic state, aU lice 
are highly specialised. Lice species are extremely host-specific, colonising one or a small 
number of animal species. They are often further adapted to a particular anatomical part, 
and therefore multiple louse species may infest a single host without competition [160].
There are three orders of lice, according to Maunder [160]. The MaUophaga or ‘chewing 
lice’ are skin eaters, this order contains 2,600 species and most are parasites of birds. The 
Rhyncophthiraptera, ‘cutting lice,’ contains two species, one parasitising elephants, the 
other warthogs. The Anoplura comprises over 565 species of sucking lice [160,62,84] and 
are found on nearly aU groups of mammals [45]. Within the Order Anoplura are two 
Families of lice that encompass the three types of louse colonising humans [134]. Each 
type infests a different area of the body. The nomenclature adopted here is that of 
Maunder [160]: The head louse, Pediculus humanus (Linnaeus) capitis and the body, or 
clothing, louse, Pediculus humanus corporis^  belong to the family PedicuHdae. Collectively, P. h. 
capitis and P.h. corporis are referred to as P. humanus. The pubic, or crab, louse, Pthiruspubis 
belongs to Pthiridae. In Western Society at present, the head louse is of greatest clinical 
concern, therefore louse-control measures and associated mechanistic aspects discussed 
here will focus on P. h. capitis, although most louse-control methods are applicable to aU 
three types.
Obligate parasites, such as P. humanus and P. pubis, characteristically occupy very narrow, 
fragile biological niches [205]. During evolution, it is almost as if characteristics which 
enabled them to survive in other habitats were exchanged for those which would allow 
them the best chance of survival in their precise yet precarious environment. Visible 
behavioural and morphological traits of lice clearly display the extremity of this adaptation.
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For example, neither head lice nor their eggs are able to survive distal to the host for more 
than 1-2 days unless provided with a climate of artificially enhanced temperature and 
humidity [205]. All human lice are obligate haematophages and carry symbiotic micro 
organisms to supplement nutrition. They have no wings and much reduced sensory 
function in comparison to even temporary parasites, yet the consequentially short 
antennae, along with the ability to retract their mouthparts, helps to minimise the potential 
for damage via fragile areas [148]. Spines and bristles on the cuticle probably help to 
protect delicate areas of the cuticle from abrasion by hairs. Adult lice are small, and all life­
cycle stages are camouflaged, which reduces the chances of host-detection. The tarsal claws 
are modified for gripping which aids movement through fibrous media, as does their 
dorsoventral flattening. The latter also allows adpression to scalp and this, along with the 
capacity to grip incredibly firmly, helps Hce to remain attached to their medium during host 
grooming activities [148].
The three varieties of human Hce have discrete, non-overlapping distributions on the body, 
hence the common nomenclature. Some of the adaptations to these three different 
microcHmates are also clearly visible, for example, the foreHmbs of P. pubis are more widely 
spaced than those of P. humanus^  just as pubic hair folHcles are farther apart than those of 
body hair. However, P. h. capitis and P. h. corporis are not easy to differentiate; there are very 
sHght but consistent morphological differences between the two groups of organisms yet 
there is also overlap between the sub-species in respect of these features [57,58]. Busvine 
suggested that a physical separation of P. humanus was foUowed by continuing adaptation of 
the two sub-populations according to the specific habitat conditions, such as food 
availabiHty and environmental stabiHty, therefore head and clothing Hce were two separate 
species. However, head and clothing Hce freely interbreed in vitro and, given that the two 
habitats are proximal in vivo, probably also do so in the wild [57]. For this reason they have 
been designated sub-species, rather than species, classification [160]. Even under the 
electron microscope, head Hce and clothing Hce appear identical without morphometric 
assessment. Figure 1.1 shows scanning electron micrographs (SEMs) of P. humanus 2ià\i\x. 
and egg.
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(a) 500 nM
Hatching occurs though the 
operculum (cap).
A cluster o f aeropyles 
(pores) allow gaseous 
exchange.
500 piM
The egg is attached to its fibrous 
substrate distal to the operculum.
Figure 1.1 Scanning electron micrographs of Pediculus humanus: (a) adult (b) egg
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The anatomy, biology, life-cycle, physiology and epidemiology of P. humanus sub-species are 
described in [45] and references therein. Briefly, P. humanus are small, 2-4 mm long 
cylindrical insects [205] with compact, highly sclerotised thoraxes, and elongate, 
membranous abdomens. The cuticle may be pigmented to varying degrees [45], with 
recendy-fed lice having a red appearance due to the ingested blood-meal. The mouthparts 
are adapted solely for blood-sucking [187] and consist of concentric piercing and sucking 
stylets with a central, long hypopharyngeal tube which delivers saliva. The mouthparts lock 
on to the host skin very tightly during feeding, owing to a series of tiny teeth-like structures 
that function as hooks [148]. The blood is sucked into the oesophagus by cavitation of the 
muscles constituting several pumps situated in the louse’s head; this builds up the high 
negative pressure required to draw the viscous substrate up through the narrow feeding 
canals. As the energy required for suction is high, lice with free access to host skin tend to 
take small, frequent feeds, 5-6 times a day [45]. Louse saliva, injected during feeding, 
contains anticoagulant to prevent blood clotting in the feeding tubes, digestive enzymes 
and also a red-cell clumping agent [160].
The eggs of P. h. capitis are creamy-white and so blend in against the scalp [160]; they 
feature a cap-like structure, the operculum, which bears complex pore structures termed 
aeropyles. When lice hatch out, the empty eggshells they leave behind, or “nits” [45], are 
highly refractile, whereas embryonated eggs are not. An ignorant host is therefore 
distracted into focussing on nit-removal, leaving the eggs intact [159]. Although the term 
‘nit’ is often used to refer to the egg, or the louse itself, authors now prefer to reserve the 
term specifically for the eggshells. Louse hatchlings, or ‘nymphs,’ are pale and partially 
transparent, but attain a fixed colour at the time of the first feed, the degree of colour 
varying from light to dark grey, depending on the host hair colour [160].
1.3 The life cycle and population structure of Pediculus species
All lice undergo incomplete metamorphosis, i.e. the form emerging from the egg is 
extremely similar to the adult [187]; there is no pupal stage. Both P. humanus sub-species 
have three nymphal instars (stages of development), each lasting 3-5 days, before the third 
moult, which unveils the adult louse. Females mate within 2 days of reaching adulthood 
[45] and begin laying around 6 eggs per day [205] soon after. The eggs are chemically
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bonded to single hair shafts, close to the roots (or fabric fibres in the case of clothing lice), 
by a clear, quick-setting, glue-like substance produced in the females’ accessory glands 
[45,81]. Hatching normally occurs in 6-9 days [45] and is achieved by the nymph taking in 
air through the aeropyles and expelling it behind. The resulting pressure forces open the 
operculum and ejects the louse from the shell, the nit remains fixed to the hair. The 
strength of the glue by which the nit is attached results in it remaining on the hair for 
months or even years [160].
Many aspects of louse biology and behaviour are dependent on the stable environmental 
conditions provided by the host. Hatching rates can be as high as 90 % at 34 °C but fall to 
less than 10 % at 22 °C [205]; instar duration is also affected by variable conditions. Adult 
lice prefer to reside within a certain climatic range; therefore in warmer countries or more 
humid situations such as during host exercise, lice may wander farther afield than their 
usual half inch from the scalp [246].
Once a person has contracted lice, their numbers will increase if unchecked [81], however, 
most cases of pediculosis capitis (the condition of head lice) feature an infestation with 
only 5-15 lice [205], as individuals are constantly being lost by death or transmission. Lice 
kept in vitro can survive as long as 30 days, but in the wild lifespan is shorter and highly 
variable. Death usually occurs by physical or chemical destruction or as a result of host 
immune reaction rather than from old age.
The small number of lice involved in the vast majority of Western cases of head lice today 
is the reason why infections are so difficult to detect [59,123]. However, extremely high 
levels of infestation are not unknown, especially historically: In 1917, Nuttall noted a case 
in an infirmary where a patient had over 1,000 lice on her scalp, and workers at the 
institution informed him that the infestation was quite mild in comparison with those of 
other admittees [187].
1.4 Symptoms and consequences of pediculosis capitis
The majority of cases of pediculosis capitis are symptom less [164] and, for this reason, 
diagnosis is usually made solely upon discovery of live lice on the scalp (not by the 
presence of eggs, as these may be non-viable or nits mistaken for eggs) [81]. In Western 
societies, social factors provide the main impetus for head louse removal on an individual 
basis. Entomologists report an ‘entomophobic reaction’ of shock and revulsion when Hce
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are discovered [81]. This is perhaps understandable for someone living in the developed 
world at the present time, where a high degree of control over both cosmetic appearance 
and contact with arthropods is expected. They may also fear that others will notice their 
miniature invaders, and worry that this could lead to social exclusion. The association of 
pediculosis with uncleanliness is common, but studies suggest lice are just as likely to infest 
clean or dirty hair [67,81], and overly dirty or greasy hair tends to inhibit colonisation [160]. 
Maunder linked the popularity of shampoo formulations with the perception of de-lousing 
as a cleansing procedure. However, he also asserts that although washing the hair with 
ordinary shampoos does not control lice, the associated grooming that goes with a certain 
level of personal hygiene is very important [159].
If a child has lice, its parents are likely to be the most anxious party. A Mori poll once 
revealed that pediculosis capitis was the childhood disease about which parents were most 
concerned [164]. In the USA, the ‘no nit policy,’ where children are banned from attending 
school until aU lice and ‘eggs’ (generally not discriminating between eggs and nits) have 
been removed, is becoming more frequently implemented [266]. Yet it is not only children 
that harbour and transmit lice, as commonly believed. In fact 30 - 40 % of pediculosis 
capitis cases occur on adults [164]. Exclusion of children from school is likely to only cause 
further distress within the family, especially as parents find egg or nit removal difficult [45], 
aside from the fact that removal of empty cases is a poindess task.
The symptom traditionally diagnostic for the presence of lice is itching. However, studies 
suggest that itching, due to irritation (pruritis) of the scalp, only occurs in 14 - 36 % of 
cases [73,179]. Allergic reactions to louse saliva, rather than the ambulatory activity of the 
louse, are the cause [59]. The symptoms pass through the classical range of immune 
responses; no reaction, delayed reaction, immediate reaction, tolerance [179]. Because 
pruritis may not occur or, if it does, may take up to 3 months to develop [212] many people 
who have hce are unaware they have them. Maunder estimates that 2, 000 to 100, 000 louse 
bites are required for primary sensitisation [160] so, with an average of 10 lice present and 
assuming each louse feeds five times a day, it would take between 40 and 2,000 days for the 
sort of infestation seen in Western societies to cause sensitisation. When pruritis does 
occur, the irritation can become quite intense [81]; Burgess reports having seen patients 
who have removed considerable areas of skin by constant scratching [45].
In general, the vast majority of cases of pediculosis capitis in the West today have little or 
no impact on the patient’s health, which causes it to be viewed as a mild complaint by the
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medical profession. However, these infestations are small and short-lived; complications 
often occur in higher density or persistent cases.
In prolonged infections of P. humanus^  lasting over 12 months, a systemic allergic reaction 
may develop, characterised by rashes distal to the site of infestation, a feverish state, 
heaviness of limbs, stiffness of muscles and a constant sense of malaise and lethargy, from 
where the term “to feel lousy” probably originates [179]. Maunder reports that, in the 
developing world, often the majority of children have Hce almost permanently and many 
exhibit to some degree the apathy, enervation and low-grade anorexia symptomatic of 
prolonged pediculosis [163] (although his observations are merely associative in this case).
Other known consequences of louse infestation include lymphadenopathy, contracted via 
infected bites [2,179], allergic reactions to louse faeces, such as pseudo-elephantiasis of the 
ear [156], and exudative crusting of the scalp [6]. Pediculosis capitis often precipitates 
impetigo and pyoderma (bacterial skin infection) [45]. These conditions develop when 
excoriated bite lesions are colonised by bacteria or fungi from either the normal skin flora, 
contaminated fingernails, the bodies of Hce or louse faeces [81]. Kidney inflammation 
(glomerulonephritis) can result if the bacterium is a nephritogenic strain of Streptococcus 
[179].
Lice are the sole vectors of classical typhus (an acute infectious fever). The infective 
organism, PJckettsiaprowai^ eki, is spread by ingestion with the blood meal and expulsion in 
faeces [59]. Head Hce are epidemiologicaUy insignificant vectors of this disease in 
comparison with clothing Hce because their faeces do not build up in large enough deposits 
next to the skin [159]. Louse-borne relapsing fever is transmitted when louse-gut rupture 
causes insect blood, infected with the spirochete Borrelia recurrentis, to enter excoriations in 
the host skin. Head and clothing Hce are equaUy good vectors of this condition [59]. 
Fortunately, these diseases are both treatable with antibiotics, and are currently restricted in 
geographical range [45]. However, the results of past epidemics of typhus have left 
Maunder to speculate that human Hce may have kiUed more people than any other insect, 
perhaps with the exception of malaria-carrying mosquitoes [160]. The question of whether 
Hce can transmit HIV has been raised, but it appears that arthropods in general make 
unsuitable vectors for such viruses [284].
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1.5 Transmission and epidemioiogy of Pediculus humanus capitis
Live P. h. capitis normally only occur on head hair although they have, on occasion, been 
found on eyebrows [81]. It is generally accepted that adult lice spread primarily by walking 
from one head to another. Lice cannot jump, although they can be thrown through the air 
by static charge during grooming [45]. Infant Hce don’t move very far on the scalp [52], so 
neither they nor the firmly cemented eggs would serve as dispersive agents. Only older 
juveniles and young adults are mobile.
Maunder beHeves that host-dependency prevents a louse from wiUingly leaving a scalp 
unless there was another in the immediate vicinity [159], although he has also asserted, in a 
somewhat contradictory fashion, that Hce experience a ‘powerful urge’ to colonise new 
habitats [160]. Other sources claim that disturbances of the hair stimulate active dispersal 
[48]. Lice possess temperature-sensing mechanisms in the antennae that enable them to 
actively remain within the 31 °C zone surrounding the host, which equates to a few mm 
from the scalp, where they Hve and lay eggs [164,205]. It is therefore easy to see the logic 
behind the claims that Hce are generaUy passed from one person to another by relatively 
prolonged (30 s approx.), head to head contact [49], and that transmission usuaUy occurs 
between people who know each other weU [81].
Transmission of Hce is undoubtedly by personal physical contact, but whether or not 
fomites (objects capable of carrying infective agents from person to person, for example, 
bedding, towels, combs) transmit Hce is contentious, and has not been investigated 
experimentaUy. Maunder beHeves that Hce found on objects other than human heads are 
non-viable [205]. This is probably true given the ferocity with which they cHng to fibres 
when disturbed, their fragiHty, and their relative immobiHty on media other than human 
hair (on suitable media, adult Pediculus can travel 1 metre in less than 3 min [187]). Perhaps 
in warmer conditions, when they stray further [245], Hce may contact intermediary objects 
between heads, for example by walking across piUows in the night, but re-estabHshment 
would depend on the louse not becoming damaged or dehydrated in the interim.
Human pedicuH occur in aU parts of the world [187] and on all age groups [5]. Children are 
important in the epidemiology of P.h. capitis because they spread Hce between famiHes or 
social groups through contact at school [122]. However, the reason control programmes 
centred on school-children usuaUy fail is that, once in a close social group, Hce can spread 
to aU the members, and deloused children simply get reinfested. The highest prevalence of
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p. b. capitis occurs in children aged between 4 and 11 [81] and in all age groups head lice are 
more common on females [168]. Social behaviour is thought to be an important 
determinant of head louse epidemiology, as females are more liable to engage in close 
contact with others, and children are more tactile than adults. Adult men also have a much 
greater number of empty or resting hair follicles, and head lice do not colonise widely 
spaced hair efficiendy [160]. Hair length does not appear to affect the chances of catching 
lice (as put forward by Nuttall [187]) nor the numbers in an infestation [45,205]. Only when 
hair is shorter than a few millimetres wiU colonisation be affected; hair-shaft diameter, 
degree of curl and follicle spacing are probably more important [160]. Although Rasmussen 
claims that middle-class Caucasians are the most commonly affected group, lice being rare 
on afro-Americans [205], his evidence was probably taken from what was or is a 
predominantly Caucasian population, as sub-populations of lice are adapted to colonising 
different types of hair [45].
It appears that any situation that increases the frequency of head to head contacts will 
increase the frequency of infestation, and reinfestation [187]. Low socio-economic 
indicators such as large family size, bed sharing, crowding and inattention to medical care 
have been identified by some authors as factors promoting louse transmission (in fact the 
results of correlative studies have been very variable [45]); poor hygiene is probably not a 
factor, for reasons discussed previously. In this country, head lice used to be most 
prevalent in working-class areas of cities. Gradually the balance tipped so that, after 1976, 
incidence was highest among rural, suburban and middle-class children. It is believed that 
the gradual rise in standards of living in this country saw a decrease in the ‘poverty’ factors 
described above in poorer households whilst, in better-off households, the lessening of 
social formality keeping adults at a distance and increased travel to see a wider circle of 
friends encouraged transmission [160].
Quoting statistics to illustrate the changes in head louse prevalence over the last Century 
presents a problem. Early surveys, mostly derived from hospital or clinic records, lacked 
specific inclusion criteria of what constituted an infestation [45]. A few scientific studies 
were made. The incidence of head Uce in developed countries in 1941 was estimated at 30 
— 50 % of the human population [168]; and this figure may still be applicable to countries 
where commercial pedicuHcides are not available [45]. Years of insecticide use in this 
country was presumably the main reason for a much lower incidence here in 1986: British 
Government statistics suggested only 1.29 % of the maintained school population in 
England and Wales had contracted head Hce that year, although these were criticised as
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being over-optimistic by one author [122]. In 1993, Maunder observed that infection rates 
had fallen substantially in recent years [164], however, it was shortly after this that 
pediculicide treatment failure became a big issue. An unpublished survey of head lice 
prevalence around rural and urban areas of Cambridgeshire suggested that the average 
incidence was 7.4 % for the late 1990s [51].
1.6 Methods to  control Pediculus humanus capitis
1.6.1 Historical aspects of louse control
Before the introduction of chemical control in the last century, treatment of pediculosis 
often just involved physical removal of lice and eggs by combing, picking, or shaving [45]. 
Because lice were associated with dirtiness, soap and water or plain shampoo were often 
employed. Yet detergents only dislodge dead or dying insects and healthy lice can survive 
under water for up to a day. General grooming may help to keep the numbers down, but 
the teeth of most combs are too widely spaced to be completely effective and are not 
applied to the roots where lice and eggs reside [205].
Sometimes crude chemical-based remedies were employed, based on either botanicals, 
inorganic poisons or petroleum based organics. Mineral oils such as kerosene have long 
been used to kill Hce and have been shown to obstruct the insect tracheal system, but in 
practise they have low efficacy and can also be highly flammable [45]. These treatments are 
stiU used extensively in the developing world because of the cost of Western medicines 
[81].
In the 20* Century, scientific research and industrial development led to the discovery and 
manufacture of more effective, largely synthetic, insect-specific pest control agents. The 
safest of these were employed in pharmaceutical preparations for the control of personal 
parasites. Speed of action is an important facet of insecticidal efficacy and, given that 
interruption of neurotransmission is one of the fastest ways to metaboHcaUy disable an 
insect, it is no surprise that aU of the most widely used insecticides act on targets in the 
insect nervous system. Most neuro-active insecticides faU into one of five chemical classes 
[163] and generaUy these structural differences reflect distinctions in mode of action. The 
classes are therefore referred to as ‘resistance groups’ because if resistance develops to one 
insecticide in the group it usually extends to all the rest, although cross-resistance between
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the groups also occurs. The following sections briefly describe the resistance groups, 
focusing on those insecticides which have been most important in louse control.
1.6.2 Resistance group I pediculicides: DDT and related compounds
DDT (dichlorodiphenyltrichloroethane) was hailed as the greatest advance yet for the 
control of disease vectors upon its introduction towards the end of the Second World War. 
However, compared to modern pediculicides it is slow acting with poor ovicidal activity. It 
has no residual action except on fabric. The detrimental effects of DDT on wildlife and the 
environment and the spread of DDT-resistance in lice resulted in its withdrawal as a 
pediculicide in North America and Europe, but low cost has maintained its use in poorer 
countries. It is less hazardous to man than popularly believed [45,81,141,163]. The neuronal 
target of DDT (and pyrethroids, see Section 1.6.6 for details) is the insect voltage-sensitive 
Na"*" channel.
1.6.3 Resistance group a pediculicides: The cyclodienes and cyclohexanes
Some cyclodiene insecticides are environmental hazards, but others, such as dieldrin, are 
safe for public health use. Only lindane (y-hexachlorocyclohexane, y-HCH) remains 
important for louse control [163], however it is no longer used for the treatment of 
pediculosis capitis in the U.K. [81]. Experiments and widespread generalised use indicated 
the efficacy and potency of this organochlorine as a pediculicide [205]. The first laboratory 
studies found it to be considerably more toxic to lice than DDT [56]. However, it needs 
careful formulation for satisfactory ovicidal activity [163]. In comparison to the 
organophosphate malathion it has poor ovicidal activity and is relatively slow to act. In one 
experiment, 1 % lindane, the concentration of use, took 190 min to kill all Hce, various 
pyrethrin-containing products took 10-30 min, and a malathion-containing lotion took 4 
min [167].
Lindane was introduced as a general insecticide in the late 1940s [45] and, foUowing reports 
of DDT-resistant head and body Hce, soon became the standard treatment for pediculosis 
[205]. In 1983, Hndane shampoo was documented as the most widely used pedicuHcide in 
the U.S. [141]. Concerns that Hndane was losing efficacy arose in the 1980s, and widespread 
low-level resistance was found before its withdrawal from use against pediculosis capitis
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[45,205]. Nowadays, lindane is available for other forms of pediculosis apart from capitis, 
with the trade names “Lorexane” and “Quellada”.
The primary mode of action of cyclodienes and cyclohexanes is the perturbation of 
inhibitory neurotransmission via the GABA (y-aminobutyric acid) receptor-Cl' channel 
complex [183]. These compounds are not selective for the insect GABA receptor and have 
similar effects at the human equivalent. However, although lindane passes relatively readily 
through human skin, it accumulates, usually harmlessly, in body fat where it has a half-life 
of 3 months; nevertheless there are contraindications against use by certain patient groups 
[161]. Concerning adverse effects via transdermal absorption from pediculicidal shampoo 
formulations, the peak mean blood level following a single application to the scalp was 
measured at 1/30 those following use as a scabies treatment [205]. Several prominent 
physicians questioned the safety of lindane, but these concerns were largely unfounded 
given the relatively few reports of neurologic toxicity [205], which have occurred foUowing 
accidental ingestion or overuse [245].
1.6.4 Resistance group ill pediculicides: The organophosphates
The organophosphates have suffered from bad press in recent years, especiaUy with respect 
to their use on children for louse control. Although some organophosphates are hazardous, 
others are among the safest insecticides known. For example, Temephos is used for the 
control of mosquito larvae in drinking water [163].
Malathion was introduced in 1971 and out-performed Hndane in eUminating DDT-resistant 
Uce in the field [22], it was also effective against Undane-resistant Uce [205]. Various 
workers found it to be the first pedicuUcide with significant ovicidal activity, furthermore, if 
malathion is left on the hair for more than 12 h before washing, a residual activity persists. 
It was once beUeved that these two novel attributes would eUminate the usual need for 
further appUcations or nit combing after treatment. However, the majority of field studies 
suggest that, even in various formulations, the ovicidal activity is not 100 % complete, and 
a second treatment is recommended to kiU nymphs hatching after the residual action has 
worn off [43]. The high pedicuUcidal and ovicidal activities demonstrated with 0.5 % 
malathion lotion [205] can be achieved with appUcation times as short as 4 min. Malathion 
is available in formulation as “Derbac-M,” “Prioderm” and “Suleo-M.” One m vitro test 
identified Suleo-M as the most effective malathion-containing lotion for head Uce as it had
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by far the best ovicidal activity (the test was not adequate to distinguish them on the basis 
of pediculicidal activity) [43]. The first report of resistance to malathion was in body lice in 
1969 [205]. Since then there have been a few reports o f isolated cases of malathion- 
resistant head lice and one cluster in southern England [81].
Most organophosphates, including malathion, inhibit acetylcholinesterase (AChE). In 
insects malathion is oxidised to malaoxon, a more potent anticholinesterase [60]. AChE 
inhibitors result in over stimulation of nerves due to raised levels of acetylcholine in insect 
synapses. In insects, this only occurs in the CNS (central nervous system), as their 
peripheral synapses use L-glutamate instead of ACh [160]. Malathion penetrates human 
skin far less readily than it does insect cuticle [161] and, in humans, malathion is rapidly 
hydrolysed to excretable products or subject to attack by phosphatases which break it 
down into harmless products. Only resistant insects are capable of rapid hydrolysis of 
malathion [161]. Pharmaceutical grades of malathion are safe for use as pediculicides; they 
are widely used in head louse control and have a high record of safety [163] based on 
correct usage. Repeated or excessive application, or the misuse of agricultural grade 
malathion, impure forms or inappropriate formulations can result in poisoning 
[45,205,161].
1.6.5 Resistance group iv pedicuiicicies: The carbamates
Again, some carbamates, including the botanical agent physostigmine, are hazardous 
chemicals. Carbaryl and propoxur are the two most used in head louse control, and are safe 
for this purpose [163]. Carbaryl lotions were introduced in 1976 [42] but use was initially 
largely confined to Europe [163]. Carbaryl is fast acting [163] and field studies proved its 
efficacy against lice, even malathion-resistant ones [205], but also showed it to be 
incompletely ovicidal [45]. Carbaryl products have suffered criticism for inadequate 
efficacy, but Burgess claims this is unsubstantiated and probably precipitated by a lack of 
residual effect [722], which means patients can be reinfected by undiagnosed carriers, and 
poor product usage [42]. Although resistance to carbaryl is theoretically possible, as shown 
by the ease with which a resistant strain could be selected for in laboratory lice [68], 
carbamate resistance has not yet emerged in field strains [81].
Formulations of carbaryl appear to be more efficacious than the isolated active on adult lice 
but less so on eggs, as other components of the formulations reduce carbaryl penetration,
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especially over short time periods. Carbaryl is available in various formulations with the 
trade names Carylderm, Clinicide, Derbac-C, Suleo-C. In 1990, Suleo-C was shown to be 
the most effective ovicidal formulation and was one of two best at killing adult Hce [42].
Carbaryl is a reversible acetylchoHnesterase inhibitor, attacking the enzyme differently from 
malathion [48,161]. It does not readily penetrate human skin and any doing so is quickly 
degraded to 1-napthol. Carbaryl has been suspected of being carcinogenic in humans at 
high doses, and, for this reason, the Department of Health made it available only on 
prescription.
1.6.6 Resistance group v pediculicides: The pyrethrins and pyrethroids
Pyrethrins and pyrethroids are particularly important in the context of this study, as they 
are the result of a successfully exploited natural resource; historical usage was foUowed by 
commercial production of refined and standardised plant material and, later, semi­
synthetics based on the active constituents were developed. Their development and use in 
personal parasite control is summarised here. The rethrins are insecticidal esters occurring 
in Chrysanthemum cinerariaefoliumNïs., and C  coccineum^\)\à. [135]. They are formed from the 
combination of chrysanthemic acid or pyrethric acid with the three alcohols, pyrethrolone, 
cinerolone and jasmolone to form two sets of three rethrins, pyrethrins I and II 
respectively. In Persia (now Iran), the insecticidal properties of plants of the Chrysanthemum 
genus were known for centuries, but were kept secret. Then, in 1840, commercial 
production of C. cinerariaefolium flower heads began in Dalmatia (now Yugoslavia). The use 
of the powdered flower heads spread quickly through Europe and, in 1860, reached the 
USA. At the end of World War I, three miUion lb per annum were being used [135,246].
Between 1919 and 1929, it was first noticed that kerosene extracts were more active than 
the dried flowers. The active components were named ‘pyrethrin I and II,’ and extracts 
were then standardised on the basis of these markers. By observing the relative levels of 
these marker compounds according to environmental conditions, one USA company 
identified which parts of the world would grow the most insecticidal pyrethrum plants 
[246]. Success of rethrin-containing products as insecticides was curtailed owing to 
inadequate suppHes of pyrethrum, the introduction of DDT, low photo-stabiHty, and rapid 
metaboHsm in insects, which Hmited their potency and appHcation. Pyrethrum extract was 
also expensive compared to synthetic insecticides, although patenting of the synergist
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piperonyl butoxide in 1949 meant that manufacturers could use less in formulations [246].
Crude pyrethrum flower extracts are refined, and standardised such that commercial 
products contain 0,17 - 0.33 % pyrethrins, the rethrin composition being variable 
depending on the type of flower and the extraction process used [205]. Such products have 
been criticised for their variable quality, poor ovicidal activity, and chemical instability 
[163]. Professionals tended to regard pyrethrins as having low efficacy, but poor 
formulation was probably to blame in many cases [45]. Pyrethrins, formulated with a 
synergist in a shampoo vehicle, were tested against head lice and performed well in 
comparison to malathion but were not as efficacious as permethrin [45]. A study by 
Meinking and Taplin showed that one fresh pyrethrin combination had very rapid killing 
time (10 min) but a 2 month old product took 30 min to achieve the same result [167]. All 
pyrethrin formulations so far available have had particularly low ovicidal activities
[45,163,205].
Both pyrethrins and piperonyl butoxide are poorly absorbed by human skin. Side-effects 
from pyrethrin use are extremely uncommon and are usually some form of skin reaction 
due to other formulation or extract components. Pyrethrins do irritate mucous membranes, 
and contact with eyes should therefore be avoided [205,163]. More stable, effective and 
selective chemical relatives of pyrethrin have been investigated since the development of 
the first synthetic pyrethroid in 1949 and, in 1987, Taplin and Meinking reported that over 
50 pyrethroids had come into use for pest control [246]. Pyrethroids include (S) — 
bioallethrin, tetramethrin, resmethrin, phenothrin, kadethrin, permethrin (the first photo­
stable pyrethroid) and decamethrin [135]. Again, these range in toxicity, the safest being 
selected for louse control. In 1991, Maunder reported that phenothrin was the most 
popular pyrethroid in Europe; permethrin was preferred in America [163]. After the 
development of pyrethroids the pyrethrins were viewed as inferior, they have remained in 
use because they are currently relatively cheap in comparison to synthetic insecticides. 
Pyrethroids can be made far more economical when formulated with synergists, but the 
British Committee for Safety of Medicines are wary about the use of synergized insecticides 
on humans [163].
When permethrin was first used in a product (NIX® 1 % permethrin crème rinse), in the 
USA in 1986, it was found to produce complete cure, even though ovicidal activity was 
incomplete [246]. This was due to the residue of permethrin which persisted on the hair 
long after the conditioning vehicle had been washed off [246].
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The toxicity margin for permethrin is good and post-marketing surveillance studies showed 
it to be relatively side-effect free [10], it is photo-stable, and actually less toxic to animals 
than pyrethrins, hence its choice for personal parasite control [246], Rethrins and related 
compounds are known to undergo rapid metabolic degradation in mammals and birds 
[135], probably via esterase activity in skin [246]. Burgess believes that the low 
concentrations of pyrethrins, permethrin and phenothrin in commercial formulations also 
partially contribute to product safety [45], Side effects may occur if the patient has a 
predisposing allergy to Chrysanthemum plants, or other members of the Compositae 
family, such as ragweed, but it is thought that the major allergens are removed by modern 
refining techniques [246]. Skin sensitisation [161] and cases of acute irritancy have mostly 
been attributed to excipients [45].
Many insect species developed resistance to pyrethrins and pyrethroids fairly quickly after 
their introduction [161]. Lice are no exception, and permethrin-resistant pedicuH are 
already widespread in Britain [47], first occurring within 3 years of introduction [48]. 
Permethrin resistance has been documented in Israel and the Czech republic, whilst 
anecdotal reports have come from a number of other countries [46]. One study has shown 
phenothrin resistance in France [66]. It is expected that this resistance will render useless 
any product containing permethrin, phenothrin, pyrethrins, or related compounds. 
However, although pyrethrin resistance was demonstrated in 1955 in body lice (no cross­
resistance with lindane or malathion is believed to occur), so far there has been no 
documentation of pyrethrin-resistant head lice [205].
Pyrethroids and pyrethrins have the same neuronal target as DDT and both types of 
compounds produce a rapid paralytic (knockdown) activity. Pyrethroids first stimulate 
nerve cells and fibres to discharge repetitively; this then leads to paralysis from exhaustion 
of neurotransmitter. The repetitive discharge is mediated by them binding to the voltage- 
gated sodium channel and increasing the duration for which it is open [183]. This prolongs 
the sodium current, which in turn elevates and prolongs the normal depolarising after­
potential. This causes the membrane to reach the threshold for action potential again, thus 
initiating repetitive after-discharges. Pyrethrins and pyrethroids are selective towards insects 
mainly because invertebrate sodium channels are more sensitive to them than are the 
vertebrate equivalents, and due to the negative temperature dependence of pyrethroid 
action on the sodium channels (the flux increases at low temperature); pyrethroid 
degradation has only a minor role [183].
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1.6.7 Miscellaneous louse control methods
Treatment failures after the use of approved synthetic and semi-synthetic chemical 
pediculicides, and the current antipathy of certain sectors of the general public towards 
them, have led to research into new avenues of Uce control, often turning to ‘traditional’ 
methods for inspiration. In the U.K., “BugBusting” is a regime for physical removal of lice 
invented by the charity Community Hygiene Concern and involves regular, thorough wet- 
combing of conditioner-covered hair. The comb should be plastic and have teeth not more 
than 0.3 mm apart [52]. Such ‘nit combs’ or ‘detection combs’ (for they are also used in 
diagnosis) can remove even the smallest first instar nymphs and may also remove eggs or 
nits [48]. Burgess suggests that this alone is unlikely to be efficacious as it can take up to 9h 
of thorough searching and grooming to be sure that all lice, eggs and nits are removed and 
few people have sufficient motivation or skiU to produce a complete cure [45].
Some chemicals have been investigated for their nit/egg-removing potential. Vinegar was 
used in lice treatment for many decades and was supposed to detach louse eggs, however, 
studies have proven it to be ineffective for this purpose [59]. Formic acid was proposed on 
the strength of its reputed chitin-dissolving properties. Unfortunately, recent studies 
suggest that the substance attaching lice eggs to hair is non-chitinous [53]. Preliminary m 
vitro work with the ‘slip-peel test’, used by the MEG to identify effective nit-removing 
agents, which decrease the amount of force required to dislodge a nit from a strand of hair, 
also indicated its inefficacy [45].
Substrate removal was the biggest factor contributing to the near extinction of clothing lice 
in the developed world: People who change their outfit daily do not harbour clothing lice, 
as the lice cling to the removed garments and cannot tolerate the ensuing periods of 
starvation, low temperature and low humidity when the clothes are not being worn. 
Unfortunately, the equivalent for head lice would be to cleanly shave the entire head and 
neck area of infected families, therefore this method of head louse control is unlikely to 
become popular.
In his 1995 review [45], Burgess highlights some potentially new avenues in pediculicide 
research: For example, some systemic drugs, taken for other purposes, appear to 
incidentally affect the survival of head lice. These include selected non-steroidal anti­
inflammatory drugs, certain antibiotics and ivermectin (avermectin BJ. New possibilities 
for topical application include natural and synthetic insect growth regulating compounds,
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and the imidazoline miranols, short-chain surfactants which were found to specifically 
remove lipids from the water-proofing layer of louse cuticles,
1.7 Shortcomings of head lice treatments
At the present time, those with pediculosis capitis are finding it very difficult to treat 
successfully. There are numerous shortcomings associated with head louse control 
methods and they, along with the resilience of lice and their eggs, make eradication prone 
to failure.
1.7.1 Insecticide resistance
Insecticide resistance occurs due to artificial selection (insecticide use is the sole selection 
pressure driving its development): when a population office is subjected to a certain dose 
of a particular insecticide which would normally be lethal, and at least one louse survives, 
owing to a difference in genetic make-up, this louse will survive to pass on its ‘resistant’ 
gene, or genes, to its progeny [74,163]. The ‘resistant’ forms of the gene(s) will therefore be 
propagated among populations office in favour of the normal or ‘wild-type’ gene(s), owing 
to the preferential reproduction of individuals with the resistance phenotype over sensitive 
individuals. The extent of genetic interchange between insect populations determines the 
total proportion of the species that will acquire the resistance aUele(s) [74] and the 
reproduction rate determines the rapidity with which the resistance will spread.
Resistance has either occurred naturally or been demonstrated possible for each resistance 
group fisted above. This is not surprising given the history of insect adaptability towards 
these chemicals. As recently as 1986, Rasmussen believed that resistance in head lice was 
uncommon and that poor ovicidal activity was the cause of most pediculicide treatment 
failures [205]. Since then, resistance has increased to the point where its impact on head 
louse control is indisputable [149].
Resistance can occur due to modification of factors determining uptake, target site 
interaction and metabolism. Resistance to carbamates and organophosphates has often 
been shown to correlate with the insensitivity of AChE variants to these insecticides in 
various species, for example, in a documented incidence of methomyl (a carbamate) 
toxicity towards wild strains of the beet armyworm, Spodoptera exigua^  no cross-resistance
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with chlorpyrifos (an organophosphate) was found, emphasising the subde difference in 
mode of action of the two types of AChE inhibitor [60]. By contrast, a variant AChE, 
encoded by the allele y4^ :eR in wild Cu/expipiens quinquefasciatus was found to confer cross­
resistance to both organophosphates and carbamates [63].
An interesting breakthrough has been made regarding resistance at the DDT/pyrethroid 
target. cDNA clones containing part of a housefly Na^-channel gene, Msc^  were found to 
generate different lengths of DNA when subjected to digestion by the same restriction 
endonuclease enzyme. This technique is used to identify sequence variation between closely 
related sections of DNA, usually different alleles of the same gene, or evolutionarily related 
genes. Related sequences that differ with respect to the pattern of digestion are said to 
contain Restriction Fragment Length Polymorphisms (RFLPs), Inheritance of Mrr RFLPs 
showed tight linkage to inheritance of a form of pyrethroid (and DDT) resistance, ‘knock­
down resistance’ (kdr) [267]. This study provided perhaps the most firm evidence so far 
that the pyrethroid target mediating toxicity is the voltage-gated Na^-channel. Confirmation 
of the molecular target of dieldrin and related compounds was also achieved by the 
observation that variations in resistance phenotype correlated with certain changes in the 
genome. The Maryland strain of Drosophila  ^which is dieldrin-resistant, was found to contain 
a mutation in a GABA receptor subunit gene, Kdl\ cloning and expression of both wild- 
type and mutant RDL subunits later confirmed that the GABA receptors they formed in 
vitro were differentially susceptible to dieldrin [87,88].
Some resistant insect tissues contain elevated levels of microsomal oxidases; these enzymes 
detoxify insecticides, thereby lowering the dose reaching target internal organs. Piperonyl 
butoxide inhibits microsomal oxidases and is often used in formulations to increase the 
insecticidal potency. Other enzymes can also contribute to resistance, including hydrolases, 
esterases, glutathione transferases and dechlorinases. Enzymatic mechanisms such as these 
can give rise to cross-resistance phenomena (as has been seen between dieldrin and lindane 
or between organophosphates and carbamates), as they are often non-specific in action, 
and can inactivate multiple chemical structures [74].
In head lice, cross-resistance via enzymatic detoxification mechanisms is thought to 
underlie the reason why both organophosphate and pyrethroid resistance currently exist 
without decreased efficacy of carbaryl [48]; both malathion and pyrethroids are normally 
metabolised by esterase enzymes in aU insects, whereas carbaryl is metabolised by oxidases.
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As insect populations have proven highly responsive to selection pressures from insecticide 
use in the past, it is important to ensure that any new compound is used wisely to remain 
effective. It has been suggested that the concomitant [74], rotational or mosaic [45] use of 
at least two insecticides (presumably with different targets) is preferable, as the probability 
of two different resistance types existing in a single population is much less than for one 
[74]; the drawback to this strategy is that alleles conferring cross-resistance render it less 
viable. Also, as with antibiotics, prophylactic use is not recommended, as this increases the 
selection duration [163].
Unfortunately, the resistance-avoidance application regimes mentioned previously are 
impossible to implement, as most pediculicides are OTC medicines. Up until the start of 
the 1990s, the majority of U.K. health authorities rotated recommended pediculicides on 
an annual or triennial basis, this being possible because clinics had a monopoly on their 
supply. When this was dropped in 1992, rotation became unenforceable [51]. Since then, 
mosaic prescribing (the simultaneous availability of insecticides from several different 
resistance groups) offers the best means of preventing resistance development [45].
It could be argued that new insecticides are not needed, but instead, a more judicious use 
of what is already available. However, in reality the ability of such application strategies to 
keep resistance at bay is contentious, due to the existence of both monogenic and 
polygenic resistance genotypes, the latter developing over a long period of time in response 
to multiple different insecticides. For example, resistance to organochlorines usually 
involves a single gene and there is little cross-resistance between organochlorines and other 
compounds, even between the closely related DDT and lindane. In contrast, resistance to 
organophosphates spans to related and unrelated compounds [141]. Insecticide resistance is 
a complex phenomenon with variable components; the huge range of possible mechanisms 
is coupled with differing probabilities of occurrence and persistencies of resistant alleles. 
The widespread occurrence of DDT-resistance in lice stopped its use in many parts of the 
world. Some time after, it was noted that some populations of lice reverted to the sensitive 
phenotype, whereas others did not, presumably due to the co-existence of more than one 
type of resistance mechanism [141]. It should also be noted that the residual action 
displayed by some pediculicides, which was once believed to be advantageous as it kills 
hatchlings from surviving eggs and also prevents reinfection following treatment, is now 
believed to hasten the development of resistance [42,163] by increasing the selection 
pressure duration. The other disadvantage of residual action is that it eliminates lice caught 
by reinfection, which prevents the identification of other pediculosis sufferers by ‘contact
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tracing’ [42].
Maunder believes the development of resistance to an insecticide is inevitable following 10- 
20 years of widespread use, but there still remains the possibility that some compounds 
exist to which insects are unable to become resistant. It could be said that a fly cannot 
become resistant to a swat; might it be possible to find the chemical equivalent? 
Unfortunately the mechanism of action of a swat is rather non-specific, it is the application 
method that provides the specificity. Because pediculicides are applied to the human head, 
factors determining their toxicity must be as insect-specific as possible. However, the 
specificity of a compound can also be its downfall, as a minor change in the target site or 
the processes determining pharmacokinetics will render them inactive. With detailed 
knowledge of the mode of action, structure and metabolism of an insecticidal compound, 
the researcher may be more equipped to predict the likelihood of resistance, however, 
given the failure of a previous attempt to design a pesticide immune to resistance, such 
assessments may be of limited success: Insect-hormone mimics are extremely similar to the 
endogenous chemicals and it was therefore thought that any mutation favouring resistance 
would render the arthropod non-viable, yet they were subsequently overcome by insects 
with polygenic resistance [141].
1.7.2 Toxicity towards humans
Concerns regarding pediculicide toxicity have been expressed by the general public and 
discussed in the popular press [81]. In fact, reports of systemic toxicity from proper use of 
these agents are rare [205], although isolated incidents have occurred [81]. In poor families 
or where Western medicines are unavailable, cheap formulations or low-grade agricultural 
insecticides have been used and these have resulted in fatalities [269]. As with most 
medicines, however, there are contra-indications, and minor side effects are not 
uncommon.
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1.7.3 Incomplete ovicidal activity
The structure of the louse egg shell is such that few molecules penetrate it. Mature eggs 
also effectively contain a fully formed louse surrounded by its own cuticle, and therefore 
have multiple protective barriers against deleterious chemicals [161]. Insecticides generally 
collect at shell level and kiU emerging nymphs rather than the developing embryo, but this 
is not ovicidal action per se, and the active ingredients on their own usually fail to kiU 
nymphs prior to hatching. Some formulations contain excipients that enhance ovicidal 
activity or may be ovicidal themselves [48,51]. Furthermore, very young embryos have no 
nervous systems and therefore neuronaUy active insecticides are unlikely to have any effect 
at this stage [45]. So far, no commercial product utilises separate pediculicidal and ovicidal 
agents; the usual approach is to formulate a product in which both activities of a single 
insecticide are optimised.
1.7.4 Product formulation
The majority of pediculicidal products are lotion or shampoo formulations. Insecticidal 
shampoos are often criticised [41] as the short application times and the dilution factor 
when mixed with water (0 to 150 fold) result in doses inadequate to kill even adult lice [50]. 
Shampoos, however, remain popular with the public, probably because of their association 
with cleanliness [41,50] and the louse’s association with dirtiness.
Evaporating lotions perform better because they are applied for a longer duration and also 
result in product being applied, undiluted, directly to the surfaces of lice and eggs [162,163]. 
Crème rinses, introduced more recendy, supposedly combine convenience, efficacy and 
protection from reinfestation by residual action [45]. Their conditioning qualities leave the 
hair more manageable so that combing and nit removal after treatment are facilitated [246]. 
A mousse formulation for application to dry hair was developed by Burgess [44]; he claims 
it wiU allow a short application time, and yet also produce a high ovicidal activity.
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1.7.5 Treatment utilisation
Finally, it seems that louse control lacks proper utilisation of the best strategies for 
treatment. The public and health-care professionals alike are often not adequately educated 
about lice and the importance of correct pediculicide use [41], else they choose to ignore 
the information they are supplied; misapplication, such as too little product being applied is 
an important cause of treatment failure [45].
Control of lice should ideally be on a global level, not something which individual families 
attempt alone. The only way to effectively control an epidemic is to co-ordinate treatment 
within the entire social setting by involving schools and local authorities [205]. As most 
infections have existed for some weeks before being discovered, contacts over the last 
month should be traced and treated to prevent reinfection and further spread by identifying 
undiagnosed carriers. Unfortunately, the social stigma surrounding lice in Western societies 
greatly impedes effective ‘contact tracing’ [81], as does the residual effect of some products 
[162].
1.8 Will more pediculicidal agents help to control head lice?
O f all the insecticidal compounds in use today in the U.K., at present there are only four 
recommended for use against P. h. capitis:, malathion, permethrin, phenothrin (all OTCs), 
and carbaryl (POM). If the products being sold were all completely and consistently 
efficacious then four different active ingredients would probably be sufficient for the 
pediculicide market. In 1991, Maunder [163] stated it was our ability to find and prevent 
lice that limited control, not our ability to kill them, and that no new insecticides were 
necessary. However, it might seem that this situation is unlikely to hold if resistance, 
especially of the polygenic or irreversible varieties, continues to take hold. Cross-resistance 
can clearly exist between both closely related and divergent molecules, indicating that new 
therapeutic agents should have both a novel chemical structure and a novel mode of action 
to have the greatest chance of success. New insecticides should be developed not only in 
case resistance occurs to all the currently available actives but also to facilitate mosaic 
insecticide use.
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1.9 The potential for natural products in pediculosis therapy
Remedies based on crude botanicals were used in the developed world before the invention 
of synthetic insecticides and are still used elsewhere for reasons of cost and availability, but 
in some Western societies in the last 15-20 years, there has been an increasing demand for 
‘natural’ therapies (with plant or other natural product derived constituents), particularly 
among certain consumer groups [124]. People who purchase natural product-based 
pediculicides out of choice (rather than those who do so out of desperation following 
multiple treatment failures) are often suspicious of the safety of orthodox preparations and 
believe that remedies based on plant extracts will be side-effect free which, of course, is not 
necessarily true. Other consumers are perhaps not exactly sure why they prefer such 
treatments, and probably do so for the sole reason that ‘natural’ is in vogue; this is evident 
from the ever-increasing number of health and beauty products with names and/or 
packaging alluding to the contents’ proximity to nature.
Scientifically proven efficacy, target-organism selectivity and medical council approval still 
do not appear to be primary factors in natural pediculicide use, despite the fact that such 
treatments have received widespread media attention in the West [48] since around the 
mid-1990s.
1.10 Plant derived insecticides
The biological activities of certain plants in insect control were known in the earliest 
recorded times, and some species were mentioned by writers as far back as the 5* Century 
BC [235]. Today over 2000 plants are known to possess some insecticidal activity [128] and 
in many instances the herbs have a history of use in folk medicine and are still utilised 
locally. This is not surprising, as the static habit of plants has necessitated their evolution of 
a vast metabolic flexibility to help them thrive in their fixed environment. Thousands and 
thousands of ‘non-essential’ chemicals are produced, some constantly and some in 
response to environmental triggers, which have proven roles in aiding the survival of plants 
in adverse conditions or promoting their proliferation. Many of these ‘secondary 
metabolites’ are known to affect insect behaviour and viability. Despite this huge number 
of potential avenues in pesticide research, for the majority of cases the use of natural 
products in pest control lacks large-scale commercial development [196]; notable 
exceptions include nicotine, pyrethrum, hellebore, and the roots of Denis and hûncbocarpus
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[135].
Disappointingly, sometimes authors of scientific literature can be found making 
generalisations about ‘natural’ and ‘synthetic’ chemicals on the same level as the general 
public. For example, Palevitch and Craker state that ‘synthetic insecticides have suffered a 
number of environmental, economic and human health problems, including persistence of 
residues, development of pest resistance and injury to non-target organisms’ [196].
Whether intentional or not, this statement may lead the reader to assume that these 
problems are characteristic of synthetic insecticides, and that natural products all fall into a 
specific category of chemicals which do not have these short-comings. Perhaps the only 
generalisation that can be made is that plant-derived substances are usually highly 
biodegradable [135], whereas synthetic compounds may or may not be; it cannot be said 
that they wiU be less likely to induce resistance, or be more selective than synthetics. In the 
same way that some authors’ generalisations cause them to appear biased toward natural 
products, those of other writers perhaps reveal a certain cynicism: the continued demand 
for natural rethrins despite worldwide success of the pyrethroids is put down to the trend 
for all things natural by Burgess [45], but Klocke argues that they are often favoured over 
their synthetic counterparts for use in the home because of low mammalian toxicity and 
lack of residues [135].
There are several ecological rationales as to why natural product insecticides might be 
superior to those designed by scientists. For example, it could be argued that these 
chemicals might be selective for particular insect species, or related species, as plants 
depend on non-pest arthropods and mammals for reasons such as dispersal of seeds or 
pollen, and their chemical defence systems must not harm them. However, specificity is 
not always conferred by the nature of the toxic substance, for example, sometimes 
compartmentalisation is used to store these chemicals or their precursors, such that only 
mechanical damage will elicit their release. In support of these ecological theories, the 
literature contains many examples of plants and their constituents that are highly specific in 
their lethality towards pest insects [135,196], others, such as pyrethrins, are classified as 
broad-spectrum.
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1.11 Plant derived pediculicides
Head lice, of course, pose no threat to plants, yet this does not preclude the discovery of 
phytopediculicides. There are even ecological arguments for their existence: it has been 
suggested that blood-sucking parasites may be evolutionarily related to tube-feeding 
phytophagous insects as both groups possess similar piercing and sucking mouthparts 
[148]; it is therefore conceivable that chemicals lethal to sap-suckers may also be useful 
against distantly related blood-suckers. The other possibility is that parasites evolved from 
skin-eating insects, which evolved from non-keratinophagous insects living close to warm­
blooded animals [148]. Such a separation from their vegetation-dwelling ancestry and a 
high degree of adaptation to the parasitic lifestyle means that parasitic insects may have lost 
any genes offering protection from plant aUelochemicals, and therefore could be 
susceptible to these compounds.
Despite the reputed pediculicidal activity of many plants and their use in traditional 
medicine systems as such, there is a relative paucity of scientific analyses of these plants. In 
his comprehensive review, Burgess [45] describes the results of research into natural 
products pre-1960: A study of Traditional Chinese Medicines used to kill lice (which has 
provided many potential leads in phytotherapy research), found that only extracts of 
Stemosa tuberosa (pai pu) were active in tests. Busvine tested a variety of botanical materials 
in the 1940s and reported them to be of limited efficacy. Buxton also disproved the 
reputed activity of vegetable oils (the information in this paragraph is summarised from 
[45]).
Although the early studies of botanical materials appeared to disprove efficacy more often 
than demonstrate it, there were notable exceptions: In the search for a cheaper nicotine 
substitute in the US in the early 1900s, interest \n Quassia amara L. arose. The wood and 
bark (quassia ‘chips’) of this small tropical tree had long been used against insects [135] and 
appeared to have a narrow spectrum of activity, being used to control aphids and sawflies 
as a contact or stomach poison. The major insecticidal principle is quassin, a degraded 
triterpenoid (decanortriterpenoid), and many related ‘quassinoids’ have been isolated from 
other plants of the Simaroubaceae [79]. Infusions of quassia chips are stiU recommended as 
a head louse remedy by Western herbalists, and were reintroduced on a wide scale in 
Denmark when DDT resistant lice emerged [130].
Rotenone was used for delousing of prisoners of war before the introduction of DDT.
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Rotenone is an isoflavonoid extracted from the roots of Denis and Donchocarpus species, 
which contain rotenone at 3-10 %. Rotenoids act by blocking transfer of electrons to 
ubiquinone by complexing with NADH dehydrogenase, thereby inhibiting respiration; they 
are selective to insects due to rapid metabolism in mammals when ingested (but not when 
entering the bloodstream) [79]. Pediculicidal studies found it slow acting and poorly 
ovicidal, but it did give a high mortality rate on adult lice and a cream formulation for 
pediculosis capitis was available in France until recently. A drawback is that rotenone tends 
to cause dermatitis with regular topical application [45]. Benzyl benzoate, from Peruvian 
balsam, persisted in mixed formulations for treatment of pediculosis capitis in some 
countries until recently. Early scientific evaluations gave mixed reports of efficacy [45], 
more recently it was shown to have reasonable ovicidal activity [32].
The most successful pediculicidal natural products so far, whether used as the active itself 
or whether used as a lead compound for development, are still the pyrethrins. Recently, 
however, there has been much discussion of the use of ivermectin as a head lice treatment 
both systematically and topically [178,279]. Ivermectin is a semisynthetic derivative of the 
avermectins, a group of macroHdes produced by Streptomyces avermectilis, Avermectins and 
ivermectin display anthelmintic, insecticidal, and acaricidal properties but low toxicity to 
humans. They act by blocking neuromuscular transmission in sensitive organisms by acting 
on GABA receptors [79]. As ivermectin is already a hugely successful drug when prescribed 
for other purposes, it may prove equally useful in pediculosis control; however, the use of 
ivermectin against lice awaits approval.
Perhaps surprisingly, even the most recent entomological and phytotherapeutical literature 
contains very few investigations of natural products as pediculicides, despite the recent 
growth of interest in both lice and phytopharmaceuticals in terms of both media attention 
and scientific studies. Studies in the last few years have identified some pediculicidal plant 
extracts, for example, organic solvent extracts of Annona squamosa Linn, (custard apple, a 
Thai folk medicine ingredient) seeds and leaves have been shown to be efficacious against 
head lice. A preliminary cream formulation consisting of 20 % w /w  of a petroleum ether 
extract killed 95% of head lice after a 3 h exposure to 20 g, a higher % kill than the 
standard drug (25% benzyl benzoate emulsion) [250]. However, aside from the most 
commercially successful agents, the plant derived pediculicidal substances for which 
efficacy has most often been reported, both historically and in modern research, are the 
essential oils and their constituents.
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1.12 Essential oils and terpenoids
Plant-derived insecticidal compounds span a large number of chemical classes. For several 
years, particular essential oils, especially tea tree oil, have been put forward as alternative 
effective pediculosis control agents in scientific and media articles and are also 
recommended for this purpose in herbal textbooks. Essential oils and the major 
constituents of essential oils, the monoterpenoids, therefore provide a good starting point 
for investigation. Although they have been thoroughly tested on a range of insect species, 
scientific studies of their pediculicidal properties have not yet been very extensive. The 
enormous variety of essential oils and terpenoid constituents offers the opportunity for 
detailed analysis of structure-activity relationships and potential additive or synergistic 
effects.
Essential oils are plant extracts that have been used for centuries as medicines, fragrances 
and insect repellents. They comprise a selection of compounds, most of which are volatile 
at room temperature and therefore can usually be harvested by steam distillation. If any of 
the constituents are unstable at high temperatures then less harsh methods such as solvent 
extraction, or sometimes expression, can be employed [79]. The yield and chemical 
constitution of a particular essential oil varies according to the species and cultivar, 
environment and extraction methods. The composition, in turn, determines the 
commercial value or “quality” of the oil, and where minimum or maximum levels of certain 
components are required, such as in medicinally important oils, the products of extraction 
are selected to meet these requirements so that the oil is “standardised”. For example, 
Australian standard number AS 2782-1985 for Oil of Melaleuca (Tea Tree Oil) now 
requires that the terpinen-4-ol content should be greater than 30 % and the irritant cineole 
kept to less than 15 % to maximise the wound healing properties of terpinen-4-ol [82]. 
Although some essential oils, such as aniseed, nutmeg and fennel, are composed primarily 
of aromatic, shikimate biosynthetic pathway products, the major constituents of most 
essential oils are the 10-carbon-based monoterpenoids, produced via the mevalonate 
pathway [79]. Constituents of plant volatile oils have been known to affect the behavioural 
responses of pests for a long time, with the terpenoid components appearing most useful 
in control of numbers or predatory activity [196].
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Terpenoids form a class of metabolites found in living organisms. The two known routes 
of synthesis and the common biosynthetic precursors define the group, to which molecules 
of extremely diverse size structure and function belong (See Figure 1.2). The mevalonate 
biosynthetic pathway was described some years ago but, more recently, a second route of 
terpenoids synthesis, the 2-C-methyl erythritol 4-phosphate (MEP) pathway, was 
discovered [153]. The MEP pathway appears to be localised in the plastids, and therefore 
probably only contributes to the synthesis of plastidic terpenoids, such as the carotenoids 
and the phytol side-chain of chlorophyll [153]. All non-plastidic terpenoids are probably 
derived via the cytoplasmicaUy localised mevalonate pathway, and therefore this 
biosynthetic route is likely to produce the vast majority of essential oil constituents.
Plants utilise the terpenoid secondary metabolic pathway extensively. All plants produce 
terpenoids; there are members of the class which are ubiquitous to all plants, such as 
phytol; there are some which are characteristic of particular species, for example, the 
essential oil of tea tree QAelaleuca altemifolid) characteristically contains a high amount of 
terpinen-4-ol. Each plant species produces its own individual array of structures and these 
fulfil diverse roles, from the 40-carbon-based carotenoids involved in the light-harvesting 
stages of photosynthesis to the smaller, volatile compounds, such as mono- and sesqui- 
terpenoids, which give flowers their scent and aid pollination by insects [101].
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Figure 1.2 The terpenoid biosynthetic pathway in plants
The terpenoid skeleton is based on specific C5 units derived from either the mevalonate pathway, or the 
2-C-methyl erythritol 4 -phosphate (MEP) pathway. Some ubiquitous terpenoids have pivotal roles in 
plant growth and survival, such as the phytol (diterpene) side chain o f chlorophyll, and the hormone 
abscisic acid (sesquiterpenoid); Some terpenoids are common but have secondary roles, such as P- 
carotene (carotenoid); Other terpenoids are restricted to certain groups o f plants and include insecticidal 
agents such as (+)-limonene (monoterpenoid), picrotoxinin (sesquiterpenoid), quassin (modified 
triterpenoid) and pyrethrin I (formed from the monoterpenoid chrysanthemic acid).
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Ecological roles have been identified for many terpenoids, and a large number appear to 
function in protecting the plant from pathogen attack. Many terpenoids are lethal to 
insects, acting in the vapour form or as contact agents [70,196]. Terpenoids and their 
derivatives already have a major role in the insecticide industry: The 6 rethrin esters, 
pyrethrin I and II, cinerins I and II and jasmolins I and II aU have a monoterpenoid 
component. However, there are particular reasons why essential oils and their constituent 
monoterpenoids might be particularly suited to the problem of pediculosis control. At 
present, there is widespread use of essential oils for their scent, aromatherapeutic, repellent 
or other biological activities. Essential oils or isolated monoterpenoids can be found in 
massage oils, dental preparations, cosmetics, various pharmaceuticals and pest deterrents. 
Many essential oils have been used in home- and commercially-produced preparations for 
years. Such ‘hallowed usage’ tends to make obtaining a licence to market them in 
formulations for other purposes much easier. The basic production processes and 
widespread use make many essential oils and monoterpenoids cheap and easy to obtain.
The close association between essential oils and aroma mentioned above is not without 
good reason: Most monoterpenoids, and essential oils, are pleasantly aromatic; in fact, the 
unpleasant smell of the first synthetic insecticides, the thiocyanates, used extensively in the 
Second World War prior to DDT, was often mitigated by the addition of an essential oil 
[55], and they are still used for this purpose in certain formulations. Burgess states that he 
has found, in unpublished observations, that terpenes can be just as insecticidal and more 
ovicidal than conventionally accepted insecticides, and that this would explain the especially 
high in vitro ovicidal activity of Suleo-M above other malathion-containing pediculicides 
[43], as it also contains terpineol and <5^ -limonene in the formulation as fragrance enhancers.
Essential oils generally have favourable toxicity profiles; Palevitch and Craker state that 
monoterpenoids exhibit low toxicity to mammals [196], but of course this is relative to the 
dose. Some monoterpenoids are more hazardous than others, and even the safest 
monoterpenoids and oils often have specific contra-indications and possible side-effects 
[251]. Commonly used essential oils can be obtained from health-stores in pure form, 
which unfortunately causes some people to view them as being innocuous and encourages 
misuse.
A low cost, specific, safe, acceptably scented, pediculicidal and ovicidal active component 
o f a head lice formulation such as monoterpenoid(s) or essential oil(s) would be ideal to 
treat this common, primarily cosmetic complaint. At present, such a product would have
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further appeal to consumers in the West as it could be marketed as containing “natural 
ingredients” or “plant extracts,” and may even be more accessible to the developed world if 
production costs were low.
Evidence for the efficacy of essential oils and monoterpenoids as pediculicides
Apart from the commercially available phytochemicals and derivatives discussed 
previously, essential oils appear to have been of particular success amongst the pediculicidal 
natural products: Oil of sassafras was used historically as a pediculicide; the active, but also 
carcinogenic, ingredient was identified as safrol [225]. The utility of eucalyptus oil was 
discussed in the early part of last Century [198] and towards the end [132]. Lavender oil 
was used to repel clothing lice around collars and cuffs in the trenches in the First World 
War.
Recently, there has been renewed interest in the scientific study of essential oils and 
monoterpenoids as pediculicides: Neem oil At^dirachta indica performed well against 
head lice when compared with other standard insecticidal treatments; the authors also 
added that although the neem oil extract was less active than malathion in terms of the 
LT50 value, they believe it to be more safe for human usage [177].
Preparations of essential oil from the leaves of LJppia multiflora Moldenke (Verbenaceae) 
were tested for knockdown activity versus body lice and head lice. Knockdown times were 
comparatively shorter than those obtained using benzyl benzoate and Delvap Super, a 
brand of dichlorvos, and the lethal effect was enhanced when applied in an enclosed 
system. Terpineol was identified as a major constituent of the oil [189].
Oils of aniseed, cinnamon leaf, tea tree, red thyme, oregano, rosemary and pine were all 
effective against lice in a study by Veal et al [256], and all except rosemary and pine showed 
appreciable ovicidal activity. The most effective oils contained large proportions of 
phenols, ketones and phenolic esters, except for tea tree, which contained a high 
proportion of alcohols. Previous work by Gauthier et al identified 1,8-cineole as the active 
component of myrtle oil [287]. Terpinen-4-ol and a-terpineol were found to be more 
active than y-terpinene by Downs et al [286]; and the oxygenated mono terpenoid 
component of Cupressus leylandii oil was more pediculicidal than the hydrocarbon 
component [259]. The results so far emphasise the importance of oxygenated 
monoterpenoids in conferring pediculicidal activity.
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1.13 Rationale for Investigating monoterpenold mode of action
The aim of this study is to gain more information on the relative pediculicidal and ovicidal 
activities of essential oil constituents and also to investigate their mechanism(s) of action.
The biological targets of the major commercial insecticides described in Section 1.6 of this 
chapter have been elucidated, but even though numerous studies have investigated 
monoterpenoid activity on various insects, no mode of action has been proven. Knowledge 
of the target site(s) can decide whether or not an insecticidal compound is sufficiently 
selective. For example, insecticidal and antifeedant furanocoumarins of various species in 
the Rutaceae and Umbelliferae are known to cross-link double-stranded DNA. As the fine 
structure of DNA is universal, this makes them potential mutagens of non-target species, 
which is likely to limit their commercial potential [101].
The target also determines speed of death. Although the concentration of insecticide 
applied affects the rapidity of action within a narrow window, the nature of the target site 
provides the timeframe within which the concentration ‘window’ occurs. For example, 
compounds acting on the respiratory chain or the nervous system are rapid, others, such as 
analogues or antagonists of the juvenile hormones and moulting hormones, affect growth 
and development and therefore have a delayed action. Although many hormone mimics are 
found in plants [111], they are perhaps not very useful in lice control as an instant cure is 
more desirable.
When the biological targets in one insect-insecticide interaction have been established, the 
application of this data to other insect species should be approached with caution. Some 
compounds obviously have different biological activities in different species, for example, 
(3-asarone was determined to be the major active component in the insecticidal essential oil 
extracted from the roots oiAcorus calamus'L. (sweetfiag) (Araceae). This oü is available 
commercially and is reputedly lethal to a range of insects, including lice. By contrast, it is a 
chemo-sterilant for red cotton bugs, an attractant for Mediterranean fruit flies, and a 
repellent towards other species [135].
Molecular-level information on an identified insecticidal target could enable a combination 
of binding-site modelling and synthetic chemistry to design more active and/or selective 
compounds. Knowledge of the target site location can help to determine the route of entry
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into the insect. Changes to a chemical structure can affect its delivery to the target, as well 
as other determinants of activity, such as metabolism and stability, so it is important to 
know as much as possible about the fate of an insecticide once applied. Variation in 
mechanistic and/or pharmacokinetic aspects may also determine the number of insect 
species towards which insecticides are lethal. The majority of the commercially successful 
insecticides are ‘broad-spectrum,’ meaning they are lethal to many different insect species. 
Studies of monoterpenoids in the literature suggest they have rather narrow spectra of 
activity, and are most effective only on certain species, groups of species or even life-cycle 
stages. Knowledge of whether the insecticide has a broad or narrow spectrum of activity 
can help determine the number of species it can be used to control and its degree of threat 
to non-target organisms.
Most commercially exploited insecticidal molecules exert their actions via the nervous 
system; previous investigations of monoterpenoids suggest they are capable of rapid 
lethality and the symptoms of poisoning in insects and earthworms, such as knock-down 
and convulsions, are similar to other neurotoxic agents [70,108]. The insecticidal 
sesquiterpenoid picrotoxinin, the active component of picrotoxin, has been shown to 
inhibit GABA action when tested on an in vitro model of native insect GABA receptors 
(GABARs) [88]. This model was chosen to investigate the potential of monoterpenoids as 
toxicants of the insect nervous system. A model for the human GABAR was also chosen 
to determine whether or not the GABA-ergic activity was insect selective.
1.14 CABAergic neurotransmission
The 4-carbon, non-protein amino acid GABA and the synthesising enzymes and receptors 
required for GABAergic neurotransmission have been described in both vertebrates 
[175,237] and invertebrates [119]. The major inhibitory neurotransmitters of vertebrates are 
GABA and glycine; in the higher centres of the mammalian CNS, GABA-mediated 
neurotransmission is by far the more prevalent, and occurs at about 30 % of all CNS 
synapses [204]. In most mammalian tissues, GABA itself is only found in traces but in 
brain tissue high concentrations of GABA are widespread, particularly so in the 
nigrostriatal system, which contains around 10 pimol/g tissue [204], along with especially 
high levels of other GABAergic synaptic components. When researchers in the 1940s first 
described the pattern of distribution for this amino acid, a derivative of glutamic acid, it 
strongly implied a specific neurobiological function for GABA. Since then, GABA and 
GABARs have been studied in a wide range of organisms. The more extensively
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characterised GABARs of vertebrates are restricted to the nervous system [268] however, 
in insects, as well as being present in the nervous system, they are also present at the 
neuromuscular junction [206,220].
In its role as a neurotransmitter, GABA is released from nerve terminals and interacts with 
specific binding sites on GABA receptors, which are integral membrane proteins. These 
GABA binding sites may be coupled to one of two types of signal transduction 
mechanism: In the case of metabotropic receptors, coupling is via G-proteins to and 
Ca^  ^channels and adenylyl cyclase, whereas ionotropic GABARs activate integral Cl- 
channels. The nature of the effector system determines the end results of receptor 
activation and how quickly responses to the transmitter occur; ionotropic receptor- 
mediated events are extremely rapid, unlike the slower actions initiated by metabotropic 
receptors. Ionotropic, GABAy  ^ [229] and GABA^ receptors [203], and metabotropic, 
GABAg receptors [30] have been identified and classified in vertebrates; ionotropic 
GABARs and GABAg-like receptors [17] have been described in invertebrates. The insect 
ionotropic GABAR does not readily fall into either of the mammalian ionotropic GABAR 
categories [119].
Although invertebrate receptors have the greater relevance in terms of this thesis far less is 
known about their structure and pharmacological profiles. Therefore in the following 
sections, accounts of mammalian GABA receptor structure, function, molecular biology 
and pharmacology precede those of insect GABARs.
1.15 Structure and function of Ionotropic GABA receptors
All ionotropic GABARs are members of the cys-loop neurotransmitter receptor 
superfamily. Other cys-loop superfamily members include receptors for acetylcholine 
(nicotinic acetylcholine receptors, nAChRs), glycine, S-HT^, AMP A and kainate. Ionotropic 
receptors in this family exhibit diverse pharmacology, but their subunits share many 
sequence similarities and the receptors they form have similar activation/inactivation 
characteristics [20], for example, they are all oligomeric integral membrane proteins 
consisting of 5 homologous polypeptide subunits surrounding a central, transmitter-gated 
ion channel. All, including GABA^ subunit genes and Kdl, a gene encoding an ionotropic 
GABA receptor subunit cloned from the fruit fly. Drosophila melanogaster, have a conserved 
pair of cysteines and four regions of hydrophobic amino acids (corresponding to four 
transmembrane domains in the subunit) at identical positions in the gene, the second of
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which translates into the putative pore-lining domain of every cys-loop receptor [131]. 
However, insect and vertebrate ionotropic GABARs share more structural and functional 
similarities than just those features demarcating the cys-loop superfamily, and are likely to 
have evolved from a single ancestral gene [190].
The variation among ionotropic GABARs extends further than the mammalian and insect 
distinction: different types of mammalian brain tissue [234] and different insect tissues 
[220] possess distinct GABA receptor pharmacology. Researchers therefore long-suspected 
a certain degree of structural heterogeneity between ionotropic GABA receptor 
populations, and this has been confirmed by gene cloning. GABAR subunit cloning has 
permitted identification of structural features responsible for the differential sensitivity to 
chemical agents [119,241]; known subunit combinations are heterologously expressed, and 
differences in pharmacology and ligand binding characteristics are related to variations in 
the primary amino acid sequence. Diversity within a receptor gene family enables a single 
neurotransmitter-binding site interaction to have a variety of consequences, not only with 
respect to the responses to the neurotransmitter itself, but also to those of antagonist and 
modulatory compounds.
The integral ion-channels of ionotropic GABARs are anion-selective; the interaction of 
GABA and the extracellular binding sites results, within milliseconds, in the opening 
(gating) of the channel and it is primarily Cl which passes through in physiological 
solutions. The direction of Cl' flow depends on the electrochemical potential gradient 
(determined by the membrane potential and the transmembrane [Cl] gradient) for this ion. 
Cl will flow down the gradient such that (the membrane potential) approaches Eq (the 
equilibrium potential for Cl), and this direction determines the effect on the receptor- 
bearing cell: ionotropic GABA receptor activation can produce hyperpolarisation, 
depolarisation or no change in membrane potential [234]. Membrane hyperpolarisation 
inhibits action potential induction by increasing the degree of depolarisation necessary to 
reach threshold. If E ,^ of the post-synaptic cell is close to the equilibrium potential for Eq 
GABA wiU not effect a change in E ,^, however, if the post-synaptic cell is simultaneously 
acted upon by an excitatory transmitter the activated GABA-gated Cl' channels act as 
electrochemical shunts; the increased conductance of the membrane negates the excitatory 
effects, if an action potential is attained, its amplitude and conduction velocity will be lower 
and conduction may even be blocked. GABA-induced depolarisations occur, for example, 
during GABA^ receptor activity on pre-synaptic neurons and lead to a reduction in 
neurotransmitter release [100,234].
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1.16 vertebrate GABAa receptors: Molecular biology and subunit 
composition
The GABA^ receptor is the primary receptor-transducer-effector system through which 
GABAergic neurons exert their action in the vertebrate CNS [100]. They have been found 
on the majority of neurons in the mammalian CNS and PANS (peripheral autonomic 
nervous system) and on various types of glia [234], GABA^  ^receptors occur presynaptically 
and postsynaptically, all serving to inhibit neuronal responsiveness (excitability) and activity 
in the postsynaptic neurone [240],
GABA^ receptor subunit genes have been cloned from several mammalian species and the 
primary amino-acid sequence data analysed. The following vertebrate subunit types have so 
far been delineated, each of which contains one or more isoforms: ot(l-6), (3(1-3), y(l-3), 
0(1), e(l), 0(1) and Jt(l) [21,25], Homology between isoforms of different subunit types is 
around 30-40 %, and between isoforms of the same subunit type is at least 70 %, 
Homology between identical isoforms cloned from different mammals can be greater than 
90 % [190], GABAyi^R subunit isoforms are encoded by members of a multigene family 
[21], and a further increase in diversity is conferred by the existence of splice variants of 
some of these genes [241], Splice variants occur when mRNAs transcribed from the same 
gene undergo differential processing events, such that the variant mRNAs transcribed 
differ in respect of certain discrete portions of the sequence. The most prevalent isoform 
with splice variants is the y2 subunit, which exists as y2^ (^ o^rt) Y^l (long)-
In addition, the vertebrate ionotropic GABA receptor subunit genes p(l-3) have been 
identified. It is stiU contentious as to whether p subunits are a pharmacologically different 
subset of GABAy  ^subunit or a different category of GABA receptor, as homomers of 
these subunits form receptors that are insensitive to bicucuUine and the aUosteric 
modulators that characterise GABAy  ^receptors [203], As a consequence of this difference 
in pharmacology, many authors refer to GABARs with these characteristics as GABA^ 
receptors; this terminology wül be adopted here, although it has come to light recendy that 
at least some of the structural determinants of GABAy^/ GABA^ pharmacological 
differences are very small, some being accounted for by a single amino acid change [169],
Given the number of isoforms of GABAy  ^subunit identified so far, there could potentially
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be thousands of different receptors formed from all possible subunit combinations, 
however, studies of expression patterns indicate that only a fraction of the theoretically 
possible combinations occur in vivo. Studies to date suggest that the majority of GABA^Rs 
assemble as pentameric hetero-oligomers of a, P and y subunits, with a stoichiometry of 
2a.lj3.2y (or 2a.2|3.1y) [21].
1.17 insect GABA receptors: Molecular biology and subunit composition
To date 6 putative ionotropic GABA receptor subunits, RDL^ .^ [87], RDI^j [147], RDL^j 
[120], DRC 17-1-2 (a presumed allelic variant of RDLyJ [65], GRD [104] and LCCH3 
[106] have been cloned from D. melanogaster. Four splice variants of the fWgene transcript 
encode the RDL polypeptides; Grd and Lxch3  ^respectively, encode the other two subunits. 
On the basis of their high sequence identity to vertebrate ionotropic GABAR subunits, the 
above polypeptides were classified as Drosophila GABA receptor subunits, for example, the 
subunits encoded by R/7/ show 30-38 % homology with vertebrate ionotropic GABA 
receptor subunits, a level of similarity akin to that seen between vertebrate GABAy^R 
subunit types [119]. However, homology also exists between these insect ionotropic 
receptors and certain other vertebrate subtype classes, for example, RDL is equally identical 
to GABAy^R and GlyR (glycine receptor) subunits, LCCH3 is also similar to GABAy  ^
receptor |3 subunits [106]. The heterologous expression of RDL and DRC provided further 
evidence that they contribute to ligand-gated Cl channels, as the reversal potentials of the 
homomeric channels formed by both subunits were close to Eq [38,88].
The Vull gene is subject to alternative splicing; Two versions of exon 3 (a and b, which 
differ at two residues) and exon 6 (c and d, which differ at 10 residues) are known to exist, 
as mRNAs of aU splice variants have been identified in embryonic Drosophila [89]. The four 
possible R/7/-encoded subunits are therefore RDL^ ,^ RDL^j RDL^^, RDL^j. Only RDI^^ has 
yet to be cloned.
The occurrence of RDL homologues in other insect species has been investigated. Subunits 
with 85-99 % sequence homology (over their known sequences) with RDL have been 
isolated from a variety of insect species, including the German cockroach Blattella germanica, 
(Dictyoptera), the house fly Musca domstica  ^the yellow fever mosquito Aedes aeg)ipti. 
Drosophila simulans (Diptera), the beetles Hypothenemus hampei and Triholium castaneum 
(Coleoptera), and the tobacco budworm Heliothis virescens (Lepidoptera) [119,270].
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Homologues of LCCH3 and GRD have yet to be cloned from other insects.
Subunits encoded by D. melanogaster Kdl form functional homo-oligomeric receptors in a 
variety of expression systems, such as 'Kenopus laevis oocytes [38,88], fall army worm 
{Spodpotera frugiperdd) Sf21 cells [147], and in a Drosophila cell line [173]. RDL homomers 
show single channel properties [98] and pharmacological profiles [38] similar to those of 
many native GABARs studied in situ in insect tissue. Neither LCCH3 nor GRD form 
functional homo-oligomers in kenopus oocytes and although, in combination with RDL, 
LCCH3 forms functional receptors, the pharmacological and kinetic properties do not 
reflect those of native GABARs on cultured Drosophila neurones [119]. Co-expression of 
GRD and RDL has not been reported.
O f the insect species listed above, all cyclodiene resistant strains investigated to date have 
been found to carry the same point mutation in their respective R/^/homologues; 
replacements of alanine 302 with serine (A302S), suggesting a key role for RDL-containing 
GABARs in insecticide action. This mutation appears to confer resistance not only to 
cyclodienes but also to other insecticidally-active compounds PTX (picrotoxin), lindane, 
TBPS (/-butylbicyclophosphorothionate), BIDN (3,3-
bis(trifiuoromethyl)bicyclo[2 ,2 ,l]heptane-2 ,2-dicarbonitrile) and fipronil in native and 
heterologously expressed Drosophila GABARs, as these compounds show reduced GABA- 
blocking abilities [23,28,39,88,113,208,280].
In Drosophila  ^RDL is expressed in embryonic nervous tissue [243], and RDL-like subunits 
are widely distributed in the nervous systems of several insect species, being particularly 
concentrated in neuropiles rich in synapses, as shown by antibody labelling [12,103]. 
Recendy immunocytochemical staining of cockroach tissue revealed that the RDL 
homologue was especially localised in brain regions involved in processing visual, olfactory 
and mechanosensory inputs, and in the corpora cardiaca, which is involved in the regulation 
of neurosecretory activity [221].
Investigations on insect ionotropic GABA receptor subunits to date have been restricted to 
economically or scientifically important insects. So far, the existence of RDL-like subunits 
has not been investigated in Pediculus species.
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1.18 ionotropic GABA receptors: AUosteric proteins
A model for the topography of the GABA^ receptor was constructed mainly on the basis 
of hydropathy profiles [234], In this form of protein analysis, the primary sequence of the 
polypeptides are examined for hydrophobic and hydrophilic runs of amino acids, to enable 
prediction of which regions of the protein reside in the lipid bilayer and therefore which 
domains are extra/intracellular. Each GABA^R subunit was found to comprise 400-500 
amino acid residues, 60 % lying extraceUularly, 20 % in transmembrane regions and 20 % 
intraceUularly. The various subunit types are very similar with respect to primary structure, 
putative secondary structure and proposed transmembrane topology [100,224,241]; Like aU 
other ligand-gated ion channels, GABA^Rs are predicted to possess the following: i) A 
large extracellular N-terminal domain, containing consensus sequences for N-glycosylation 
and residues contributing to the Ligand binding site; ii) Four membrane-spanning regions, 
TM1-TM4 (transmembrane domains 1-4), with each TM2 contributing to the pore lining; 
iii) A large, variable, intracellular hydrophilic domain or ‘cytoplasmic loop’ between TM3 
and TM4, which contains consensus sequences for phosphorylation by protein kinases (in y 
GABA^R subunits, this is also where alternative splicing occurs) [241]; iv) A short 
extracellular C-terminal portion; v) The model also predicts the presence of other, small 
intra- and extra-cellular loops between the TMS.
The hydropathy plot analysis of the vertebrate GABAR subunit was combined with other 
data on assembled GABARs, such as the identification of a 5-fold rotational symmetry of 
subunits around a central pore identified by electron image analysis [184], the pentameric 
rosette shape of GABARs as visualised by electron microscopy [33] and the high homology 
with other pentameric receptors such as nicotinic acetylcholine receptors and glycine 
receptors [241]; this led to the construction of a speculative topology of the heteromeric 
GABA^ receptor, the pertinent features of which are shown in Figure 1.3.
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Figure 1.3 Schematic diagram of a GABAa receptor molecule
Schematic representation o f  the major type o f GABAa receptor thought to be expressed in adult 
mammalian brain, (al)2(P2/3)2(Y 2)l. The five polypeptide subunits surround a central Cl' ion channel, 
each subunit consisting o f  4 transmembrane (TM) domains, large extracellular and small intracellular 
portions. The precise arrangement o f  subunits and transmembrane sections is not known, however, the 
binding pocket for GABA exists at the interface between a  and P subunits and the residues upon which 
benzodiazepine pharmacology depends are at the a-y interface. There is evidence that the TM2 
hydrophilic domains o f  each subunit line the anion channel.
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This structure allows for the binding of ligands arriving at the surface of the cell to portions 
of the large N-terminal domain and extracellular loops. Many of the extracellularly-located 
amino acids possess charged side-chains and/or the ability to form dipoles and these 
enable ligand receptor interactions at specific binding sites; some of these sites are likely to 
have evolved to interact with particular structures (molecules or ions) found in vivo [234] 
but many non-endogenous compounds, with appropriate structures, also bind to these 
sites. For example, the GABA^ (3-subunit is photo-affinity labelled by the agonist 
[^H]muscimol [40] and mutations at the N-terminus affect agonist potency of recombinant 
GABA^ receptors [8] suggesting an extracellular agonist binding site. Furthermore, residues 
of the GABA^ a-subunit also influence agonist activity, suggesting that binding occurs at 
the interface between two different subunits, a  and (3 [236]. Recently novel determinants of 
agonist potency have also been defined at the N-terminus of RDL [120].
Competitive G ABA antagonists such as bicucuUine and SR95531, by definition, must also 
bind extracellularly, and GABA-hke motifs have been identified in both [76,105]; it is 
therefore likely that at least part of the antagonist molecule interacts with exactly the same 
portion of the receptor as GABA. However, competitive antagonists are often larger than 
agonists and probably also interact with other areas around the agonist binding site; 
differences in these additional binding domains probably account for the fact that there are 
substantial differences between the competitive antagonist profiles of GABA^ and RDL^g, 
yet their agonist profiles and the potency of GABA are similar [115].
The binding site of the non-competitive GABA antagonist picrotoxinin has been studied 
and several lines of evidence, including the position of the A302S mutation, suggest that 
the (uncharged) picrotoxinin molecule binds within the channel lumen rather than to 
extracellular residues [23]. Furthermore, there are a multitude of sites for aUosteric 
modulation on ionotropic GABARs, many of these are in the extracellular portion with 
probably at least some at subunit interfaces [100]. Apart from regulation by external ligands 
binding, receptor function can also be regulated by kinases, which affect the 
phosphorylation state of the receptor at the intracellular face [231].
A combination of molecular biology and electrophysiological techniques have enabled 
identification of areas on ionotropic GABAR subunits which could be instrumental in 
ligand interaction: binding site models are constructed by comparing the amino acid 
sequences of pharmacologically different subunits and observing changes in the ligand- 
interaction properties of a single subunit by site-directed mutagenesis, the model can be
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further developed by structure-activity analysis of radio-labelled ligands which bind to an 
identified site. For example, the generation of chimaeric receptors using cloned sequences 
for the alcohol sensitive GlyR a l  subunit and the alcohol insensitive GABA pi subunit 
enabled researchers to pinpoint areas that conferred alcohol sensitivity to GABA pi 
subunits [169], and the nature of the convulsant binding site has been investigated using 
several series of structurally related compounds to construct a pharmacophore model [209 
and refs within].
1.19 Ionotropic GABA receptors: Pharmacology
The Cl'-conducting activity of GABA^ receptors and insect ionotropic GABARs is 
influenced by a diverse array of chemical structures, encompassing naturaUy-occurring, 
semi-synthetic and synthetic moieties. In the absence of pharmacological agents, ionotropic 
receptors usually spontaneously open and close, albeit with low frequency. For GABAy  ^
receptors, spontaneous openings are absent or rare in native and heterologously expressed 
recombinant receptors [100]; and the same was found recently in single-channel recordings 
of native Drosophila GABARs and heterologously expressed RDL homomers [280,281]. 
Increasing concentrations of GABA increase the frequency of channel opening of GABA^ 
receptors [158], but the higher the concentration of GABA and the longer the time it is 
applied the more channels become desensitised and unresponsive. Receptor desensitisation 
is a common feature of ligand activated transduction mechanisms, and probably serves to 
prevent over-stimulation of the cellular processes influenced by receptor activity.
Other ligands binding to the GABA receptor affect the activity of the channel, either 
directly or by altering the agonist-induced response. Such effects are mediated either by 
ligand-induced conformational changes of protein structure, affecting gating characteristics, 
or by physical occlusion of either the agonist binding site or the chloride channel itself. 
Agonists capable of eliciting the greatest possible response (current flow) through 
GABARs are “fuU agonists,” those agonists whose maximal response falls short of the full 
response are “partial agonists” [see for example 129]. Some Ligands bind to the agonist site 
but do not have intrinsic activity, and only serve to block the agonist effect, these are 
“competitive antagonists.” Non-competitive antagonists also reduce the efficacy of the 
agonists but instead of competing for the agonist binding site, they either occlude the ion 
channel, preventing Cl' ion flow, or bind elsewhere and affect the conformation of the 
receptor such that the agonist cannot activate it to the same degree [see for example 71]. 
Whereas agonists preferentially bind to and stabilise the active conformation of the
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receptor, inverse agonists have greater affinity for the inactive conformation, thus 
producing the opposite pharmacological effects to an agonist [see for example 129]. 
Furthermore, many “positive aUosteric modulators” [100,102], agents whose binding to a 
separate site on the receptor serves to increase the efficacy of the agonist, have now been 
characterised for both vertebrate GABA^ and invertebrate bicucuUine-insensitive channels. 
Despite the convenience lent by such classification, interactions of ligands and their 
receptors do not always faU into a single category: for example, at vertebrate GABARs, 
DMCM (methyl 6,7-dimethoxy-4-ethyl-(3-carboUne-3-carboxylate) inhibits GABA currents 
at nM concentrations but stimulates sub-maximal GABA responses at p,M levels [230]; 
many GABA^ general anaesthetic positive modulators, such as barbiturates, act as agonists 
at high concentrations [102]; and some agents act in different ways on different receptors, 
for example, 4’-chlordiazepam is an antagonist at GABA^Rs but potentiates at insect 
GABARs and RDL homomers. Table 1.1 provides an overview of GABA^, native insect 
and RDL receptor pharmacology.
GABA^ receptors are distinguished by their sensitivity to the pthalide isoquinoline alkaloid 
bicucuUine and are subject to regulation by numerous aUosteric modulators [229]. By 
contrast, GABA^ receptors are insensitive to both bicucuUine and the GABA^ modulators 
[201] and furthermore GABA^ and GABA^ receptors have distinct agonist 
pharmacological profiles; for example isoguvacine and ZAP A are effective at GABA^Rs 
but not at GABA^Rs [7,203,273].
Insect ionotropic GABARs do not fuUy match the pharmacology of either vertebrate class: 
the majority of native insect GABARs are bicucuUine-insensitive [220] but, in contrast to 
GABAcRs, they can be modulated by a similar range of structures to those affecting 
GABA^Rs [29,119,183] and are also activated by isoguvacine [219] and ZAPA [247].
Native insect GABARs are also distinct from both GABA^ and GABA^ receptors in terms 
of the relative potency and efficacy of a series of various GABA analogues [115]. Subtypes 
of native insect GABA receptor also appear to exist, for example, some bicucuUine- 
sensitive insect GABARs were found in the antennal lobe oîManduca sexta [263], 
furthermore, isoguvacine and 3-APS (3-aminopropane sulphonic acid) are active agonists at 
several insect GABARs, but not at those of the giant interneuron GI2 from Periplaneta 
americana [220]. Variation amongst insect GABARs is not necessarily due to interspecific 
differences, but may depend more on the tissue from which they originate, as is the case in 
vertebrates. GABARs of insect muscle appear to share some pharmacological properties 
with those of insect neurons, but not aU [222].
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V erteb ra te  G A B A aR s Native Insect Iono trop ic  
GABARs
RDL.C H om om ers Refs
Agonists
GABA Full agonist Full agonist Full agonist 234,206,115
Muscimol Full agonist Full agonist Full agonist 234,220,115
Isoguvacine Agonist Agonist at some; Agonist 234,206,219,
Similar potency as on 115
GABAa
3-APS Agonist Agonist at some; Agonist; 206,220,115
Less potent than on Less potent than on
GABAa GABAa
A ntagonists
BicucuUine Antagonist Inactive at most; Inactive 229,220,219,
antagonist at a distinct 263,38
subset
Picrotoxinin Antagonist Antagonist Antagonist 74,220,206,38
Pitrazepin Antagonist Antagonist, less potent n.t. 234,206,219
than on GABAa
Dieldrin Antagonist Antagonist, less potent n.t. 183,206
than on GABAa
BIDN Antagonist Antagonist Antagonist 209,114
y-h c h Antagonist Antagonist n.t. 181,183,206
Fipronil Antagonist n.t. Antagonist 288,113
Benzodiazepines
4 ’- chlordiazepam Antagonist Potentiates Potentiates, but potency 202,14,116
lower than on native
insect receptors.
Fiunitrazepam Potentiates Potentiates at some. Inactive 219,247,14
inactive at others 116
P-carboIines
DMCM Potentiates at high conc.s; Inverse agonist n.t. 230
inverse agonist at low
3-HMC n.t. Inverse agonist Inactive 16,116
B arb itu ra tes
e.g. Phenobarbitone, Potentiate; intrinsic effect Potentiate, but less potent Potentiate, but less potent 102,213,249,
pentobarbitone at high conc. than on GABAa; no than on GABAa; no 116,24,29
intrinsic effect. intrinsic effect.
S tero ids Potentiate; intrinsic effect Potentiate, but less potent Potentiate, but less potent 24,144,207,
at high conc. than on GABAa; no than on GABAa; no 24,29
intrinsic effect intrinsic effect
Propofol Potentiate; intrinsic effect n.t. Potentiate, but less potent 3,216,217
at high conc. than on GABAa; no 24,29
intrinsic effect
Ô-HCH Potentiates n.t. Potentiates 181,24,29
Zn*^ Antagonist at some Antagonist at some Inactive 234,
Loreclezole Enhances at p2 and P3- n.t. Enhances: same potency 258,24,29
containing Rs, less at p i as on GABAa p i
Table 1.1 Pharmacology of vertebrate GABAa receptors, and invertebrate 
ionotropic GABA receptors
Overview o f  the pharmacology o f  vertebrate GABAa receptors, native insect ionotropic GABA receptors 
and heterologously expressed homomeric insect GABA receptors containing the Drosophila  
melanogaster RDLac GABA receptor subunit. Electrophysiological data only; n.t. =  not tested; intrinsic 
effect = agonist effect when applied alone.
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Délinéation of insect GABA receptor pharmacological subtypes is less extensive than in 
vertebrates, as relatively few subunits have been cloned and successfully expressed in 
heterologous systems. The three insect subunit homomers that have been expressed,
RDL^ç, DRC 17-1-2 (RDI^J and RDL^j, appear to differ only in their affinity for GABA, 
the relative potency of GABA analogues is preserved, and only very modest differences in 
sensitivity to selected modulators (pentobarbitone, propofol and anaesthetic steroids) were 
observed between RDL^  ^and DRC 17-1-2 [24,115,120].
Regarding the modulator pharmacology of native insect ionotropic GABARs and 
mammalian GABA^ receptors, in general, the structural classes of aUosteric modulators are 
the same, differences He in the potencies and efficacies of individual compounds. The most 
widely researched classes of GABA-modulating molecules are outlined in Table 1.1 and are 
as foUows:
Barbiturates
Barbiturates have a wide variety of cUnical effects in mammals, including sedation, 
reduction of anxiety, induction of sleep, and inhibition of convulsions. AU of these can be 
attributed to their CNS-depressant actions, most of which are known to result from 
enhancement of GABAergic neurotransmission. For example, pentobarbitone has been 
studied on both native [213] and recombinant GABA^  ^receptors of varied subunit 
combination [249]. In aU cases it eUcited three different effects consisting of potentiation, 
direct activation and putative channel block, each requiring a higher concentration of 
pentobarbitone to occur. Both RDL^g and DRC 17-1-2 homomers expressed in Xenopus 
oocytes are potentiated by pentobarbitone [24] but, in the same study, pentobarbitone was 
far less potent at enhancing the GABA response of the insect homomers than that of the 
mammaUan GABA^ GI3P1Y2L receptor; furthermore, high concentrations of pentobarbitone 
had direct agonist activity at the mammaUan receptor but not on the insect homomers. As 
a modulator, pentobarbitone has low potency on native as weU as heterologously expressed 
insect receptors; maximum enhancement due to 100 juM pentobarbitone appUed to Locusta 
migratoria and Schistocerca gregaria nem onts (170 % of control) was similar to the degree by 
which 10 p,M pentobarbitone potentiated the response to EG^ q GABA on RDL homo- 
oUgomers [116].
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Steroids and propofol
Other anaesthetics, the effects of which have been documented for various GABA^ 
receptors and insect receptors, include propofol and the mammalian endogenous steroid 
5a-pregnan-3a-ol-20-one (also known as allopregnanolone, 3a-OH-DHP and 5a3a). The 
GABA potentiating effects of propofol have been observed in native [3] and recombinant 
GABA^ receptors [216,217], but not native insect receptors. In a comparative study [24] 
propofol was found to enhance GABA action at a recombinant insect (RDI^J and a 
mammalian GABA^ receptor with equal potency, but the degree of potentiation was again 
far less for the insect receptors. Propofol also showed direct agonist action at mammalian 
receptors at concentrations higher than those required for potentiation, but this was not 
observed in homomers of RDL or those of the RDL splice variant. 
5a-pregnan-3a-ol-20-one displayed the same pattern of potentiation and direct effect on 
mammalian native and recombinant receptors [24,144], coupled with only weak 
potentiation but no direct effect on RDL or splice variant homomers [24]. GABA 
responses in the cell body membrane of P. americana were not affected by 5a-pregnan-3a- 
ol-20-one or 5a-pregnan-3a-ol-ll, 20-dione [207].
Hexachlorocyclohexanes
In contrast to the GABA-potentiating compounds mentioned so far, Ô-HCH potentiates 
both recombinant GABA^ and RDL [24] with a similar potency, although on the latter the 
maximal effect was much greater. Potentiation induced by Ô-HCH has also been 
documented for rat dorsal root ganglion GABA^ receptors [181]. Furthermore, the 
loreclezole-mediated potentiation of GABA responses in RDL homomers is similar to that 
seen in some recombinant GABA^ receptors but not others: loreclezole is three times 
more potent on RDL homomers as on (31-containing GABA^ receptors [24], but twenty­
fold lower than on GABA  ^receptors containing (32 and (33 subunits [258].
Benzodiazepines
Benzodiazepines have similar clinical effects in mammals as barbiturates (they are also 
sedative, hypnotic and anticonvulsant). They are also anxiolytic and reduce aggression, 
muscle tone and coordination in mammals. Insect benzodiazepine binding sites are 
pharmacologically quite distinct from those of vertebrate CNS GABARs, as demonstrated 
initially by binding studies: the ligands Ro 5-4864 (4’-chlorodiazepam), diazepam.
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fiunitrazepam and clonazepam are displayed here in order of most potent to least potent at 
displacing the ligand [^H]-fiunitrazepam from P. americana nervous tissue, but this order of 
potency is almost the reverse of that found in human brain [220]. Pharmacologically, 
differences between benzodiazepine binding sites of ionotropic GABARs are illustrated by 
the actions of 4’-chlorodiazepam as a non-competitive antagonist of GABA^ receptors 
(probably at a site distinct from that of other benzodiazepine modulators) [202], and as a 
positive aUosteric modulator of both native insect receptors [14] and recombinant RDL 
homomers [116], although it has reduced potency on recombinant as opposed to native 
insect receptors. Furthermore, fiunitrazepam is an aUosteric enhancer at GABA^ receptors 
and also some native insect ionotropic GABARs [219,247], but has no effect at other 
native insect receptors [14,247] and RDL homomers [116]. Various (3-carboUnes act as 
inverse agonists of GABA^ receptors at the benzodiazepine site, and have similar effects at 
some insect GABA receptors; 3-HMC (3-hydroxymethyl-|3-carboUne), for example, 
partiaUy blocked the GABA response of an identified cockroach neuron [16], however, it is 
apparently without effect on RDL homomers [116].
O f aU the compounds that potentiate the activity of ionotropic GABARs, only one, Ô- 
HCH, is documented as insecticidal; aU other GABAergic insecticides known to date are 
antagonists. Although there are certain antagonist compounds which are largely specific for 
vertebrate GABA^Rs, such as bicucuUine, pitrazepin and the steroid derivative RU 5135 
[219], insecticidal antagonists such as the cyclodienes (e.g. dieldrin) hexachlorocyclohexanes 
(including Undane, but not Ô-HCH) and picrotoxinin, are not selective for invertebrate 
receptors and can even have equal or greater activity on GABA^Rs[206]; Ô-HCH possesses 
simUar potency on GABA^ and insect GABARs. The avermectins are also not specificaUy 
invertebrate GABA receptor modulators, however they do exhibit low mammaUan toxicity 
[78]. The relatively novel insecticide fipronil is, so far, the most successful in exploiting the 
distinct pharmacology of insect GABA receptors; although it blocks Cl currents at both 
insect [38] and mammaUan [288] ionotropic GABA receptors, it has much greater binding 
selectivity for the insect type [289].
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1.20 Natural Products provide potential and confirmed GABA receptor 
ligands
The wide spectrum of structures that interact with GABA receptors encompasses both 
naturally-occurring and synthetic compounds. Many well-known GABA receptor ligands 
are native to plant and/or animal tissue and GABA itself is a significant component of the 
free amino acid pool in most pro- and eukaryotes. Although it is not known whether 
GABA performs a physiological role in plants, interestingly its synthesis is induced during 
stress conditions [228], and therefore could have a protective or reparatory role, or may be 
a precursor to compounds with such a function.
Benzodiazepines of the type used as drugs in the treatment of anxiety, sleep disturbances 
and seizures are found in mammalian tissue in trace amounts, although the possibilities for 
biological effect at the concentrations found are largely speculative [215]. The origin of 
these benzodiazepines is also in dispute: they may, in fact, originate from ingested 
microorganisms or plant material, both of which are known to synthesize them [100]; 
recendy the production of benzodiazepines by plant tissue rather than by their associated 
flora was confirmed by observing the synthesis of delorazepam and temazepam from 
sterile plant regenerates in tissue culture [133]. The positive aUosteric modulator ethanol is, 
of course, best known as a product of yeast fermentation. Furthermore, many endogenous 
steroids and steroid metaboUtes modulate GABA^, such as the two progesterone 
metaboUtes aUopregnanolone and 5a-pregnanediol, although so far no activity of insect 
steroids, such as ecdysone, on insect GABARs has been noted [206].
Some of the most widely used tools for studying the GABAR are naturaUy-occurring: 
muscimol, a fuU agonist which binds with high affinity to GABA^ receptors, is found in the 
fungus Amanita muscaria (Fly Agaric); bicucuUine, an antagonist used to distinguish between 
the two major types of ionotropic GABAR in both insects and mammals, is an isoquinoUne 
alkaloid found in species of Corydalis and Dicentra (Fumariaceae) [70]. Picrotoxin has been 
isolated from plants of the moonseed famUy, Menispermaceae; it is a mixture of picrotin 
and picrotoxinin, the latter of which is GABAR-active. The picrotoxinin pharmacophore, 
as predicted by molecular modeUing, was the basis for the successful insecticidal compound 
BIDN [209].
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In the last few years, there have been increasing numbers of investigations of plant extracts 
and their constituents on GABARs, especially those derived from herbs having 
physiological effects reminiscent of other GABAergic compounds, such as pro-convulsant 
or hypnotic activities. Earlier studies commonly only explored binding activity, such as the 
numerous reports of flavonoids binding to the GABA^-Hnked benzodiazepine receptor 
[152,214,257]. Some studies focussed on the reversal of natural product-induced 
physiological effects by application of known GABAergic ligands; Rubus brasiliensis Martis 
(Rosaceae) hexanic fraction has anxiolytic, hypnotic, anti-convulsant and muscle relaxant 
effects in mice, aU of which are reversed by pre-treatment with flumazenil [186]. Only in 
recent years have studies on ethnopharmacologically interesting plants become more 
comprehensive and included binding, electrophysiological and behavioural experiments. 
The majority of these studies have been carried out on small mammals and/or mammalian 
tissue; there are, at present, far fewer investigations of natural products, insecticidal or 
otherwise, at insect GABA receptors. A selection of the work on GABAergic natural 
products is given below and comprises plants and compounds with both convulsant and 
benzodiazepine-like properties.
Water hemlock, Cicuta virosa (UmbeUiferae) is toxic to mammals, causing convulsions and 
respiratory paralysis. It contains several chemicals which inhibit the binding of fH]EBOB 
(ethynylbicycloorthobenzoate), a GABAR antagonist, to rat brain cortex, and the efficacy 
of inhibition was positively correlated with toxicity [252]. One of these toxins, virol A, 
inhibited GABA induced Cl flux in rat hippocampal CAl neurones, apparently acting both 
at the GABA binding domain and the PTX site in the channel [253]. Anisatin, a toxic and 
insecticidally active component of the Sikimi plant was studied electrophysiologically by 
whole and single cell patch-clamp on rat dorsal root ganglion; suppression of Cl flux was 
only attained during or after application of GABA, not before, and PTX attenuated 
anisatin-suppression of GABA-induced currents; in binding studies anisatin inhibited 
[^H]EBOB binding. Both lines of evidence suggest that anisatin acts at the PTX site in the 
channel [126]. The alkaloid ricinine, from BJanus communis^  was identified as having a novel 
mode of inducing seizures, via the benzodiazepine site rather than the via convulsant site; 
induction of seizures in mice was blocked by diazepam (but not phenobarbitone), and 
ricinin blocked fH] fiunitrazepam binding to cerebral cortex membranes [85].
St John’s Wort (SJW), Hypericum perforatum L. (Hypericaceae), is used for many purposes in 
herbal medicine, such as for insomnia, and its anti-depressant activity has been proven in 
clinical trials. Hypericin used to be considered the only active principle. However, recent
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studies of total SJW extract showed an anxiolytic activity in mammals which was blocked 
by pre-treatment with flumazenil; in electrophysiological studies on GABA^  ^receptors, 
hypericin reduced GABA activated Cl currents, whereas pseudohypericin, another SJW 
constituent, enhanced them. Pseudohypericin is therefore more likely to be responsible for 
the anxiolytic effect of SJW extract than hypericin [255].
Kava is an intoxicating beverage prepared from the pepper Piper methjsticum  ^it is widely 
consumed by people native to the South Pacific island. It’s most popular use in traditional 
medicine is as an anxiolytic, and in this respect it is reported to perform as effectively as 
benzodiazepines. The kavalactones (also known as kavapyrones) were reported to be the 
active ingredients, as four of these showed significant anaesthetic and analgesic effects. 
However, an apparently non-kavalactone-related GABA^ binding activity from Hawaiian 
kava has been described in methanolic leaf extracts [77,80].
The bark from the roots and stems of various Magnolia species are used in Traditional 
Chinese Medicine to treat a variety of disorders including anxiety and nervous disturbances. 
Honokiol and magnolol are major constituents of this material; both of these biphenolic 
compounds have anxiolytic and CNS depressant effects in mammals and both were found 
to potently enhance [^H]muscimol binding to various mammalian CNS tissues [4,239]. As 
propofol, a monophenolic, also increases muscimol binding at GABARs, honokiol and 
magnolol may also potentiate the GABA-induced Cl' current at GABA^Rs, but this effect 
has yet to be studied.
Extracts of Valerian, the common name given to the crude drug made from underground 
organs of plants from the species Valeriana (Valerianaceae), are used in folklore medicine 
for their sedative, hypnotic, tranquiiising, and anti-convulsive effects. There appears to be a 
dual activity with relation to their GABAR activity, as low concentrations of extracts 
enhance [^ H] fiunitrazepam binding to GABA^Rs but higher concentrations inhibit it [191].
Ginkgo biloba and ginseng are herbal drugs reputed to have remedial effects on various 
neurological disorders. Bilobalide is a sesquiterpene isolated from the leaves of Ginkgo 
biloba L.; it has anti-depressant qualities, shortens pentobarbital-induced sleeping-time in 
mice [34], enhances the excitability of rat CAl pyramidal neurones and reduces the 
neuronal inhibitory actions of muscimol [218]. The major component of Vietnamese 
ginseng saponin, majonoside-RZ has a preventative effect against psychological stress 
induced lipid peroxidation in mouse brain, an effect that was blocked by flumazenil and
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pregnenolone sulfate (a negative aUosteric GABA^  ^modulator) [278] suggesting an action 
via the benzodiazepine site.
The dried flowers of Matricaria chamomilla L, (a species of chamomile) are used in herbal 
preparations to provide sedative and spasmolytic effects. A study of one of its biological 
constituents revealed confUcting bioactivities: the flavonoid apigenin was isolated and 
found to act as an anxiolytic and a sUght sedative in mice, but did not have anticonvulsant 
or myo-relaxant activities. It also displaced fH] fiunitrazepam from central benzodiazepine 
sites [257]. However, electrophysiological analysis revealed that apigenin reduces GABA 
activated Cl currents in cultured cerebeUar granule ceUs, and this was reversed by 
flumazenil, suggesting a negative modulatory activity via the GABA i^^R-Unked 
benzodiazepine binding site [13].
O f course, not aU GABAergic activity is via GABA receptors and studies into natural 
products have also addressed this. For example Caesalpinia sappan wood extracts have anti­
convulsant properties; further investigation revealed two compounds, sappanchalcone and 
braziUn, both of which were found to inhibit GABA degradative enzymes [15].
1.21 Monoterpenoids and other volatile natural products affect the 
activity and ionic balance of nerve and muscle ceils
In this thesis, mechanistic studies of pediculicidal monoterpenoids focus on the phenolics, 
thymol, and carvacrol. Eugenol, a structurally similar insecticidaUy-active phenylpropanoid 
derived from the shikimic acid pathway, was also investigated. To date, mechanistic studies 
on the interaction of these compounds with insect neuronal receptors have not been 
carried out. However, there are various studies that examine the effects of thymol and 
eugenol on vertebrate neurotransmission and/or cellular ionic composition; some of the 
physiological effects of these compounds may be related to events at the molecular level.
Eugenol and oil of cloves are renowned for their anaesthetic qualities, especially when 
applied locally as analgesics. Eugenol is still widely used for this purpose in dentistry, being 
present in periodontal dressings and eugenates (cements containing eugenol), which are 
employed in potentially painful restorative dentistry. Eugenol anaesthetises mice when 
administered intraperitoneally [226], and suppresses the electrical activity of some nerve or 
neuromuscular preparations, as expected from an anaesthetic agent: eugenol elicited
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reversible inhibition of the compound action potential of rat phrenic nerve [35], and also 
extinguished impulse transmission in the bullfrog sciatic nerve [139].
In rat dorsal root ganglion (DRG) neurons, 1 mM eugenol activated both Ca^  ^and Cl 
conductances [188] and, although at lower concentrations (0,1-2.5 mM) eugenol blocked 
K^-induced contracture of toad skeletal muscle, higher concentrations (3-12 mM) induced 
contractures, probably via release of Ca^ "^  from sarcoplasmic reticulum [146]. In guinea pig 
heart muscle, eugenol had a negative inotropic effect and reduced resting state contractions 
due to inhibition of the Ca^  ^current, probably via Ca^  ^channel block; a conflicting effect 
of current inhibition was also detected [227]. However, in one study involving in vitro 
and in vivo tests for anaesthetic action, the rat phrenic nerve hemidiaphragm preparation 
and rabbit conjunctival reflex, respectively, eugenol was inactive on both accounts [95].
The effects of eugenol on electricaUy-active cells are clearly diverse. Despite having an 
inhibitory action on many preparations, eugenol elicits responses in olfactory receptor 
neurones distributed in the nasal cavity [31]. Olfactory neurons respond to volatile 
compounds as part of their function in recognising potential food sources [165]. 
Furthermore, the enhancing action of eugenol at heterologously expressed vertebrate ion 
channels was investigated by injection of rat whole brain mRNA into Xenopus oocytes. 
Ionotropic receptor-mediated GABA responses achieved after injection were potentiated 
by eugenol and also by the monoterpenoids pinene, citronellol and citronellal [285].
Thymol is used as a stabilising agent in halothane anaesthetic preparations, but is not 
considered anaesthetic itself; thymol is best known as an antimicrobial component of 
preparations such as mouthwashes and toothpastes. The local anaesthetic effects of 
thymol, and other monoterpenoids, have been studied in the rat phrenic nerve 
hemidiaphragm preparation, where (+)/(-)-menthol, but not thymol or (-)-menthone, 
increased the number of stimuli needed to elicit a response, and in the rabbit conjunctival 
reflex test where both menthol isomers, but neither thymol nor (-)- menthone, suppressed 
responses [93]. However, these experiments were the same as those described in the 
previous paragraph in which eugenol was also found to be inactive, and therefore other 
tissues or experimental models may yield positive results. Other monoterpenoids that were 
active in these tests included terpineol and trans-anethole, inactive compounds included 
+ /-  citronellal, a-terpinene and (+)-carvone [95].
The activity of thymol in releasing Ca^ "^  from intracellular stores has also been well- 
documented. In neurones of the snail Helixpomatia, thymol induces release of stored Ca^ "^
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[138], and thymol is also known to release Ca^  ^from sarcoplasmic reticulum vesicles, a 
property shared by menthol and also chloroform and halothane [195]. Furthermore, the 
dye thymol blue was shown to be a potent inhibitor of InsPj (inositol 1,4,5 trisphosphate) 
binding activity [211].
Recently, the moUuscicidal activity of thymol was attributed to its effects on the activity of 
various cellular enzymes of the snail hymnaea acuminata  ^ thymol was found to have in vitro 
and in vivo acetylcholinesterase-inhibiting actions in this organism [232], and, after 96 h of 
exposure to sub-lethal thymol concentrations, 5-hydroxytryptamine (5-HT) and dopamine 
(DA) levels in vivo were also reduced. More new research has demonstrated the direct 
agonist activity of thymol and six related phenolic compounds at a neuronal receptor, the 
rat a l  (32y2 GABA^R, expressed in HEK (human embryonic kidney) cells. At these 
receptors, only compounds with a phenolic -OH attached directly to the benzene ring and 
aliphatic substituents in ortho position with respect to the phenolic -OH were able to elicit 
currents [176].
Carvacrol, like thymol, has been assayed on numerous occasions for its anti-bacterial 
activity, but evidence for biological properties that may influence neurotransmission, or 
indicate the existence of a neuronal target, is rare. One study showed that both carvacrol 
and thymol were the main components contributing to the anti-spasmodic activity of 
Origanum compactum [254]. Again, the stimulatory actions of carvacrol on sensory nerves 
have been documented: carvacrol and several other monoterpenoids were shown to induce 
fast wave bursts of activity in the rat rhinencephalic cortex, an activity which appears to be 
a common feature of many compounds that are anti-feedant towards herbivores, including 
another monoterpenoid, eucalyptol [283].
So far, numerous studies have indicated similarities in mechanisms of action between 
monoterpenoids and anaesthetic compounds; many anaesthetics are also physicochemically 
similar to the mono terpenoids, being volatile and lipophilic. However, just as there are 
non-volatile anaesthetics there are also non-volatile monterpenoids with certain anaesthetic 
properties: the valepotriates, isolated from Valerian, possess sedative [261] and spasmolytic 
activity [260], the mechanism of action is currently unknown although valepotriates bind 
to, and therefore may block, CNS dopamine receptors [121]. Furthermore, not aU 
monoterpenoids have anaesthetic-like biological activities; the essential oil of wormwood 
has convulsant activity and also kills worms and insects, the most likely constituent 
responsible for its toxic effects is a-thujone. Four observations establish that a-thujone is a
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GABAR modulator: it gives poisoning signs in mice similar to those induced by 
picrotoxinin, and the symptoms due to both PTX and a-thujone are alleviated by diazepam 
and phénobarbital; Drosophila melanogaster flies of the 'Rdl strain (with the A302S mutation) 
are resistant to a-thujone as well as PTX; a-thujone is a competitive blocker of ^ H[EBOB] 
binding to mouse brain membranes; most conclusively, GABA-induced, Cl -mediated, 
peak currents in rat dorsal root ganglion neurones are suppressed (reversibly) by a-thujone 
[110]. These results suggest that vertebrate GABA^ and insect bicucuUine-insensitive 
GABARs may be simUarly susceptible to a-thujone inhibition. The effects of a-thujone on 
heterologously expressed GABARs have not yet been investigated.
Summary and direction
Natural products have a firm place in the history of human louse control. Among the 
chemicals of this type that provide avenues for future exploitation as pedicuUcides, the 
monoterpenoids and related essential oil constituents appear promising. So far, the activity 
of these compounds on human Uce and eggs has not been investigated extensively. 
Particular monoterpenoids are already known to be especiaUy influential towards the 
viability of certain other insects, but the mechanism by which monoterpenoid lethaUty is 
caused is not known. Many other insecticidaUy active compounds have a neuronal mode of 
action and there is already evidence that certain monoterpenoids are active at mammaUan 
GABA receptors.
In Chapter 2, the activity of monoterpenoids against human Uce and their eggs wiU be 
explored. Later chapters wiU discuss a possible mode of action at insect GABA receptors.
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Chapter 2 
Monoterpenoids and essential oils as pediculicidal agents
2.1 Methods
2.1.1 The Orlando strain of clothing louse as a model organism for in vitro pedlcullclde 
bloassays
Lice are said to be the most fully parasitic of all organisms, and, as discussed in Chapter 1, 
this particularly applies to head lice, which must remain adjacent to host skin at all times. 
Maunder believes that this is why it is so difficult to culture head Uce in vitro [160]; the high 
degree of adaptation to the host environment means that no artificial substitute wiU lead 
them to thrive as well; they are fragile, and highly susceptible to dehydration. Clothing Uce 
are less fragile, as they have adapted to the temporary changes in environment that occur 
when garments are removed. These Uce survive weU in laboratory incubators, given cloth to 
cUng to, high relative humidity (RH) and appropriate temperature (50-90 % RH, 24-31 °C). 
These features make clothing Uce more suitable than head Uce for laboratory-based in vitro 
pedicuUcidal assays. A major drawback to rearing human pedicuU is that wild-type head and 
clothing Uce must be fed on human blood at least once a day. In the past, variations on the 
theme of artificial membranes were employed to negate the necessity for contact with 
human skin but, unfortunately, historical versions were obviously not very reUable, as 
Maunder remarked that the practical difficulties associated with their use were so great that 
it was better to find human volunteers [160]. However, if the colony is to provide enough 
adults and eggs for daily insecticidal assays and stiU have sufficient numbers to survive, it 
must consist of at least several hundred insects, and to support this many Uce would require 
an impractical number of volunteers in order to avoid sensitisation of individuals to louse 
bites and faeces.
Lice are normaUy extremely host specific, and rodent blood is actuaUy toxic to wild-type P. 
humanus. However, a laboratory strain of P. h. corporis^  bred by Culpeper in the 1940s, is able 
to feed entirely on rabbit blood, and can therefore be fed more conveniently. This, 
“Orlando,” strain was first raised entirely on humans, where the Uce were graduaUy
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acclimatised to being fed one large blood meal per day instead of smaller frequent feeds. 
They were then fed alternately on humans and rabbits until being gradually accustomed to 
feeding on rabbits alone. A sub-colony of the Orlando strain is maintained by MEC Ltd, 
Cambridge, and these lice were used for screening essential oils and terpenoids in this study 
[160]. Employees of MEC Ltd fed the Orlando lice once daily on anaesthetised rabbits; 
between feeds the lice were kept in a large glass bowl at 24-31 °C, 50-90 % RH with pieces 
of cotton corded cloth on which they laid eggs. The humid environment is attained by 
placing a large bowl of saturated saline solution, containing filter paper to act as a wick for 
evaporation, in the bottom of a thermostatically controlled incubator.
Aside from the convenience offered by Orlando strain lice with regards to feeding, it is also 
advantageous that the colony was established when only a few insecticides had been used 
to kill lice on a large scale. This means that the occurrence of resistance alleles in this 
population is far less likely than in lice harvested fresh from the wild. In wild populations, 
resistance alleles are not evenly distributed, which would necessitate collection of lice from 
several different areas, possibly countries, to ensure any bias due to differential 
susceptibility was detected. The utility of the Orlando strain as an in vitro pediculicide 
screen is illustrated by the use of both adults and eggs in numerous studies [42,43], and by 
Maunder’s claim that it is the standard model organism across the world to represent head 
and clothing lice in both comparative insecticide resistance assays and in pediculicide 
efficacy tests. This in vitro model has, however, not been without its critics [125]. Details on 
techniques for rearing head, clothing and Orlando strain lice in captivity and references for 
other methods are given in [187,160].
Table 2.1 lists the monoterpenoid structures tested against lice in this study. Although the 
pediculicidal activity of the phenylpropanoid eugenol was not tested. Chapter 3 of this 
thesis demonstrates the action of monoterpenoids and eugenol at the same biological 
target, and it is therefore included in Table 2.1 for comparison. Included with the 
monoterpenoids in Table 2.1 and also in the experiments in Chapter 2 is nerolidol, strictly 
classified as a sesquiterpenoid, but structurally very similar to other monoterpenoids 
included in these tests, such as geraniol. For the purposes of this thesis, where 
monoterpenoids are referred to in terms of the pediculicidal and ovicidal activity, the 
reader should note that this refers to “monoterpenoids and neroHdol.”
Terpenoids and eugenol were obtained from Sigma-Aldrich, U.K.; Lancaster Synthesis, 
U.K.; Acros Organics, U.K.; Fisher Scientific, U.K. or Avocado Research Chemicals, U.K..
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Tea tree oil was obtained from Boots Co. PLC; eucalyptus and lemon oils were obtained 
from Country and Harvest, Evergreen Distribution, U.K; lavender oil was purchased from 
The Herbal Apothecary, U.K.
The alleged constitution of the samples of monoterpenoids and other individual essential 
oil constituents was examined and confirmed by thin layer chromatography (TLC).
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LimoneneCamphene
Linalool
(+/-)Camphor
ÇH;
i-C H j
HO.
Carvacrol Linalyl Acetate
OH
Carveol Menthane-3,8-diol
Cineole Menth-6-ene-2,8-diol
HgC'
DHQ. OHO
X  XtransC IS
Citral,
cis/trans
Menthol
(+/-)
Citronellic acid 
(+/-) Menthone)OH
Geraniol Myrcene
*NerolidolGeranyl Acetate
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:h o
Perillaldehyde
(S)-(-)
(-)-Terpinen-4-oI
ÇH;
a-Pinene a-Terpineol
;h .CH.
P-Pinene Thujone
Pulegone
(R)-(+)
Thymol
OCH3
HO.
a-Terpinene Eugenol
(+)-Terpinen-4-ol
Table 2.1 Monoterpenoids tested for lethality against Pediculus humanus adults and
eggs
*Nerolidol, strictly a sesquiterpenoid, but structurally sim ilar to some monoterpenoids such as geraniol, 
was also tested on both adult lice and eggs. For the purposes o f  this thesis, where monoterpenoids are 
referred to in terms o f  the pediculicidal and ovicidal activity, the reader should note that this refers to 
”monoterpenoids and nerolidol. "
**Eugenol, a sim ple phenylpropanoid, is included here fo r  comparison. Although eugenol was not tested  
on P. humanus, its activity at a molecular target o f  monoterpenoids is examined in later chapters.
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2.1.2 The in vitro pediculicide bloassay
The method used to assess the pediculicidal activity of essential oils and their constituent 
monoterpenoids was adapted from an established pediculicide efficacy test involving 
contact exposure via insecticide-impregnated filter paper [264]. Preliminary tests were 
carried out to determine suitable experimental parameters, such as the dilution factors of 
test substances and duration of exposure to lice. The finalised assay was carried out as 
follows:
Essential oils and terpenoids were used at 10 % (w/v or v/v), diluted in absolute ethanol, 
or diethyl ether if ethanol-insoluble. A volume of 0.6 ml of diluted sample was spotted 
onto a 9 cm diameter filter paper, held in the lower half of a 9 cm glass Petri dish. After 5 
min, the liquid had spread out such that the filter paper was fully impregnated; no excess 
moisture was left in the dish. Impregnated papers were hung in a fume cupboard for 5 min 
to allow the solvent to evaporate. After this time, the papers were returned to their dishes 
and 10 clothing Hce gently placed on top using blunt forceps. The clothing lice used were 
adult males and females of the Orlando strain, which had been fed 1-6 hours previously 
and kept at 24-31 °C, 50-90 % RH until required.
Petri dishes containing impregnated filter papers and lice were covered with glass lids and 
incubated at 24-31 °C, 50-90 % RH. At least two control dishes were run with each batch 
of insecticide assays, one containing lice on an unimpregnated filter paper, others with lice 
on solvent-impregnated filter papers which had also been dried for 5 min before use. Lice 
were observed every 15 min, by lifting the petri dish lid, and the number of fatalities 
recorded. In this test, death was defined by lack of movement of limbs and gut, and failure 
to respond when the legs were stroked with forceps. Each agent in the screen was tested 5 
times in this manner. The individual essential oils and terpenoids were ranked according to 
their pediculicidal efficacy at 10 %, those showing no effect on Uce at this dilution were 
unranked. Combinations of some oils were also assessed, using 0.3 ml of each of two 10 % 
solutions that were combined just prior to use.
PedicuUcidal efficacy was expressed both as the mean (± one s.e.m ) % mortaUty for 
various time points and also as the LT50, the time taken to kiU 50 % of the Uce population; 
log-logit transformed data was subject to Unear regression analysis and the LT50 was then 
estimated from the regression Une by eye as the intercept with the X-axis. Data
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transformation and regression analysis were performed using the in-built equations in 
Graph-Pad Prism Software (Graphpad, U.K),
2.1.3 Observing physiological and behavioural effects of test substances
To gain an insight into the mechanism of action of a pharmacological agent on an 
organism, the first step usually involves either a casual or scientific observation of the 
physiological and behavioural results of application of the agent to the species in question. 
As lice are so small, only the grossest of symptoms can be observed; however, these may 
StiU prove useful for the purpose of grouping compounds with simUar effects, in case this 
leads to the identification of distinct classes of test substance with different modes of 
action.
2.1.4 Method for assaying effects of test substances on movement and 
behaviour of lice
The method described in 2.1.2 was applied to a range of test substances for which 
observational data were to be gathered, using 5 Uce per paper instead of 10. The point at 
which the last louse was placed on the paper was the time (t=0) when recordings began, 
and these were made continuously over a period of around 1 -3 hours until the Uce had died 
or the response to the test agent remained constant over 3 time points; 2 repUcates were 
carried out for each substance. A checkUst of possible effects had been prepared 
beforehand from casual observation of the Uce during mortaUty assays, and this was used as 
a guide when describing symptoms. When each dish was observed, the behaviour of the 
majority of the Uce (displayed by at least 3 out of the 5) was noted; if the same symptom 
was not present in at least 3 Uce, no score was given. The test was repeated to ensure that 
the results were reproducible. To faciUtate analysis, the descriptive data generated was 
converted to table format, where each type of response seen was designated a letter of the 
alphabet. By comparing patterns of letters assigned, similarities between the effects of 
different monoterpenoids could be assessed.
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2.1.5 in vitro assessment of ovicidal assay
Given the poor ovicidal effect of many of the modern pediculicides, and the reputed 
ovicidal activity of essential oil constituents, a screen was used to distinguish whether the 
test substances differed in their activity on Pediculus eggs, and whether those that were most 
active on adult Pediculus were also most active on louse eggs. Such information could be 
used to determine if a single compound would suffice in a pediculicidal formulation, or 
whether a combination of agents would perform significantly better,
2.1.5 Method for assessing ovicidal activity
The method used for testing monoterpenoid ovicidal activity was based on a method used 
by MEC Ltd. [42,43]. The louse eggs used were those of the Orlando strain of clothing lice. 
Although these lice prefer to lay eggs on tufted fabrics such as the cotton cord normally 
supplied, they will also lay on thick-fibred gauze if provided with no other substrate. Gauze 
is more suitable than cord for ovicidal assays, as the material is less absorbent, allowing the 
test substance to be washed off if desired. Also, the squares formed by the gauze fibres 
provide reference points for counting eggs and nits at the end of the test. The gauze is left 
in with the colony for 2-3 days to ensure a good yield of eggs, but removed at the end of 
day 3, as eggs laid after this time would be significantly less developed than those laid on 
day 1. The egg-laden gauze was removed from the incubator and immediately placed in a 
plastic Petri dish, packaged in bubble wrap and posted to The School of Pharmacy, where 
the tests were carried out on day 3 or 4. As soon as they arrived they were placed at 24-31 
°C, 50-90 % RH and kept in these conditions before and after treatment with test agents.
Preliminary experiments were carried out to determine suitable test concentrations and 
duration of exposure to enable the relative efficacies of all agents to be assessed. In the 
assays, prior to immersion in the test solutions, the sheets of gauze were cut into squares of 
convenient size (2 cm x 2cm approx.). Terpenoids and essential oils were diluted in 
absolute ethanol, or diethyl ether if ethanol-insoluble, and used to fill 20 ml glass bottles. 
Approximately 300 eggs (200 minimum) were immersed in each test substances for 10 min. 
After this time, the gauze was removed, blotted with tissue paper and left for 5 min on a 
clean piece of tissue laid flat in a fume cupboard, on low setting, to dry off the solvent and 
leave the fibres of the gauze impregnated with the test substance. Eggs exposed to solvent
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only were included with each batch of tests to enable correction of results with control 
mortality data; a control with no treatment was carried out at intervals to ensure that 
treatment with solvent alone continued to have no significant effect on the background 
mortality rate.
The eggs from individual treatments were incubated in separate glass Petri dishes at 
24-31 °C, 50-90 % RH until all the nymphs in the control batches had hatched and died. 
The eggs and nits were scored according to the identification key in Figure 2.1. For 
calculation of total percentage mortality, aU half-hatched and unhatched nymphs were 
grouped together; to assess the mechanism of ovicide action, aU the categories in Figure 2.1 
were treated separately. In the first stage of screening, 10 % (w/v or v/v) solutions were 
used, the most effective terpenoids from the 10 % stage were then screened at 5 %, and the 
most effective from this stage were screened at 2 % and 1%. As the control (solvent alone) 
mortality values were regularly above 5 %, Abbott’s Correction [1] was used to adjust the 
results of % mortality caused by test agents.
Where at least 3 replicates with corresponding control mortalities of less than 20 % (higher 
values render the data less reliable) were obtained for a test agent at one test concentration, 
the data were subjected to statistical analysis: the quantal response measure of % mortality 
is not directly amenable to ANalysis O f VAriance (ANOVA), as the scale of 1-100 % sets 
upper and lower limits for the distribution of data; if data are to follow the assumptions for 
the ANOVA of normal distribution and equal variance, the scale must be continuous. A 
common transformation for percentage values, arcsin(^ /lOo), where Y = percent 
mortality, was used with the intention of correcting the data sufficiently for analysis by 
ANOVA. Tukey’s post-test was employed following one-way ANOVA to identify pairs of 
results with significantly different means; both analyses were performed by Graph-Pad 
Prism computer package.
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Category
Hatched
Appearance
Half-hatched
Developed
%
Undeveloped
Empty shell (nit) is transparent and 
shiny. Operculum open or absent.
Any louse nearby has no limbs inside 
the shell.
Interpretation: The agent did not kill 
either unhatched nymph or hatchling. 
Operculum partially or completely 
open or absent. Louse nymph either 
wholly or partly inside the shell.
Interpretation: The agent killed the 
hatching nymph, but not the 
unhatched louse. This is most likely 
because the agent is prevented from 
having a true ovicidal effect as it 
cannot penetrate the shell, instead it 
persists on the fabric and kills the 
hatching louse when the seal around 
the operculum is broken.
Operculum Kilïy closed. Correctly 
positioned black eyespots are present 
(near the cap). The formed body of 
the louse nymph may or may not be 
present within the egg: in both cases 
the egg appears translucent but 
yellow and matte in appearance.
Interpretation: The louse embryo 
reached a stage o f development 
where a functional nervous system 
was present, and then ceased to 
develop further. The agent was only 
active on a neuronal target.
Operculum closed and egg appears 
matte yellow. Eyespot is either black 
but incorrectly positioned, red 
(correctly or incorrectly positioned) 
or absent. Often the inside of the egg 
has a homogeneous appearance, 
although a bubbly liquid interior is 
also common. The egg may appear 
shrivelled.
Interpretation: The agent arrested 
development before the nervous 
system formed. The agent either has a 
non-neuronal mode o f action or has 
neuronal and non-neuronal targets.
Figure 2.1 Key to Identifying the stage at which a Pediculus humanus egg is killed
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2.1.7 A potential alternative pediculicide screen -  The house dust mite
As explained in Section 2,1 of this chapter, it is impractical if not completely impossible to 
rear head lice in the laboratory. Furthermore, the use of the clothing louse as a model, even 
the Orlando strain, is not entirely convenient; Currently, the only accessible colony of 
Orlando strain lice are held at MEC Ltd, Cambridge, and to ensure that the Hce are as 
healthy as possible before performing pedicuHcidal assays, the experiments must be done 
on site. To estabUsh a sub-colony of this strain elsewhere would not only require special 
permission from MEC Ltd., but also animal care faciHties and the daily availabüity of 
personnel trained to perform the animal anaesthesia and associated procedures to feed and 
tend to the Hce. The colony would also take time to grow in number so that it was large 
enough support daily intensive removal for insecticidal assays. The discovery of a more 
convenient experimental model for P. h. capitis would therefore faclHtate preHminary in vitro 
pedicuHcidal testing.
In a previous study of pedicuHcidal agents from oil of Leyland cypress (Cupressus x  leylandii 
L.), the brine shrimp was utiHsed as a model organism with which to screen plant extracts 
and fractions [259]. Although the author reported that the brine shrimp was a suitable 
model with which to screen for pedicuHcidal agents, this assay is normaUy used as measure 
of cytotoxicity and may therefore not be ideal for the detection of louse-selective 
compounds; if bioactivity extends to unrelated arthropods it may be more Hkely to affect 
mammals, especiaUy as insecticidal monoterpenoids appear to have a relatively narrow 
spectrum of activity on target insect species. Furthermore, it is impossible to deHver 
insecticides to brine shrimp in the same manner as they are deHvered to Hce, as brine 
shrimp are obHgately aquatic and therefore test substances must always be appHed 
dissolved in water. Not only are the majority of insecticides, including monoterpenoids and 
essential oils, mainly hydrophobic in nature, therefore making it preferable to use a non- 
aqueous based deHvery system for screening experiments, it has also been shown that 
formulation is an important factor in the efficacy of an anti-louse product, therefore 
preHminary tests should minimise variation in excipients between the model and the 
species it represents.
A potentiaUy more suitable organism to replace the Orlando strain louse is the house dust 
mite, Dermatophagoidespteronyssinus. House dust mites have recently been a subject of 
scientific interest, as certain aUergens they produce are thought to precipitate not only
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sensitisation in atopic individuals but also the consequent clinical symptoms of several 
closely related conditions: asthma, allergic rhinitis and atopic dermatitis [83,131]. A colony 
of dust mites are kept at MEC Ltd and their method of culture requires minimal time and 
expenditure. The following sections describe the development of a method for screening 
the acaricidal properties of essential oils and their constituents with a view to this species 
becoming a model for P. h. capitis in place of the Orlando strain in pediculicidal bioassays.
It was speculated that the two species might respond in a similar manner to invertebrate- 
selective toxins, as neither is associated with plants at any stage of the life-cycle and 
therefore both may lack evolved species specific resilience towards plant compounds. 
Furthermore, neither dust mites nor the Orlando strain have been exposed purposefully to 
modern synthetic pesticides (it is only extremely recently that any dust-mite control 
products have appeared on the market); hopefully, therefore, neither will possess alleles for 
resistance to standard insecticides or any structurally-related compounds.
In comparison to the habitats colonised by other arthropods, the environment preferred by 
the house dust mite bears some resemblance to that required by the louse. D. pteronyssinus 
thrive in the warmest, most humid and least disturbed areas of the house, such as the stable 
climates provided deep within mattresses and pillows. They live in dust and aU manner of 
soft furnishings and stored fabrics in houses, anywhere which traps moisture and shed skin 
tissue, their food source.
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H a lf  P etri-dish
Plastic tube
Hole in tube
Wire
Filter paper
Mite
Tissue soaked in 
saturated NaCl
Figure 2.2 A mite-chamber for testing acaricidal activity
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2.1.8 The house dust mite: Method of propagation
This method of propagation of dust mite colonies was devised by MEC Ltd [52]; it 
promotes rapid growth and multiplication of mites and is also extremely economical on 
resources, with respect to the establishment and maintenance of these colonies.
Dried liver granules (Oxoid) were ground into a dust using a pestle and mortar and added 
to brewer’s yeast powder to give a 1:1 w /w  mixture. This was used to half-fiU sealable 
plastic containers and a number of mites introduced, for example, a 1:1 v /v  combination 
of fresh substrate and saturated colony/substrate is ideal. To facilitate gas and water 
exchange, parts of the plastic container should be removed and replaced with sections of 
porous tape, which can also be used to seal over any holes the mites can escape through. 
The mite colonies were incubated at 25 °C, 75 % RH and, again, saturated saline was 
placed in the incubator to attain high humidity.
When handling mite colonies it is important to keep allergen exposure to a minimum, and 
dust masks should be worn for this purpose. It is advisable to keep some of the colony in 
very small (50 ml max.) containers, which can then be accessed regularly during 
experimentation without allowing too much allergen, present in the mite faeces, to become 
airborne.
2.1.9 Testing for acaricidal activity
A novel assay was employed in this study to investigate the acaricidal activity of essential 
oils against D. pteronyssinus. The assay was adapted from the filter-paper test mentioned 
previously [264], firstly to give the best chance of observing a correlation between the 
results of the pediculicidal and acaricidal assays, and secondly because previous assays 
applied to this species would not have allowed the observation of all individuals over the 
course of the experiment [see for example 131,223]. Dust mites are extremely small 
(practically invisible to the naked eye) and highly mobile; unlike Hce they can scale vertical 
polished surfaces. The problem with any assay is containment of the creature in a localised 
area such that it to remains in contact with the acaricide and can also be found when the 
assay is complete. The only way to keep the mites on the test paper is to limit their route of 
escape or make it so unappealing that they stay on the paper for as long as possible. Initial
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experiments revealed another difficulty: although mites, even dead ones, stick to fibres on 
the filter paper, which has the advantage of allowing them to be observed from underneath 
the paper as well as from above, any slight disturbance will propel them into the air and 
once a mite is lost from the paper, it is unlikely to be found again. The best filter paper 
assay for D. pteronyssinus devised in this project is described below.
2.1.10 The 'mite chamber' acaricidal bloassay
A clean piece of very fine wire was used to make holes at opposite edges of a 3 cm 
diameter piece of filter paper, the paper was handled with forceps and contact with fingers 
was avoided. Sections of wire, 8-10 cm long, were then threaded through each hole a short 
way and the end hooked round. The filter paper with wires attached was lowered into a 
section of transparent tube, 5 cm tall by 5 cm diameter, until it was exactly central with 
respect to the length and the diameter of this tube. The free ends of the wire were threaded 
through holes in the tube and the ends taped to the outside. One of these pieces of 
apparatus, or ‘mite-chamber,’ was prepared for each test substance, one for a solvent-only 
control, and another for a chemical-free control (See Figure 2.2).
The acaricidal activity of each essential oil was assessed using a 10 % v /v  solution in 
absolute ethanol, 0.1 ml of which was used to wet the entire filter paper, leaving no excess 
fluid. After waiting a few seconds to ensure that the solution had spread throughout the 
paper, the mite-chamber was left in a fume cupboard on low setting for 5 min to allow the 
solvent to evaporate. After drying, each mite chamber was placed on one half of a 9 cm 
Petri dish, which contained a layer of tissue paper soaked in 15 ml saturated NaCl solution 
in the bottom to ensure adequate humidity. Ten of the largest mites were transferred from 
the colony to each filter paper, using a soft paintbrush with just a few (5-10) hairs. The top 
of the mite chamber was covered using the other half of the Petri dish. The mites were 
returned to the 25 °C, 75 % RH incubator. When making observations, the location of 
each mite remaining on the filter paper was ascertained first using the naked eye, and then a 
binocular light microscope (at 25 x magnification) was used to determine whether the mite 
was mobile or immobile, alive or dead. The mites were assessed at 30 min for mobility and 
at 2 h for mortality. Mortality was defined by lack of response to stroking with a paintbrush
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2.2 Results and discussion
2.2.1 Monoterpenoids as pediculicidal agents 
The relative pediculicidal activity of monoterpenoids
This study demonstrates that essential oils and the monoterpenoid constituents thereof 
show wide variations in lethality against adult P. h. capitis (see Table 2.2), The LT50 values 
were estimated as described in the ‘Methods’ section of this Chapter, and the compounds 
were placed in rank order of efficacy, those with the lowest LT50 value having the highest 
efficacy (Table 2.1.1, below).
Compound LT50 (min) Compound LT50 (min)
(+)-terpinen-4-ol 30 perillaldehyde 85
pulegone 31 geraniol 102
C-)-terpinen-4-ol 45 citral 123
thymol 45 carved 135
a-terpineol 66 menthol 178
menthone 66 geranyl acetate 295
carvacrol 74 linalyl acetate 355
linalool 83
Table 2.1.1 LT5 0  values, estimated by logit analysis, demonstrating the relative lethality of
a series of monoterpenoids.
Lice were placed on filter papers impregnated with test agent and monitored over 3h for mortality. Other 
agents, not listed, caused insufficient mortality to estimate this parameter.
The ranking by LT50, in Table 2.1.1, is similar to those obtained at individual time points, 
shown in Table 2.2.
It should be noted that, of the effective compounds, perillaldehyde was of a lower percent 
purity than others as it was ‘technical grade’. Although its position in the ranking wiU 
consequentially be less certain, as the activity could be due to a minor impurity, the 
indicates that either perillaldehyde or a contaminant has a high activity, and in future 
studies the sample could be separated into its constituent parts by phytochemical methods, 
and these tested individually.
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The relationship between monoterpenoid structure and peducullcldal activity
This work supports previous observations that the components of essential oils that confer 
pediculicidal activity are oxygenated [259], All of the compounds selected that lacked an O- 
containing functional group were inactive throughout the 3 h test period when applied as 
10 % solutions and were as follows: camphene (bicyclic isocamphane structural type); 
myrcene (linear type); a- and ^-pinene (bicyclic pinane types), a-terpinene and limonene 
(monocyclicy>-menthane types).
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Percentage m ortality (%  M) o f  lice at various timepoints (min) during exposure to the test agent shown
30 min % M 60 min % M 90 m in % M 120 min % M 150 min % M 210 min % M
(+)-T4ol 62 (± 1 3 ) (+)-T4ol 100 (± 0 ) (+)-T4ol 100 (± 0 ) (±)-T4ol 100 (± 0 ) (+)-T4ol 100 (± 0 ) (+VT4ol I0 0 (± 0 )
Pulegone 40 (± 7 ) Pulegone 78 (± 8) (-)-T4ol 96 (± 4 ) (-)-T4ol 98 (± 2) (-VT4ol 100 (± 0 ) (-)-T4ol 100 (± 0 )
Thymol 28 (± 10) (-)-T4ol 74 (± 6) Pulegone 92 (± 6) Pulegone 94 (± 4 ) Pulegone 100(± 0 ) Pulegone 100 (± 0)
(-)-T4oI 22 (± 2 ) Thymol 62 (± 10) Thymol 86 (± 7) Thymol 92 (± 6) Thymol 94 (± 6) Thymol 98 (± 2 )
Menthone 18 (± 9 ) M enthone 54 (± 1 2 ) Carvacrol 70 (± 10 ) Carvacrol 90 (± 8) Carvacrol 94 (± 6 ) Carvacrol 98 (± 2 )
Carvacrol - Carvacrol 36 (± 8) M enthone 68 (± 15 ) Perillal- 78 (± 8) Perillal- 86 (± 6 ) g-Terpineol 96 (± 4 )
g-Terpineol - g-Terpineol 32 (± 1 5 ) Linalool 60 (± 8) g-Terpineol 76 (± 6) g-Terpineol 86 (± 7 ) Linalool 96 (± 2 )
Citral - Linalool 30 (± 6) g-Terpineol 58 (± 1 5 ) M enthone 74 (± 1 5 ) Linalool 86 (± 7) M enthone 96 (± 4 )
Geraniol - Geraniol 28 (± 1 0 ) Perillal- 54 (± 6) Linalool 74 (± 9) M enthone 84 (± 1 2 ) Perillal- 90 (± 4 )
Linalool - Perillal- 24 (± 9) Citral 38 (± 1 2 ) Geraniol 64 (± 7 ) Geraniol 70 (± 7) Geraniol 82 (± 4 )
Perillal- - Citral 16 (± 9 ) Geraniol 38 (± 10 ) Citral 52 (± 7 ) Citral 62 (± 7 ) Menthol 74 (± 1 1 )
Carveol - Thujone 12 (± 6 ) Carveol 30 (± 9) Carveol 46 (± 1 0 ) Carveol 60 (± 10) Carveol 68 (± 12 )
GerAce - Carveol 10 (± 4 ) Thujone 18 (± 7 ) Thujone 38 (± 1 6 ) M enthol 42 (± 4 ) Citral 66 (± 9)
LinAce - GerAce - Menthol - Menthol 14 (± 9) Thujone 26 (± 4 ) Thujone 32 (± 4 )
Menthol - LinAce - GerAce - GerAce 10 (± 4 ) GerAce 14 (± 7 ) GerAce 26 (± 9 )
Thujone - Menthol - LinAce - LinAce - LinAce 14 (± 7 ) LinAce 24 (± 9)
Inactive: Cam phene, Cam phor, Cineole, Citronellic Acid, Limonene,
M enth-6-ene-2,8-diol, M enthane-3,8-diol, M yrcene, Nerolidol, 
  g -P in en e , P-Pinene, a-Terpinene,
Table 2.2 Activity of selected monoterpenoids against the human iouse, P. humanus
Lice were placed on filter papers impregnated with a single monoterpenoid.
Percentage mortalities (% M) caused by the test agents at set times after application (at t = 0) are shown ±  
one s.e.m. The test agents are shown placed in rank decreasing order o f  efficacy at each time point 
according to % M. Scores o f  less than 10 % (-) were discounted for the purposes o f  this ranking, test 
agents marked should therefore be considered o f equal rank.
Perillal- = Perillaldehyde; GerAce = Geranyl Acetate; LinAce = Linalyl Acetate
Percentage mortality (%  M) o f  lice at various timepoints (min) during exposure to the test agent shown
30 min % M 60 min % M 90 min % M 120 min % M 150 min % M 210 min % M
Tea Tree 10 (±10) Tea Tree 34 (±17) Tea Tree 56 (±15) Tea Tree 74 (±12) Tea Tree 80 (±8) Tea Tree 90 (±8)
Lavender - Lavender 10 (±8) Lavender 10 (±8) Lavender 22 (±12) Lavender 32 (±10) Lavender 50 (±14)
Inactive: Lemon, Eucalyptus.
(b)
Percentage mortality (%  M) o f  lice at various timepoints (min) during exposure to the test agent shown
30 min % M 60 min % M 90 min % M 120 min % M 150 min % M 210 min % M
TT/Laven - TT/Eucal 22 (±9) TT/Eucal 36 (±14) TT/Eucal 48 (±19) TT/Laven 64 (±7) TT/Laven 78 (±7)
TT/Eucal - TT/Laven - TT/Laven 14 (±5) TT/Laven 36 (±5) TT/ Eucal 50 (±19) TT/Eucal 50 (±19)
TT/Lemon - TT/Lemon - TT/Lemon 10 (±5) TT/Lemon 14 (±9) TT/Lemon 22 (±7) TT/Lemon 22 (±7)
Table 2.3 Activity of selected essential oils and essential oil combinations on P. humanus
Lice were placed on essential oil impregnated filter papers.
The % mortality (% M) caused by the test agents at regular time intervals after application (at t = 0) are 
shown ±  one s.e.m. At each time point, the test agents are shown placed in rank order o f  efficacy 
according to % M, with the highest first. Scores o f  less than 10 % (-) were not utilised in the ranking.
a) Relative potency o f  selected essential oils (0.6 ml o f  a 10 % solution o f  oil was applied to filter 
paper and the solvent evaporated)
b) Relative potency o f  combinations o f  oils (0.3 ml aliquots o f  two different 10 % dilutions were 
mixed prior to application to the filter paper).
TT = Tea tree; Eucal = Eucalyptus; Laven = Lavender
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However, the possession of two O-containing functional groups appears to be detrimental 
to activity: menthane-3,8-diol and menth-6-ene-2,8-diol (saturated and unsaturated 
monocyclic ^ -menthane types, respectively) were both completely inactive as 10 % 
solutions despite the fact that, in both cases, removal of either —OH group would produce 
a structure almost identical to far more effective compounds such as menthol and a - 
terpineol, and similar to terpinen-4-ol and carvacrol. It might perhaps be the decrease in 
lipophilicity conferred by the extra —OH group on such a small molecule that is responsible 
for the low activity. This theory is supported by the absence of activity for citronellic acid 
and the low efficacy of the esters geranyl acetate and linalyl acetate (all linear 
monoterpenoids). On a low molecular weight hydrocarbon, a single ester group would 
render the molecule less lipophilic than a single —OH group, but more lipophilic than a 
carboxyl group or two —OH groups. Louse cuticles are particularly waxy, therefore it may 
be speculated that small non-polar or slighdy polar molecules might be able to enter via a 
trans-cuticular route, whereas more polar molecules may be prevented from doing so. The 
route of entry of monoterpenoids into the louse has not yet been established however, 
given their low molecular weight and lipophilicity, cuticular penetration is entirely feasible. 
The cuticle is a common route of entry for other insecticides, furthermore, lipophilic oils 
(‘penetrants’) are often added to an insecticide formulation to enhance insecticide solubility 
in the cuticle, this being especially important if the insect’s cuticle is very waxy [78]. Veal 
suggested that monoterpenoids may be too lipophilic to be soluble in the haemolymph 
after crossing the cuticle, and therefore suggested a route of entry through the tracheae 
[256].
Another factor that may also influence pediculicidal activity is the bulkiness of the 
structure: linalool, geraniol and nerolidol are all linear types, with increasingly extended 
structures and decreasing efficacies. Camphor, cineole and thujone (camphane,^-menthane 
and thujane type bicyclic monoterpenoids, respectively) are more bulky than other 
oxygenated compounds in the plane perpendicular to the ring and, given their negligible or 
absent efficacy over 3 h, it appears that bicyclic structures are less effective than 
monocyclics in this test.
At timepoints of 60 min and above, the top 6 ranking test substances in Table 2.2 are 
consistently unsaturated (mono-) cyclic monoterpenoids with a^m enthane skeleton. At 
timepoints of 90 min and after, the top 4 ranking compounds in this pediculicidal assay 
were consistently (+)-terpinen-4-ol, (-)-terpinen-4-ol, pulegone and thymol, in that order. 
These top 4 compounds additionally have the following structural features in common: a
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methyl group at position 1, a C attached to the ring via either a double or single bond at 
position 4, to which are bonded two methyl groups, and an = 0  or -OH functional group 
at position 3 or 4. There is some evidence that the particular arrangement of methyl groups 
may be an important determinant of activity. For example, this methyl group arrangement 
is present in the top 8 ranking pediculicidal terpenoids, discounting perillaldehyde (on 
account of impurity levels). Furthermore, the phenols thymol and carvacrol have similar 
pediculicidal activities consistent with their close structural similarities, yet carveol, which is 
identical to carvacrol except for the double bond between C7 and CB, has relatively low 
activity. The lower activity of carveol is surprising given that unsaturation in other parts of 
the molecule appears to enhance activity, for example, pulegone is more potent than 
menthone, suggesting that the methyl group arrangement is more important than increased 
unsaturation in the molecule.
A further consideration is that certain monoterpenoids may be more effective on account 
of their potential resilience to metabolism in the insect: for example, the tertiary alcohols 
terpinen-4-ol, a-terpineol and linalool, the ketones menthone and pulegone, and the 
phenols thymol and carvacrol would aU be more resistant to oxidation than the secondary 
alcohol menthol, the primary alcohol geraniol, and the aldehyde citral. However, this factor 
is likely to be secondary to those previously discussed, as the tertiary alcohols nerolidol, 
menthane-3,8-diol and menth-6-ene-2,8-diol are aU inactive.
The activity of menthol is of particular interest, as it appears to increase sharply over time 
after an initial lag. Menthol is similar in many respects to the most active monoterpenoids, 
being monocycHc with the same pattern of methyl groups and a single —OH group, but it is 
distinguished by being a secondary alcohol, having no unsaturated bonds and has relatively 
low pediculicidal activity. The more efficacious menthone is structuraUy homologous with 
menthol except that the functional group at position 3 is a ketone instead of an alcohol. 
Table 2.2 shows that, although initiaUy the two compounds have very different relative 
activities, the margin appears to decrease over time: at 30 min menthone is ranked 5*, at 
210 min this has dropped to joint 6*; menthol has negUgible activity until 120 min, where it 
is 14*, but by 210 min, this rank has increased to 11*. It may be hypothesised that 
oxidative metabolic enzymes in the insect are initiaUy able to quench the activity of a 
secondary alcohol, but then become saturated over time; alternatively, the lower 
UpophUicity of menthol may result in a delay to sufficient amounts penetrating into the 
louse. Further investigation of this phenomenon is required.
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The unique feature of the structure of terpinen-4-ol is that the —OH group resides at 
position 4, but further investigation would be needed to confirm whether or not this is the 
factor determining its top ranking status. It also appears that there is a difference in activity 
between the (+)- and (-)- optical isomers. Variations in bioactivity between isomers are an 
important consideration in the study of monoterpenoids, as most are optically active. It is 
already known that different monoterpenoid enantiomers can elicit different biological 
responses, especially at nasal olfactory receptors; for example, (+)-limonene smells of 
oranges, (-) limonene smells of lemons [79]. Therefore, even if not all optical isomers have 
been tested in a monoterpenoid structure-activity series, it is important to at least specify 
whether the test agent was the (+)-form, the (-)-form or a racemic mixture, and to identify 
which form(s) are present in plant essential oils.
Tea tree oil was the most effective oil in this test followed by lavender. Lemon and 
eucalyptus were inactive in this study (Table 2.3a). In this case, the activity of the essential 
oils could be predicted by first observing the activities of their major constituents, as good 
quality tea tree oil contains high levels of terpinen-4-ol, lavender contains mainly linalool 
and linalyl acetate, lemon contains mainly hydrocarbons, and the major constituents of 
eucalyptus are cineole and pinene [79]. In table 2.3b, the tea tree/eucalyptus combination 
appears to perform better than expected in comparison to the tea tree/lemon combination, 
and so perhaps synergy between these oils could be investigated.
The study by Downs [286] used a similar filter paper test to investigate pediculicidal activity 
towards freshly collected head lice from U.K. inhabitants. Tea tree oil, terpinen-4-ol, and 
a-terpineol were aU more effective against lice than y-terpinene, as the experiments 
described in this thesis have also shown. However, y-terpinene did show a much higher 
mortality in the Downs study, and this may have been due to slight variations in protocol; 
for example, the filter papers were dipped in 10 % solution rather than set amounts of 
solution being measured out; also, the lid was left on the Petri dish for the whole of the 
study, whereas it was removed at regular intervals (every 15 min) in this investigation. 
Perhaps the activity of y-terpinene is more dependent on its activity as a vapour than that 
of terpinen-4-ol, as, after 2 h, some terpinen-4-ol treated lice in Downs’ study were still 
alive. Experimental differences probably also underlie the reason that 1,8-cineole and 
pinene were found to be effective by Gauthier, as it was noticed when the experiments for 
this thesis were being carried out, that lice subjected to cineole and a-pinene were highly 
afflicted, but did not cease movement throughout the course of this experiment; perhaps a 
longer incubation period would have resulted in a higher mortality for these compounds.
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Although the study by Veal on individual essential oils did not discriminate between them 
in terms of their pediculicidal activities to a great extent; the most effective oils, giving 100 
% mortality when dissolved in ethanol, were those that normally contain at least one 
phenolic compound in ‘large’ amounts consistent with the high efficacy of phenols found 
in this thesis (the activity profile for oils dissolved in water showed slight differences from 
that obtained when oils were dissolved in ethanol).
Development of the pediculicidal test for use as a screen In pharmacognosy
The purpose of the filter paper assay, as devised by the WHO (World Health Organisation) 
[264], is to assess the level of resistance to insecticides in the field, presumably because of 
the detrimental effect of transportation on head lice viability. The filter paper test is 
therefore likely to have been designed primarily for convenient use in any location, whereas 
other in vitro pediculicidal assays have attempted to replicate clinical application methods, 
for example, sometimes Hce (and eggs) are dipped in insecticide solution, washed 
afterwards with a mild shampoo and then rinsed with tepid water [42,43]. It may be argued 
that such tests might be more accurate in identifying agents that will be active in the field, 
as asserted by Burkhart [54], however, this may not necessarily be so if the formulation or 
appHcation method changes during product development. In this test, as the solvent is 
completely evaporated it effectively enables monoterpenoids to be appHed to Hce 
unformulated. Different formulations and durations of exposure can influence the activity 
of malathion and carbaryl [42,43] and for this reason further consideration should be given 
as to the most suitable method by which to assess the efficacy of monoterpenoids with 
respect to these positive controls. One consideration of the filter paper test that particularly 
appHes to essential oHs, is that by enclosing them in Petri dishes, the agents are given the 
opportunity to act either by contact, vapour or both. Although the relative contributions of 
these two routes to pedicuHcidal essential oil efficacy has not been determined, in the study 
of Uppia oil on Hce it was found that the toxic effects of the oil were enhanced in an 
enclosed test system [189], therefore it is Hkely that at least some volatile constituents of 
essential oils act partiaUy or whoUy when vaporised. The use of an enclosed system may 
therefore compHcate comparisons with substances having only contact activity.
The next stage in determining the most pedicuHcidal monoterpenoids is to experiment with 
simpHfied possible essential oil/monoterpenoid formulations using various different in vitro 
methods, considering also the potential mode and duration of appHcation of a pedicuHcidal 
product to the scalp, to see how factors such as the type of excipients and the degree of
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enclosure affects the structure-activity series. These investigations will be important to 
determine how different experimental circumstances might affect the outcome of a 
pediculicidal assay, and such information may help to interpret any future results obtained 
in vivo.
The parameter used here to describe lethality, the LT50 (representing the time-response 
relationship) is a legitimate measure of insecticidal potency [5,143]. Although the majority 
of toxicological and insecticidal assays use LD50 (representing the dose-response 
relationship) to describe mortality; the LT50 was measured here because it is a useful 
substitute when time and insects are limited. However, if such resources become less scarce 
in future, the advantages of generating dose-response data should be revisited: Most 
insecticidal studies use the LD50, and therefore comparisons between the results generated 
with those of other studies wiU be more accurate; there is also the potential to relate dose- 
response curves obtained at possible molecular targets to LD50S obtained in toxicological 
studies; finally, the most effective compounds in the UD50 tests could be assayed for 
rapidity of action (LT50) by selecting several concentrations from the dose-response curve, 
for example, LD50 and LD95.
It should also be noted that, although probit transformation and subsequent linear 
regression analysis is the standard manner by which insecticidal assay data is handled, 
specialised computer packages are required for probit plots and in this case the logit 
transformation of GraphPad Prism was successful in transforming the data to produce a 
linear curve.
The mortality assay employed in this study utilised the assumption that either the lice were 
moving and therefore alive, or immobile and unresponsive to stimuli and therefore dead. 
Although lack of response to stimuli has been used in other studies to define death [see for 
example 286], perhaps future studies should be modified to gauge recovery of 
responsiveness upon removal of the lice to insecticide free conditions. A different set of 
lice would be needed for each concentration or time point, and the insects would be 
incubated without disturbance for the duration of each test. At the end of the experiment, 
the number of lice that ‘appeared to be dead’ (‘moribund’) would be assessed as before and 
these lice then removed to clean filter papers and reincubated alongside controls to observe 
recovery of movement over the next 24 hours. This would empower the protocol with the 
ability to determine if there is a minimum time of exposure or concentration required to 
ensure irreversibility of terpenoid action. Although lice are fragile they can, for example,
86
survive in water for a day via a reflex action which closes their spiracles. Some of the test 
compounds precipitated an almost instantaneous curtailment of motion (see Section 2.2.2 
below) and, although this may reflect rapid lethality, it could also be the result of a reflex 
defence mechanism in Hce, or even a temporary anaesthetic-type action of some 
terpenoids. In fact, many studies do not assay for death but ‘knock-down,’ the point at 
which the insect suffers acute neurotoxicity [143], manifested as the inabüity to cHng to 
substrate or to right itself. It may, therefore, be informative to examine the effects of both 
lethal and sub-lethal concentrations or durations of exposure, and the points at which the 
effects are irreversible: Perhaps future studies could include the categories ‘knocked-down’ 
(no movement unless stimulated), reversibly paralysed (stimulated movement absent but 
recovers when test agent removed) and irreversibly paralysed/dead. This modification can 
only be included in assays if the mortaHty from control Hce remains less than 20 % over the 
24 h period (so that the data can stiU be corrected with Abbott’s formula) [1]; the benefit of 
the current filter paper-Orlando strain protocol here is that no Hce died in any of the 
control experiments, and the same control Hce were stiU aHve in the incubator the day after 
experimentation.
A disadvantage of the filter-paper assay is that it is not particularly suitable for the bioassay- 
guided fractionation of pedicuHcidal compounds from raw plant material: Dilute solutions 
of monoterpenoids and essential oils spread out evenly on filter papers very weU, but 
preHminary experiments confirmed that crude extracts do not. In this case a dip test 
involving solutions, suspensions or crude formulations of extracts may be preferable or, 
alternatively, painting the backs of the Hce with extracts could be considered. As bioassay- 
guided fractionation requires huge numbers of test samples to be screened, to save time 
and to be economical with insects, a pared-down version of the time-action curve would be 
particularly useful, where fewer repHcates and/or concentrations were employed, reserving 
dose-response work for more pure fractions. As the availabiHty of Orlando strain Hce is 
Hmited, to increase the convenience and speed of the assay, an alternative organism could 
be used as a pedicuHcidal indicator (259). This possibiHty is discussed in further detail in 
Section 2.2.4.
2.2.2 The effect of monoterpenoids on louse physiology and behaviour
A  further advantage of the filter paper-based insecticidal activity test is that the Hce can be 
observed through the Petri dish Hd for the duration that they are in contact with the
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insecticidal substance, and there are no other factors which may influence their behaviour 
apart from the terpenoid or oil itself, such as the lice being wet from immersion in 
insecticide. The collated results from the observational study are shown in Table 2.4, with 
the key below. The purpose of this study was to report the occurrence of different 
physiological effects of monoterpenoids, to assess the value of the results of this 
preliminary work, and to discuss whether such data should be recorded in tandem with 
mortality, or whether separate observations would be more appropriate.
Experiments that report gross morphological, behavioural or physiological responses of 
target organisms to drugs can be problematic in their design, as the parameters of interest 
are often difficult or impossible to quantify in a wholly objective manner, and the resulting 
subjective element in their assessment leaves the experiment open to scientific error. For 
example, in humans, a change in blood pressure can be ascertained objectively, by its value 
in mm Hg, but the effect of a chemical on a skin condition such as eczema is not so 
straightforward; as there are multiple interrelated aspects to consider, such as the size of 
the inflamed area, the severity of inflammation, and the appearance of the lesions. The 
problem can partially be solved by careful experimental design; the severity of an eczema 
lesion could be judged on a scale of 1 to 5, or relative to those lesions normally 
experienced. The patient, or better still an independent, trained observer, could make the 
assessment, and this would go some way to quantifying, or at least scientifically describing, 
the effects, but the decision will still be based on subjective judgement. An improvement 
for future experiments would be to take a video recording of the lice throughout the 
duration of test substance exposure; at least then the diagnoses made by the primary 
researcher could be scrutinised at any time by a second party, although analysis of the data 
would still present a problem.
Response profiles
Response categories (1-8) are shown with the symptom (letters A-X) elicited by 
the test agent displayed below. Refer to the key to this figure for symptom
definitions.
Test Agent 1 2 3 4 5 6 7 8
Control B C H J M R U w
Camphor A D I K P T U w
Carveol A F H J 0 Q U X
Carvacrol A F H J G Q U X
Cineole A D I K P T U w
Citral A E I J G R U w
Geraniol B E I J G S V w
Linalool A F I L N S V w
Menthol B E I J N S u w
Menthone A D I K P T u w
Perillaldehyde B E I L N R u w
Pulegone B F H J G S u w
(+)-T erpinen-4-ol B D H L N S V w
(-)-Terpinen-4-ol B G H J G R u w
a-Terpineol B F H I G S u w
Thujone A E I J G var u X
Thymol A F H J G Q u X
Table 2.4 Physiological and behavioural responses of the human louse, P. humanus, to
monoterpenoids
Lice were observed during exposure to various monoterpenoid-impregnated filter papers. The symptoms 
displayed by the majority o f  lice were recorded and transferred to table format using the key on the 
following page.
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Key to Table 2.4
Behavioural response to test substance:
(1) In the initial stages of exposure, the lice visit the edge of the Petri dish:
A - more frequently than control lice B - with the same frequency or less
Movement:
(2) During exposure, the rate of walking and/or limb movement was:
C - similar to control lice D - initially faster, then became gradually slower.
E - initially no different, then became gradually slower.
F - instantly slower, but increased with mechanical stimulation.
G - instantly slower, and was unchanged by stimulation.
(3) Ability to perform co-ordinated movement:
H - Movement was either normal, or featured only minimal mal-coordination.
1 - Movements were distinctly mal-coordinated, and included staggering, non-directional perambulation and falling- 
over.
(4) Body movement along antero-posterior axis:
J - normal, with neither of the attributes K or L. K - the lice became rigid
L - arching; exaggerated movement along the antero-posterior axis
(5) Limb movements when inverted:
M - normal N - twitching; erratic jerking movements, may also be accompanied by flailing motion.
O - flailing; slower constant limb movements no twitching. P - curling; limbs bent inwards in a curling
motion.
Dehydration:
(6) The abdomen was:
Q - bloated in appearance. R - normal; was turgid but distensible.
S - displaying loss of turgor. T - shrivelled & hard
Var - turgidity varied between individuals.
Gut activity:
(7) U - normal, or not discemibly abnormal. V - distinctly increased.
Proportion of lice with ruptured guts at death:
(8) W - same as control X - greater than control.
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During initial insecticidal activity studies, it was quite obvious that lice exposed to different 
monoterpenoids behaved differently and it was speculated whether such diverse effects 
might reflect different modes of action. However, breaking down the overall physiological 
effect into defined symptoms, so that compounds could be classified on the basis of the 
spectrum of symptoms they elicited, was not straightforward. General problems 
encountered included the limited duration of available observation period: many of the 
monoterpenoids rapidly incapacitated lice, so the time-frame in which the initial symptoms 
could be observed was often short and contained a rapid progression of overlapping 
physiological effects. Furthermore, although the response shown by the majority of lice 
was recorded, there was some evidence of symptom variability within individual dishes of 
insects; typically, one louse would behave differently from all the rest. In the case of subtle 
physiological effects, it can be difficult for the observer to decide that what is being 
observed is outside the range of normal behaviour. It should also be considered that certain 
responses to monoterpenoids may not be physiological indicators of a certain mechanism 
of action but merely general symptoms of distress, which wiU complicate mechanistic 
analyses.
Although the main purpose of using this observational method is to ascertain information 
on the biological effects of monoterpenoids on lice, with the expectation that compounds 
eliciting the same symptoms may have identical or related modes of action, it can only be 
speculated as to what the biological targets are; effects occurring at the level of the insect 
may not be directly related to the mechanism by which progression to death is elicited.
The symptoms of monoterpenoid toxicity, and discussion of the chosen parameters
In this study, the terpenoids camphor, carvacrol, citral, linalyl acetate, menthone and 
thymol cause the lice to congregate around the edge of the dish during the initial period of 
exposure, probably because the insects were repelled by these test substances and could 
presumably sense fresh air entering the dish at the perimeter. Repellent activity of 
terpenoids is not necessarily related to toxicity, and is probably more effectively observed 
at a concentration which is sub-lethal (perhaps LD5_2o), or at least which does not 
incapacitate the lice immediately, so directional movement is allowed. The apparatus should 
also be modified so that the lice are able to escape the test environment, then the 
parameter could be assessed quantitatively, i.e. the number moving to the terpenoid-free 
environment over time would be related to the degree of repeUency of the compound.
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Distinguishing different types of movement in response to terpenoids was of partial 
success in this study: it was envisaged that a compound with a neuronal mechanism of 
action may either be stimulatory or inhibitory in nature, and therefore either increase or 
decrease louse activity respectively. Observing rapid immobilisation of lice is 
straightforward, as this behaviour starkly contrasts with the constant activity of control lice. 
Estimating the number of Hce that were hyperactive was not so simple: Many terpenoids 
induced some form of mal-coordination, such as walking in a ‘staggering’ fashion and 
inabiHty of Hce to right themselves. In this case the nature of the movements was so 
different from control Hce that it was difficult to decide if the speed of those movements 
was faster or slower. Furthermore, effects such as mal-coordination or jerky movements of 
Hmbs varied between compounds, being subtle for some terpenoids, but more exaggerated 
for others; whether these were different degrees of the same response, as caused by 
differentiaUy potent compounds, or completely distinct effects could not be ascertained. 
Another compHcation was that sometimes Hce appeared to show more than one type of 
movement in a category, for example, both twitching and flaiHng Hmbs might be seen at 
different times in response to the same terpenoid, making scoring difficult, or impossible in 
the case of thujone.
The effect of terpenoids on gut activity was also not clear-cut, mainly because gut motiHty 
of control Hce could be quite erratic. A more satisfactory parameter was the proportion of 
Hce with a burst gut, as this feature was very distinctive (the abdomen turning bright red), 
and rare in control Hce. However, it was not possible to score for the presence of ruptured 
guts in ‘shriveUed’ Hce, as their abdomens became very smaU and dark coloured.
The results obtained thus far suggest that different terpenoids eHcit different responses in 
Hce. With the current methodology, some of these parameters are more reHable than others 
for describing the differences in physiology observed. An assessment of the most 
distinctive effects of terpenoids on louse physiology, as seen in this study, reveals that there 
are at least three bioactivity groups:
Certain terpenoids appear to cause a profound shriveUing effect in Hce (see Table 2.4); 
although other terpenoids appeared to influence abdomen volume, either resulting in 
bloating or loss of turgidity, these states were less easy to distinguish from the variation in 
control Hce because variation in both control and test groups meant a degree of overlap. 
ShriveUed Hce were the major type found in the camphor, cineole and menthone- 
containing dishes. It has been suggested before that monoterpenoids, such as those present
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in Suleo-M (a formulation containing malathion and terpenoidal fragrance compounds), 
might affect the water balance of lice [52]. It is conceivable that a large increase in the rate 
at which the louse loses moisture, for example, by alterations in metabolism, cuticle 
permeability or the properties of water-balance mechanisms, such as diuretic hormone 
secretion, could result in this profound dessicatory activity. Furthermore, other symptoms 
induced by these compounds were similar (see Table 2.4) and aU three induced highly 
exaggerated writhing with death occurring a relatively long time after the symptoms first 
appeared. A characteristic curling limb movement was also noted and, although this may be 
a direct effect of the compounds in question, it could be a secondary effect; perhaps 
dehydration of insect tissue surrounded by rigid exoskeleton may have resulted in distorted 
appendage movement, due to loss of internal hydrostatic pressure.
Another, particularly marked effect was rapid immobilisation: Many compounds, such as 
the alcohols, geraniol, linalool and menthol, induced a period of mal-coordinated activity in 
lice before locomotion slowed and eventually stopped. Thymol, carvacrol, linalool, carveol, 
a-terpineol, pulegone and (-)-terpinen-4-ol, however, appeared to induce a sudden decrease 
in voluntary locomotory activity, although in most cases the lice remained aHve for some 
time, as touching with forceps was prone to eHcit movement. The two immobiHsing 
compounds that were most similar in terms of their other physiological effects were thymol 
and carvacrol, the two phenoHcs. SwoUen abdomens and burst guts were characteristic of 
Hce exposed to these compounds.
The remainder of the compounds showed neither rapid immobiHsation nor shriveUing 
effects, although other interesting physiological effects were noted. Some of these, such as 
mal-coordination and twitching, were reminiscent of the previously reported effects of 
neuroactive insecticides, such as pyrethroids. There were differences in the symptoms 
induced by these mono terpenoids, but the assay requires further development to clearly 
distinguish other bioactivity groups.
Suggested revisions to the observational assay
The observational study could prove to be even more informative with further 
development. For example, the scoring system could be revised to aUow changes in 
symptoms over time to be compared. The symptoms assayed could also be expanded, for 
example, Hce exposed to a-thujone were often seen to expel gut contents at a far more 
rapid rate than other Hce, and also female Hce appeared to be more afflicted by thujone
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than males, these effects were not anticipated in the first study. The study could also be 
made more quantitative by scoring for traits at the level of the individual louse, and the 
data summarised. Because of the small size of lice it will probably be wise to only attempt 
to score discontinuous data, i.e. the presence or absence of a trait, rather than its degree or 
severity. Categorisation of the symptoms induced in lice could be further aided by 
observation of the effects of standard insecticides, or other noxious chemicals with 
identified biological targets, for comparison. It may also prove useful to observe these 
effects in larger insects first. To distinguish between specific physiological effects and 
general signs of distress, perhaps a non-specific, or non-neuronally active control such as a 
dip in olive oil or kerosene, could be included for comparison.
The observation of lice movement and other physiological events would be facilitated if an 
equipotent concentration of each terpenoid was used, for example, LC30, ensuring that this 
was low enough to observe symptoms over a period of at least 1 h, before death occurred. 
This would hopefully reduce differences in the ferocity of effects due to differential 
potency of the compounds.
Electron microscopy has often been utilised to aid the examination of louse structure. This 
technique might be useful to confirm changes in gross morphology of the louse cuticle, 
such as the surface texture, caused by deleterious substances. However, this technique 
should be approached with caution. Although invaluable for its ability to resolve fine 
structure, the preparation of specimens for electron microscopy is prone to producing a 
range of visual artefacts [194] and the surfaces viewed by scanning electron microscopy are 
particularly liable to become distorted during this process if their shape is dependent on 
hydrostatic pressure. Because lice have soft distensible abdomens designed to fill with 
blood, their shape may be even less faithfully reproduced by this technique than that of 
other insects. Consultation with an insect-imaging expert would be wise before this 
technique is used in observational studies of pediculicide action, and multiple replicates of 
control and treated insects should be analysed.
In the future, further investigation is needed into how pediculicide action at the molecular 
level translates into the physiological response at the level of the whole louse. Although the 
use of standard insecticidal compounds with pre-determined mechanism(s) of action may 
be informative in this respect, there are likely to be some novel effects of monoterpenoids 
or other essential oil constituents for which previously identified equivalents cannot be 
found.
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2.2.5 Ovlcldal Activity 
Ovlcldal activity of monoterpenoids
The results obtained in this study suggest that monoterpenoids show vast differences in 
potency towards P. humanus eggs. The method employed to evaluate lethality served a dual 
purpose in that it also provided information regarding the mechanism of action of the 
ovicidal substance. The following discussion will examine the results obtained so far, and 
also propose improvements to increase efficiency in the future.
The potential of monoterpenoids as ovlcldal agents
The method for determining ovicidal activity described in section 2.1.6 was used to assess a 
selected array of essential oil constituents. A preliminary screen at 10 % w /v (solids) or v /v  
(liquids) allowed the test agents to be classified into two groups, one high activity, where 
the total mortality was 82 % or above, one low activity, giving mortalities of 34 % and 
below. As there was a clear demarcation between the high activity and the low activity 
group i.e. none of the compounds gave a (mean) mortality result in the 35 % to 81 % 
range, the number of replicates were kept to a minimum (n =1-3, see Figure 2.3 (a)) which 
was important as the supply of eggs was limited. However, the low number of replicates 
means that these results should only be used as preliminary findings; they cannot be 
analysed statistically.
The compounds from the high activity group were then screened at 5 %, in addition to one 
other agent, geraniol (See Figure 2.3 (b)). To increase the accuracy of the mean percentage 
mortality estimate at this concentration, the number of replicates was increased so that n = 
2-5. From this screen, 6 test agents with the highest mean mortalities of 89 % and above 
were selected for testing at two lower concentrations, those rejected gave mean mortalities 
of 70 % and below. The selected agents were then tested at 2 % and 1 % w /v or v /v  (See 
Figure 2.3 (c) and (d)).
The data in Figure 2.3 suggest that there are some similarities between the results obtained 
for toxicity against louse adults and eggs: mono-oxygenated monocyclic terpenoids 
performed relatively weU in the preliminary ovicidal screen at 10 %, whereas there was 
either no activity (cineole, a-pinene, a-terpinene) or low activity (Umonene, menth-6-ene- 
2,8-diol, (3-pinene) from the non O-containing terpenoids, the mono-oxygenated bicyclic
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terpenoid or the monocyclic terpenoid with 2 O-containing functional groups. Linalyl 
acetate again showed low activity in comparison to the alcohols. Notable differences 
between the results of the pediculicidal and ovicidal assays include high activities from 
citronellic acid and nerolidol in the ovicidal assay, which were completely inactive in the 
pediculicidal study, and also lack of activity of the relatively highly pediculicidal menthone. 
At present these are only preliminary observations, as the data for terpenoids at 10 % 
suffers from insufficient replication and high control mortality. At 5 %, lower control 
mortalities, most likely resulting from various attempts to decrease fluctuations in the 
incubation environment, were attained and the data for citronellic acid, linalool, menthol 
and (-)-terpinen-4-ol contained sufficient replicates where the control mortality was 20 % 
or less to be suitable for statistical analysis. Despite large differences in mean mortality for 
these compounds, when the data was transformed and analysed by one-way ANOVA, 
followed by a Tukey post-test, no difference in the mean percentage mortalities were found 
for these compounds. In the light of the large s.e.m.s found for this data, it would seem 
appropriate to perform further replicates in an attempt to decrease the variance and to 
subject the data to a further ANOVA before concluding that there is no difference in % 
mortalities of these compounds at 5 %. For comparison, a non-parametric t-test, Welch’s t- 
test, was performed on each untransformed pair of data sets. At the p=0.05 level, a 
significant difference was found between the mean % mortality results for linalool and 
menthol, tested at 5 %. Although analysis of more than two treatments by multiple t-tests 
rather than ANOVA is not recommended, these results may indicate that the equation 
used to transform the data to make it suitable for the parametric one-way ANOVA test 
was not entirely successful; if further replicates are obtained, the distribution of the 
variances before and after transformation could be examined to confirm the suitability of 
the chosen corrective equation.
Statistical treatment of the results at 1 % by transformation, followed by ANOVA and 
Tukey post-test, appeared to be more successful. This test revealed significant differences 
(at p = 0.05 level) between the mean % mortalities of certain pairs of compounds; nerolidol 
and menthol/carveol/a-terpineol; geraniol and menthol/a-terpineol; thymol and 
menthol/a-terpineol, and these results agree with the graphical representation of the data 
in Figure 2.3.
Considering primarily the results of this ANOVA, and secondarily the graphed results 
(mean and s.e.m.) in Figure 2.3, a ranking for monoterpenoid lethality towards V.humanus 
eggs was produced, with the compounds being grouped according to the mean and
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standard error of the resulting mortalities. Nerolidol, thymol and geraniol were the most 
effective ovicidal terpenoids in this screen. This data, from aU the concentrations tested, 
was used to construct a ranking table of preliminary structure-activity relations; different 
groups having performed differentially at the various concentrations tested.
The ranking is as follows, with groups 1-4 listed in order of decreasing ovicidal potency. 
Top ranking compounds are shown next to mean percentage mortality ± one s.e.m when 
tested at 1 % w /v  or v /v  :
1 - nerolidol, 85 ± 13 %
2 - thymol, 59 ± 20 % geraniol, 56 ± 12 %
3 - carveol, 25 ± 14 %
4 - menthol, 2.6 ± 2.6 %, a-terpineol, 1 ± 1 %.
On the basis of the preliminary screen at 10 %, the following test compounds have 
tentatively been assigned joint 5^ and joint 6* rankings, however, at present there are 
insufficient replicates to confirm these positions:
5- citral, citronellic acid, linalool, (+)-terpinen-4-ol, (-)-terpinen-4-ol.
6- cineole, a-pinene, a-terpinene, limonene, menth-6-ene-2,8-diol, p-pinene, linalyl acetate, 
menthone.
The evidence for the relative positions of the top 6 compounds is more firm than for the 
remainder, and these results alone show that there are differences between the structure- 
activity relations of monoterpenoids on louse adults and eggs, using the methods described 
in this study. For example, some straight chain structures such as nerolidol and geraniol 
have equal or higher ovicidal activity than cyclics or phenolics, whereas they have 
comparatively low pediculicidal activity. Furthermore the top ranking compounds are two
tertiary alcohols, one secondary alcohol and one primary alcohol and two phenolics, if
metabolic protection from toxicity via oxidation is a determinant in monoterpenoid 
activity, it may be that it is less active in the embryo.
The louse egg cuticle is hydrophobic and almost impenetrable, gaseous exchange can only 
occur via the small group of aeropyles in the operculum. Insecticides entering via these 
pores require careful formulation to do so: the narrow entrance to the pore creates surface 
tension to prevent penetration of aqueous solutions, and the hydrophilic inner structure of 
the pore lining hinders absorption of organic solvent; the physicochemical properties of 
insecticides are therefore of the utmost importance. It may be speculated that surface
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tension-lowering ability is the reason why geraniol and nerolidol perform better in the 
ovicidal assay than the pediculicidal assay; they may be acting as weak surfactants by the 
virtue of a single —OH molecule at or near one end of a long aliphatic portion, and 
therefore may be able to penetrate the pores more effectively. As the phenolics are less 
likely to have this property, it could be considered whether their route of entry is actually 
different from that of the straight chain alcohols; perhaps as they are more hydrophobic, 
small, flat molecules, they may be able to cross the shell cuticle. Further analysis of 
structure-activity relationships is clearly required, but it may reveal that there are, in fact, 
two groups of ovicidaUy-active monoterpenoids with different routes of entry.
Regarding the differential ranking between the pediculicidal and ovicidal assays, one 
consideration is that it may perhaps have been the result of the differences in methodology 
between the two tests. In the pediculicidal test, the lice effectively did not contact ethanol 
because it was evaporated before they were placed in contact with the test papers, the eggs 
were exposed to it for 10 min. Although ethanol alone does not significantly affect 
hatching when only applied for 10 min, it may be that the presence of certain 
monoterpenoids, which are used in some drug formulations to improve penetration of the 
active components through membranous barriers, may actually be enabling ethanol to enter 
the egg. Alternatively, ethanol may be enhancing the activity of particular monoterpenoids 
over others. In future tests where comparisons of pediculicidal and ovicidal activity are 
required, the methodologies should be modified such that the vehicle, mode of application, 
and all other associated procedures are as similar as possible.
The results obtained here agree with the results of Veal g/a/[256], who showed that the 
relative proportions of oxygenated compounds and hydrocarbons in an essential oil were 
crucial to determining ovicidal activity in vitro. Rosemary and pine were the only oils not to 
cause any ovicidal mortality when tested individually [256]; rosemary contains primarily 
hydrocarbons and bicyclic monoterpenoids, and both types of compound were ranked in 
the least ovicidal group in this study; the composition of pine oil depends on the species, 
but hydrocarbons are sometimes the primary constituents [79]. The Veal et al study also 
provides further proof that the terpenoid components of ‘Suleo’ insecticides are 
responsible for their high ovicidal activities, as the constituent terpineol was among the 
most ovicidal in this test, and limonene also appeared to show moderate activity.
This study indicates the potential for some monoterpenoids to be included in formulations 
as ovicidal agents. Provided that the environmental conditions remain favourable, viable
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louse eggs are very resilient entities in terms of their ability to withstand exposure to 
chemicals; some preliminary studies with ethanol revealed that the mortality rate was not 
greatly affected by incubations in ethanol of up to 2 hours. Conversely, some 
monoterpenoids with a similar structure to ethanol in that they are small, O-containing 
volatile agents, are highly active against eggs in a very short space of time. The results of 
this work show that a 2 % solution of thymol could achieve a near 100 % kill in 10 min, 
and preliminary studies suggest that a 10 % solution can achieve 100 % mortality with just 
a 10 sec incubation time. It has not yet been determined whether these short application 
times will be as successful in vivo and clinical studies will therefore be necessary. Although 
these concentrations of terpenoids are quite high for therapeutic agents, provided that the 
safety margins are sufficient, topical application of an insecticidal substance at 1 — 10 % 
may be feasible. Any necessary reduction in concentration could probably be rectified by 
extending the application time; the current recommendation for most pediculicidal 
products sold in the U.K. is to leave them on for 12 h, therefore exposure times for 
essential oil constituents longer than 10 min may be permissible.
Developing a strategy for assessing ovlcldal activity
Unlike other biochemical assays or knock-down lethality assays on adult insects, assessment 
of ovicidal activity towards P. humanus eggs is inherentiy slow, as it takes around 2 weeks 
for them to hatch. With the added complication of a variable natural mortality rate, making 
it necessary to discard some of the batches if the 20 % threshold for control mortality is to 
be adhered to, assessment of ovicidal activity is consequently a very low-throughput 
screening process. It is therefore especially important in this case to devise two different 
strategies for assessing the ovicidal potential of a chemical; a quick ‘look-see’ test could be 
implicated to ascertain that the compound is active above a certain threshold for 
preliminary work or bioassay-guided fractionation work. A lengthy screen, involving a 
greater number of eggs, multiple replicates, and strict rejection where the control mortality 
is greater than 20 %, could be employed for work of publication standard, and fuU dose- 
response and/or time-action data of this nature could be considered for particularly active 
compounds. If percent mortality alone is to be assessed accurately in a batch of eggs, rather 
than the percentage contributions of all possible stages at which death did or did not occur, 
the number of eggs could be reduced (possibly to 50-100) which would also make better 
use of time and resources. Mechanistic studies could then be reserved for the most active 
compounds.
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By analogy with the discussion of pedicuiicidal activity testing, the next phase of the in vitro 
work on ovicidal monoterpenoids should examine the effects of different formulations and 
methods of application, for example, the hair would normally be washed within 1-2 days of 
the product being applied. Similarly, the effects of monoterpenoids with and without 
washing of eggs with mild shampoo and rinsing after application could be studied.
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Figure 2.3 Ovicidal activity of monoterpenoids towards eggs of the human louse,
Pediculus humanus, Part I
Eggs were immersed in (a) 10 % and (b) 5 % solutions of the test agents for 10 min. The solvent was then 
evaporated and the eggs incubated. The percentage of eggs which did not hatch to give rise to viable 
nymphs (% mortality) was calculated as a percentage of the total number o f eggs in the test. The % 
mortality data shown here have been adjusted for control mortality utilising A bbott’s correction (see text). 
The number o f replicates (n) for each test is shown alongside the number o f these replicates where the 
control mortality was less than 20 % (n*), control mortalities for all other replicates were more than 50 %.
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Figure 2.3 Ovicidal Activity of monoterpenoids towards eggs of the human louse,
Pediculus humanus, Part II
Eggs were immersed in (c) 2 % and (d) 1 % solutions o f the test agents for 10 min. The solvent was then 
evaporated and the eggs incubated. The percentage mortality was calculated and adjusted as described in 
Figure 2.3, Part I. The number o f replicates (n) for each test is shown. The number o f these replicates 
where the control mortality was less than 20 % is indicated (n*), all other replicates had control 
mortalities o f 20-22 %.
1 0 2
Modes of action of essential oil constituents on louse eggs
The data above compares the monoterpenoids on the basis of percent mortality, i.e. the 
total number of eggs rendered non-viable by the monoterpenoid. By observing the 
different stages at which each embryo was killed, MEC Ltd has studied the mode of action 
of compounds on louse eggs [52]: A lethal agent not dependent on a fully functional 
nervous system for ovicidal activity is able to kill eggs early on, at the ‘undeveloped’ stage 
(although observing lethality predominantly of the undeveloped nature does not preclude 
dual neuronal and non-neuronal activity). The presence of a correctly positioned black 
eyespot in the dead embryo is indicative of a stage of development that also features a fully 
functional nervous system; ‘developed’ eggs are therefore likely to have been arrested at 
this stage by specifically neuroactive compounds, as they were not able to kül the egg 
without the presence of a nervous system to mediate toxicity. Compounds resulting in 
‘half-hatched’ eggs may have Idlled the nymphs via either a neuronal or a non-neuronal 
mechanism, but either way lethality did not occur until the nymph began to hatch; these 
compounds are generally lethal to lice and highly persistent, but are not able to penetrate 
the unperforated eggshell, and therefore act residually; when the louse breaks the 
operculum open upon hatching, residually-acting compounds are allowed to enter and thus 
kill the insect, approximately 2 weeks after their application to the egg. This activity can be 
confused with true ovicidal activity in clinical studies, due to the subsequent absence of live 
nymphs on the scalp. It should be noted that in the mortality studies of the previous 
section, eggs of the half-hatched type were included in the overall percent mortality. This 
would have had little impact on the outcome in this case as the number of half-hatched 
eggs resulting from monoterpenoid application was minimal (the mean percentage of half­
hatched eggs resulting from monoterpenoid application was never more than 5 % above 
the mean control percent half-hatched). Future ovicidal studies should perhaps consider 
the merit of counting half-hatched eggs as ‘hatched,’ depending on the objectives of the 
test.
Although hatched, half-hatched, developed and undeveloped data were obtained in all 
ovicidal activity experiments, only a selection of this data is presented in Figure 2.4; the 
criteria for inclusion was the availability of at least two replicates per test compound with 
corresponding control mortality values of 22 % mortality or less. Because of the low 
number of replicates, the following discussion of the data should be treated as preliminary 
observations only.
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The data presented in Figure 2.4 suggest that monoterpenoids may not always kill eggs by 
the same mechanism; the stage at which the eggs are arrested in development by a 
particular compound may be concentration-dependent: carveol, geraniol and thymol at 5 % 
all leave eggs 98-100% ‘undeveloped.’ At 2 %, as the percentage of eggs in the undeveloped 
category decreases, instead of a concomitant increase in the ‘hatched’ category as might be 
expected, there is a large increase in the proportion in the ‘dead’ category; the increase in 
‘hatched’ eggs is largely delayed until the concentration is decreased to 1 %. The effects of 
nerolidol appear to differ in that at 5% the predominant category is ‘dead’ and the 
proportion of undeveloped eggs is increased at 2 %. In fact. Figure 2.4 suggests that both 
neuronally-dependent and non-neuronally dependent mechanisms of death can occur as a 
result of application of many monoterpenoids, at particular concentrations. Furthermore, 
the relative frequency of mortality types in the ethanol-treated control group was the same 
as that of the control, again providing evidence that incubation in 100 % ethanol for short 
periods has no effect on louse eggs.
The data in Figure 2.4 suggest that most monoterpenoids do not generally give rise to ‘half­
hatched’ lice, indicating a lack of residual activity of these essential oil constituents. Only 
two, citronellic acid 5 % and thymol 1 % raise the percent half-hatched above the minimal 
0-6 % normally seen, giving 13 % and 7 % respectively. Because of their volatile nature, it 
is likely that most monoterpenoids wiU not persist long enough at sufficient concentration 
to have a residual effect.
Although currently more data is required to confirm these findings statistically, the trends 
illustrated in Figure 2.4 may have important consequences in terms of the use of 
mono terpenoids as ovicidal agents. For example, the data obtained for thymol suggest that 
lowering the concentration from 5 % to 2 % causes an 25 % decrease in the undeveloped 
category, presumably as the more resilient eggs resist the non-neuronaUy dependent action; 
instead of these eggs escaping to hatch, aU except 2 % are then killed at the ‘developed’ 
stage, probably by a neuronally-dependent mechanism of action. If thymol was applied as 
an ovicidal agent such that initially aU eggs were left at the undeveloped stage, the presence 
of another mode of action may prevent the compound losing efficacy in certain types of 
resistance, such as decreased target site sensitivity. However, this ‘back-up’ mode of action 
would probably not be beneficial in types of resistance such as those involving reduced 
entry of the active. The lack of residual action, even when the eggs and substrate are not 
washed after application, would also contribute to resistance avoidance.
104
Even if the data obtained are more complex than perhaps anticipated, it has revealed that 
the ovicidal activities o f at least several o f the test substances may be highly dependent on 
an activity at neurones in the developing embryo, especially those o f citral and nerolidol 
(see Figure 2.4). Although this lends weight to the theory that m onoterpenoids can affect 
neurotransmission in a lethal manner, it appears unlikely that a single target can account for 
the observed dual effect.
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Figure 2.4 (a) Mechanisms of action of ovicidal monoterpenoids on Pediculus humanus
eggs
This data is continued in Figure 2.4 (b) and (c). Eggs were dipped in 10 % solutions o f test agents for 10 
min and then ineubated following solvent evaporation. When the control lice had hatched, the stage at 
which mortality occurred was assessed in all eggs. The test agent results have not been adjusted for 
corresponding control mortalities and, instead, typical control results are included for comparison in 
Figure 2.4 (c). Corresponding control mortalities were all 20 % or less for this data, except for those 
marked ' where one replieate had a control mortality o f 22%.
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Figure 2.4 (b) Mechanisms of action of ovicidal monoterpenoids on Pediculus humanus
eggs
Refer to Figure 2.4 (a) for details
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Figure 2.4 (c) Mechanisms of action of ovicidal monoterpenoids on Pediculus humanus
eggs
Refer to figure 2.4 (a) for details
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improvements to the strategy for assessing ovicidal mechanism of action
This assay, like the pedicuiicidal observational assay described previously in this Chapter, is 
another example of how a primary screen for lethality can be extended to gain additional 
information about the mode of action of a compound with carefully planned extensions to 
the protocol.
Whereas the observational data gained on lice described the manner in which different 
monoterpenoids appeared to have different modes of action, the results obtained in this 
study so far suggest that one monoterpenoid can have multiple lethal mechanisms of action 
on the same organism, the predominant one observed depending on the concentration. If 
monoterpenoids have multiple targets in lice it is perhaps not surprising that the behaviour 
of lice in the pedicuiicidal observational study was not easy to describe; the tremors and 
convulsions characteristic of neuroactive agents may have been masked by the symptoms 
arising from other biological effects.
This observation underlies the importance of standardising the doses applied in both 
pedicuiicidal and ovicidal mechanistic studies, and testing multiple concentrations. When 
ovicidal activity dose-response curves have been carried out for active terpenoids, 
mechanistic studies could then be carried out using a few, equipotent concentrations, for 
example, L D 3 0 ,  L D 5 0 ,  L D 7 0  & L D 9 5 .  This would facilitate structure activity comparisons as, 
by removing the influence of potency from the mechanistic studies, compounds with a 
similar mode of action (but different potencies) would hopefully be easier to distinguish, 
thus facilitating the definition of multiple structure activity series.
2.2.4 The action of essential oils on house dust mites
The most effective acaricidal essential oil in these tests was tea tree oü, as shown in Figure 
2.5; it gave 100 % (0) immobility at 30 min and 100 % (0) mortality at 2h. Lavender oil was 
second most effective, taking into account both immobilisation and mortality data; it 
caused 87 % (± 3) immobility at 30 min and 87 % (± 3) mortality at 2 h. Lemon oil was 
least acaricidal, with 63 % (± 9) immobility at 30 min and 80 % (± 12) mortality at 2 h. 
None of the control group were affected. All of the results above are the mean of three 
observations with ± one s.e.m shown in brackets. Only the mites remaining on the paper 
were scored, as there were some, particularly in the control group, which escaped from the
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filter paper thereby terminating their contact with the test agent. The mites available for 
counting at the 30 min and 2 h time-points were generally all immobilised or dead, 
respectively, except in the control group (see Figure 2.5)
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Figure 2.5 The effects of essential oils on the house dust mite, Dermatophagoides
pteronyssinus
Essential oils were used at 10 % v/v to impregnate filter papers, and the solvent (absolute ethanol) 
evaporated. Mites were placed on the papers and their escape routes limited. Mobility and mortality were 
assessed over time. Results are shown as the mean of 3 observations, with the s.e.m as enor bars.
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The house dust mite as a model organism for pedlcullclde bloassay
The results obtained in the pilot study to determine the effects of essential oils on house 
dust mites are suggestive of a correlation between insecticidal activity on lice and mites, as 
the rank order of activity for the three essential oils studied on D. pteronyssinus (tea tree, 
lavender and lemon oil) was the same as that found on lice. For this reason, and the fact 
that they reproduced highly successfully in vitro with the use of minimal resources, D. 
pteronyssinus showed potential as suitable model with which to screen for pedicuiicidal 
agents. The disadvantages of using them are their minute size, their incredibly high mobility 
and their translucency: The ‘mite-chamber’ was developed in this project with the aim of 
finding the most suitable apparatus with which to study small numbers of these acari, 
however, the problems of mites escaping from the test paper (which occurs via the thin 
wires holding the paper up) or being thrown off by movement of the apparatus could not 
be overcome. Handling the mites was also challenging; loading a test paper with 10 acari 
could take up to 20 min.
Perhaps the methods used in this thesis could be applied in other studies of D. pteronyssinus'. 
the culture system developed by MEC Ltd is superior to many alternatives [see for example 
131] in that it utilises substrates which are both hygienic and readily available. Furthermore, 
the mite-chambers developed here may prove useful in studying the behaviour of isolated 
mites; their dimensions allow them to be placed on to the stage of a light microscope, and 
can be inverted to foUow the mites as they move around. The filter paper provides enough 
traction for them to cling to, and the bright white colour enhances the visibility of the 
creamy-brown mites. Because the filter paper with mites on is fixed inside a tube, the 
observer’s hands are free to focus the microscope or move the mites with a brush.
The results obtained in this study indicate that the presence of mites on the test paper after 
a certain length of time is a good indicator of more acaricidal compounds, the test could 
therefore be used as a quick preliminary screen for activity, for example, in the bioassay- 
guided fractionation of plant extracts such as essential oils. If  escape of mites via the 
supporting wires could be prevented this would enhance the accuracy of the test.
Acaricides have been shown to reduce allergen levels and clinical symptoms of house dust 
mite allergy when teamed with household cleansing regimes but, although both allergy to 
the house dust mite and mortality due to asthma are rising [83,154], none of the presently 
available acaricidal formulations are widely used, probably for reasons of cost, low efficacy, 
and consumer fears over potential adverse effects on humans, pets or furnishings. Some
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natural products have previously been investigated for activity towards house dust mites, 
and tea tree oil was reported to be effective when added to laundry [131]. The utility of 
essential oils and their constituents as anti-dust mite agents around the home is debateable, 
as their volatile nature may aggravate the respiratory conditions they would be designed to 
help alleviate. Further investigation is clearly required.
Even though D. pteronyssinus are particularly easy to culture, they are very difficult to handle 
and observe. Although these preliminary tests suggest there may be a correlation between 
pedicuiicidal activity and acaricidal activity, if an alternative to the Orlando strain louse is 
required it may be best to consider another organism, perhaps a larger mite species, before 
working with D. pteronyssinus.
Summary and direction
Thus far, the activities of a range of monoterpenoid constituents of essential oils have been 
confirmed on P. humanus adults. Some of these compounds also appear to be highly active 
against louse eggs. The evidence so far suggests that the rank order of volatile terpenoid 
activity on P. humanus ova may differ from that on adult insects, however, at this stage, the 
possibility that using a different application method in the ovicidal activity test influenced 
the order of potency cannot be ruled out.
Observation of lice and eggs during experimentation revealed that, upon exposure to 
certain monoterpenoids, physiological symptoms result which are reminiscent of those 
induced by neurotoxic pesticides. Past literature has identified mammalian GABA 
receptors as targets for several monoterpenoids; Chapter 3 of this thesis wiU investigate if 
pedicuiicidal and ovicidal terpenoids can influence the activity of insect GABA receptors, 
using a well established in vitro model.
I l l
Chapter 3 
Investigating the effects of monoterpenoids on gaba- 
mediated neurotransmission in insects
3.1 The use of a model insect caba receptor as a starting point for 
mechanistic study
Although there are some insect-lethal compounds with non-neuronal sites of action [79], 
the majority of current commercially successful insecticides act on targets in the nervous 
system, including acetylcholinesterase (AChE), nicotinic acetylcholine receptors (nAChR), 
Na"^  channels and GABARs [29,182].
The results presented in Chapter 2 of this thesis indicate that at least some monoterpenoids 
may act on neuronal targets in lice: The most effective pedicuiicidal monoterpenoids 
caused rapid incapacitation of adult insects. Behavioural studies also suggested that 
monoterpenoids could induce variable degrees of ataxia, malco-ordination, sudden loss of 
locomotion, or twitching; furthermore preliminary evidence suggests that some 
monoterpenoids at certain concentrations may cause substantial mortality in embryos in 
the later stages of development, when functional nervous systems are present, and not 
before.
Methods for studying a putative mechanism of action might include observing the 
distribution of terpenoid binding sites in insect tissue with a radio-labelled ligand, or 
terpenoid binding to isolated potential targets such as enzymes or receptors. 
Monoterpenoids are generally lipophilic and therefore high levels of non-specific binding 
to cell membranes may hinder labelling studies. For this reason, pharmacological 
investigation of their activity at isolated insect tissues, enzymes or receptors may prove 
more fruitful than binding studies. As many insecticides affect the activity of ligand-gated 
ion channels, a member of this proteinaceous receptor superfamily would provide an ideal 
candidate for a putative monoterpenoid pharmacological target.
The study of compounds active at ligand-gated ion channels, like picrotoxinin (see Chapter 
1), has been greatly facilitated by electrophysiology. Electrophysiological techniques can be
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used to explore the fine details of neuronal ionotropic receptor pharmacology either in situ 
or when cloned and heterologously expressed; the activity of ion channel populations in 
cells and tissues can be monitored, or just the behaviour of single channels.
The insect GABA receptor model chosen by the SatteUe Laboratory to study insect 
GABAR-picrotoxinin interactions was employed in this investigation. This model, the 
RDL,g homomeric insect GABAR, has been proven to be suitable for the study of insect 
GABARs, as it faithfully reproduces several aspects of the pharmacology of the most 
frequendy encountered native insect ionotropic GABARs: In Chapter 1 of this thesis, the 
pharmacologies of GABA^  ^receptors, native insect GABARs and RDL homomers were 
compared; from this account it is clear that RDL homomers possess similar properties to 
the majority of insect receptors in terms of the agonist, antagonist and modulator profiles. 
The pharmacology of RDL homomers and most native insect receptors differs principally 
with respect to benzodiazepine sensitivity, which is interesting considering benzodiazepines 
appears to require both a  and y subunits for potency [237], whereas other modulators, 
such as pentobarbital, can potentiate certain homo-oligomeric GABA^ receptors [26 ]. This 
suggests that most native insect receptors may be hetero-oligomers, possibly consisting of a 
least one RDL-like polypeptide and one other subunit type.
Whether or not there are any native insect receptors that are homo-oligomers of RDL-like 
subunits is still not known: Single channel properties of heterologously expressed RDL 
homomers are reported to differ from those of GABARs on cultured, RDL-expressing 
Drosophila neurones [280,281], although the expression systems for these experiments were 
different, and this may have led to variations in post-translational modification or 
surrounding membrane chemistry [119].
The widespread occurrence of RDL-like subunits throughout insect nervous systems 
[12,103,221] and the fact that the A302S mutation has such radical consequences in terms 
of insecticide resistance in a number of species (described in Chapter 1), are other factors 
leading to the conclusion that RDL-like subunits are key determinants of insect 
GABAergic neurotransmission and pesticide action. The fact that RDL-like subunits exist 
in numerous insect species provides a rationale for investigating pedicuiicidal 
monoterpenoid activity on this Drosophila GABA receptor subunit; even though 
monoterpenoids can have different effects on different insects or insect stages, this is not 
necessarily due to interspecific differences at the target site level.
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5.2 The use of the xenopus laevis oocyte as an expression system for 
studying recombinant GABA receptors
Oocytes of Xenopus laevis, a large South African clawed toad, were first used in the 1970s 
for the expression of microinjected foreign polynucleotides. Since the first experiments by 
Barnard, Sumikawa and Miledi [19,171,244], the Xenopus oocyte has now become an 
established in vivo expression system for mRNA and cDNA encoding neurotransmitter 
receptors and ion channels. The features of these cells which make them such useful tools 
for this purpose include their enormous reserves of the components required for protein 
synthesis, and their large size and distinct polarity which enable reliable microinjection of 
nucleotides into either the nucleus or the cytoplasm and facilitate 2-electrode voltage-clamp 
electrophysiological studies. From injected polynucleotides, Xenopus oocytes synthesise 
neuronal receptor subunits, assemble the polypeptides and insert the resulting multi­
subunit receptor into the plasma membrane. Receptors expressed heterologously in 
Xenopus oocytes display the pharmacology and gating characteristics of those found in 
native tissue in the vast majority of cases; two isolated studies identified differences 
between the channel properties of certain nicotinic acetylcholine receptors (nAChRs) 
expressed in Xenopus oocytes and other cells [150,233], but no similar cases have been 
found for GABA receptors. The oocyte plasma membrane makes an ideal selective barrier 
such that the passage of ions through ligand-gated channels can be monitored by most 
electrophysiological methods. GABA receptor physiology/pharmacology was first studied 
by heterologous expression and electrophysiology in Xenopus oocytes by Miledi in 1982 
[172].
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3.3 Methods for RNA synthesis and In vitro expression of insect caba  
receptors
3.3.1 Molecular biology
Insect CABA receptor (RDLad subunit source, sub-cloning and vector Isolation
Wild-type Rdl^ c cDNA was a gift from Dr. Richard Roush (Cornell University, U.S.A), it 
had been inserted into the vector pNB40 [36] (See Figure 3.1). Dr. Emmanuel Culetto of 
the SatteUe laboratory at The MRC Functional Genetics Unit, Department of Human 
Anatomy and Genetics, University of Oxford, U.K used this plasmid to transform 
competent E. co/iDH5oL host ceUs. The plasmid was cloned and sub-cloned foUowing 
estabUshed methods [118]. These procedures aUowed repUcation of the vector and division 
of host ceUs to occur, in order to increase the plasmid copy number, thereby ensuring a 
high yield of RDL,,. upon ceU harvest. Dr. Culetto extracted the plasmid from E. coli using 
endotoxin-free maxi-prep kits (Qiagen, U.K.). Subsequent stages of RDL^  ^cDNA and 
cRNA synthesis were carried out by myself and are described later, they were adapted from 
the suggested protocols in the instruction booklet avaUable for the Ambion “mMessage 
mMachine” SP6 RNA synthesis kit.
Quantification and qualitative analysis of extracted plasmid DNA
A sample of the plasmid DNA extract was run on an analytical ethidium bromide (EtBr) 
tris-acetate-EDTA (TAE)-agarose gel to examine its purity and integrity, and to estimate 
the DNA concentration. A 1 % TAE-agarose gel was prepared, to which EtBr was added 
as an intercalating stain at a final concentration of 0.2 \kg/ml, and left to set. When 
polymerisation was complete, TAE was poured over to a level of 0.5 cm above the surface, 
to act as a running buffer.
A mixture of plasmid DNA, 2 pi, ultra-pure water (^HgO), 14 pi, and 10 x Orange G 
loading buffer, 4pl, was loaded onto the gel alongside a sample of 1 kb marker DNA, for 
later comparison, to estimate the plasmid concentration. Current was applied to mobilise 
the DNA and the resulting bands were viewed under U.V. light, which causes bound EtBr 
to fluoresce. The presence of one discrete band in the extract, corresponding to the 
plasmid DNA, was confirmed.
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The exact concentration of plasmid DNA in the extract was quantified 
spectrophotometrically by measuring the optical density (OD), or absorbance of light, of a 
diluted sample at a wavelength of 260 nm (Ag^ o). A single OD unit is given as ~log,o 
(intensity of transmitted light)/(intensity of incident light). An OD of 1 at Ag^ o corresponds 
to 50 pig of double-stranded DNA (dsDNA) per ml. To obtain an accurate value of the 
plasmid DNA concentration using this method, a minimum cuvette concentration of DNA 
of Ing/pil in ^HzO is recommended [75]. The amount of sample to add to the cuvette can 
therefore be gauged from the concentration of plasmid DNA estimated by TAE-agarose 
gel.
The ratio Aggg/Aggo was also calculated. Pure samples of DNA have Ag^ g/Aggg ratios of 1.8 
and, as proteins absorb light with a wavelength of 280 nm, values of less than 1.8 indicate 
that the sample is contaminated by protein or phenol and should not be used.
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Figure 3.1 Plasmid pNB40, the transcription vector
RDLac cDNA is cloned into the polylinker site. The first strand o f  each cDNA was tailed with 10-15 
cytosines, such that the second strand would be synthesised with a string o f  guanines at the 5' end, and the 
subsequent cRNA would bear the poly A tail characteristic o f  eukaryotic primary transcripts. The SP6  
and T7 promoters are start sites for the respective bacteriophage RNA polymerase enzymes. The 5' 
untranslated sequence between promoter and cDNA insert is from sequences upstream o f  the Xenopus 
laevis P-globin gene, and is intended to facilitate transcription o f  heterologous c D N A 'm. Xenopus oocytes. 
HinD III and Not I restriction endonuclease cleavage sites are also marked; Use o f  Not I prior to 
transcription linearises the plasmid, disconnects the T7 promoter from the insert, and provides a stop site 
for SP6  to synthesise a discrete transcript o f sense cRNA. The P-lactamase gene confers ampicillin 
resistance, allowing selection o f  transformed bacterial colonies during cDNA cloning. The remainder o f  
the sequences are derived from the bacterial plasmid Col E l.
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Preparation of linearised template dna
The extracted circular pNB40 plasmids were linearised, using the restriction endonuclease 
Not I, to provide an RNA polymerase stop site immediately after the RDL j^. gene. Cleaving 
the plasmid on the 3’ end of the insert ensures that only sense mRNA strands (with the 
same nucleotide sequence as that found in vivo) will be synthesised when the SP6 mRNA 
polymerase is added. Not I also cuts dsDNA in a staggered fashion leaving a 5’ overhang, 
this prevents non-specific transcription initiation, which can occur at 3’ protruding ends.
The restriction digest comprised 10 |xl lOx NEB3 buffer, 1 p,l lOOx bovine serum albumin 
(BSA), 10 jig of DNA and up to 95 p.1, to which 5 [xl of 10 U ptl'^  Not I were added 
(1 U of enzyme will cut 1 p,g of DNA in one hour given optimal ionic conditions, which 
are provided for here by NEB3). The tube was flicked to mix the contents and droplets of 
liquid brought down by brief centrifugation. The reaction was incubated at 37 °C for 2h. 
Prior to termination of the reaction by SDS (sodium dodecyl sulphate) and proteinase K, 
(described in the following section), a sample of the restriction digest was run on a TAE- 
agarose gel (as before) against a sample of the original plasmid DNA to check the progress 
of the linearisation. A digest which has run to completion will migrate as a discrete band 
and to a shorter distance than the non-digested plasmid. The full protocol for this gel is 
described in a later subsection, “Confirmation of linearisation and purification by gel 
electrophoresis and quantification by spectrophotometry.”
During the following procedures involving the synthesis and handling of RNA, all steps 
were taken to avoid contamination by RNases.
Purification of the linearised template
Before RNA synthesis can proceed, the DNA template must be purified to remove 
proteinaceous reagents used in previous stages, especially RNases. This is done by non­
specific dénaturation, precipitation and extraction of proteins by phenol/chloroform 
partition. These organic solvents precipitate proteins, leaving nucleic acids intact.
The protein dénaturant, SDS was added to the restriction reaction to give a final 
concentration of 0.5 %. Proteinase K was added at a final concentration of 100-200 |Xg/ml. 
This enzyme digests the denatured proteins leaving smaller polypeptide units, which 
require fewer phenol extractions to remove. The reaction was incubated for 1 h at 50 °C.
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After this time, the reaction volume was increased by 150 % by the addition of to 
ensure a large aqueous phase upon partition.
To a final volume from above of 250 fxl, 200 p,l of phenol/chlorofbrm/isoamylalcohol 
(lAA), 25:24:1, were added and the extraction vortexed for 5 s. Partition was completed by 
centrifugation at 12000 rpm for 5-10 min at 4 °C, as low temperature enhances phase 
separation. After centrifugation, three layers were apparent: a large upper aqueous phase, 
approx 300 p,l, containing the nucleic acids; a narrow interface, containing denatured 
proteins, and the lower phenol/chloroform phase. The aqueous phase was removed, 
avoiding contamination from the interface, and transferred to a new microfuge tube. The 
interface and lower phase were discarded.
Assuming the volume of the aqueous phase removed was 250 fxl, 50 p.1 of HgO and 200 |xl 
of chloroform were added. The tube was vortexed and centrifuged at 12000 rpm for 5-10 
min at 4 °C. This step removes final traces of polypeptides and also phenol, which 
partitions into the chloroform layer. The nucleic acid-containing supernatant was removed, 
again avoiding the organic layer, and transferred to a new microfuge tube. To a volume of 
supernatant of 200-250 p,l, 3 volumes of absolute ethanol and 1/10 volume of sodium 
acetate (3 M, pH 5.2) were added. The tube was inverted gendy to mix the contents and 
incubated at -20 °C for 1-18 h. Ethanol effectively precipitates polymeric nucleic acids at - 
20 °C or less in the presence of monovalent cations; precipitation allows concentration of 
the DNA by subsequent resuspension in a smaller volume.
The precipitated nucleic acids were pelleted by centrifugation at 13000 rpm for 30 min at 
4 °C and the colourless pellet washed carefully by addition of 100 [xl of 70 % ethanol in 
RNase-free water. Washing the peUet removes salts, which inhibit transcription enzymes. 
The tube was centrifuged at 4 °C for 5-10 min at 13000 rpm to re-peUet the nucleic acids. 
All visible traces of ethanol were removed with a drawn-out, glass Pasteur pipette. The 
pellet was air-dried for 2-3 min by leaving the microfuge tube in an RNase-free laboratory 
environment with the cap off.
For transcription, the DNA template should be at approximately 0.5 pg/|xl such that the 
resulting RNA is not too dilute for injection into the oocytes. The pellet, which was 
assumed to consist entirely of linearised pNB40, was re-suspended in 15-20 p-1 RNase-free 
water at room temperature for 15-20 min with the microfuge cap closed. The pNB40 
concentration was estimated by agarose-gel electrophoresis (below) and adjusted if
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necessary.
Confirmation of DNA template linearisation and purification by gel electrophoresis 
and quantification by spectrophotometry
The DNA template was examined for successful linearisation and purification by running 
the following samples on a TAE-agarose gel (prepared as before):
1 - Linearised and purified pNB40, 0.5|Xg; RNase-free water, 7p,l; and a volume of 2x 
running buffer (Ambion, U.K.) equal to the total volume of DNA plus water.
2 - Non-linearised pNB40, 0.5|Xg; RNase-free water, 7p,l; and a volume of 2x running 
buffer (Ambion, U.K.) equal to the total volume of DNA plus water.
3 - Marker DNA to enable the estimation of the linearised pNB40 concentration in sample
i)-
The exact concentration of the linearised template and proteinaceous contamination were 
evaluated by taking the Ag^ o and Aggo/Aggoof a sample as described previously.
in vitro transcription
RNA was synthesised from the linearised plasmid template using an SP6 Message-Machine 
kit (Ambion, U.K.), reagents from which are denoted by ‘(kit).’ The following were added 
to an RNase-free microfuge tube: 2 |xl Reaction Buffer, whirUmixed and centrifuged briefly 
before use (kit); 10 fxl Ribonucleotide Mix, 2x, whirlimixed and centrifuged briefly before 
use (kit); 1 p,g linearised plasmid, flicked and centrifuged before use; nuclease-free water 
(kit) to give a final volume of 18 |xl; 2 [il lOx Enzyme Mix (kit), which contains DNA- 
dependent RNA-polymerase specific for the SP6 promoter and an RNase inhibitor, were 
added last. The tube contents were mixed by flicking and brief centrifugation, and 
incubated for 1.5 - 2 hr at 37 °C. The ribonucleotide mix contains the components of 
eukaryotic mRNA required for its assembly, these being aU four nucleotides and a 7- 
methylguanosine cap analogue which is incorporated at the 5’ end.
Removal of the dna template
To yield a pure, quantifiable amount of RNA it was necessary to remove the DNA 
template, this was done by DNA-specific enzymatic digestion and precipitation: DNase I,
1 [xl (kit) was added and the digestion incubated at 37 °C for 15 min. After this time, 30 fxl 
nuclease-free water (kit) and 25 pil LiCl (kit) were added to precipitate the RNA, the tube
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was flicked to mix the contents and then incubated at -20 °C.
After 0.5-1 h, the tube was centrifuged at 12 x 1000_g for 15 min at 4 °C to pellet the RNA. 
The supernatant was removed immediately and the pellet washed by addition of 500 p,l 
70 % ethanol in RNase-free water. The tube contents were thoroughly mixed prior to 
centrifugation at 12,000 x^ for 5 - 15  min at 4 °C, to re-pellet the RNA. Using a drawn-out 
glass Pasteur pipette, aU visible traces of ethanol were removed. The microfuge tube was 
left with the cap off in RNase-free laboratory conditions at room temperature for 5 min to 
evaporate the final traces of liquid. Between 15 and 20 jxl nuclease-free water were added, 
depending on the pellet size, the tube capped and the RNA left at room temperature for 10 
min to re-suspend.
Confirmation of synthesis and Isolation of RNA, Its allquotting and storage
A  tris-borate-EDTA (TBE) analytical gel was run to confirm the integrity, homogeneity 
and purity of the prepared RNA. The RNA solution should contain no significant amounts 
of other nucleotides. All equipment used was either autoclaved, treated with HgOg solution 
or specialist RNase removing product, or purchased RNase-free. All solutions were either 
autoclaved or double nitrocellulose-filtered to remove deleterious proteins, or purchased 
RNase-free. A 1 % TBE - agarose gel was prepared with EtBr at 0.2 pig/ml. After the gel 
had partially cooled, it was poured into a gel tank to set. TBE was poured on top as a 
running buffer to a level of 0.5 cm above the surface. In a microfuge tube, 1 pil of RNA 
suspension was added to 5 pi blue loading buffer (kit) and 4 pi nuclease-free HgO (kit).
The tube was incubated at 65 °C for 10 min to denature RNA secondary structure. The 
RNA sample was run alongside a molecular weight marker and visualised under U.V. as 
before. A single band confirmed the purity of the RNA and the homogeneity of its 
structure.
The concentration of the RNA solution and the degree of contamination are assessed in 
the same manner as described previously for DNA, by measuring Aj^ o and Aggo/Aggo. The 
RNA suspension was diluted in an RNase-free microfuge tube in RNase-free HjO. The 
approximation of the RNA concentration in the suspension from the gel enabled a 
sufficient amount of RNA to be included to give a reliable OD reading, as this requires at 
least 1 pg/ml [75]. The tube was flicked, quick-centrifuged and the contents transferred to 
a quartz cuvette.
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The A260 was measured (relative to RNase-free water) and the concentration of RNA 
estimated by applying the formula:
1 OD = 1 X A260 of ssRNA = 40 |Xg/ml. The A2gowas also taken, the degree of protein 
contamination of the RNA sample being given by the ratio Ag^ o/Aggo, which should be 
between 1.5 and 1.9.
The RNA sample was diluted with RNase-free water to give a final cRNA concentration of 
1 pg/p l and divided into aliquots of 3 fxl. Each aliquot provided sufficient injections of 
50 ng for 60 eggs. The RNA was stored in a manner which minimised trauma to preserve 
its integrity. Batches of RNA about to be used or being subjected to multiple rounds of 
defrosting and refreezing were stored at -20 °C. RNA to be stored for long periods was 
frozen to - 70 °C.
xenopus laevis oocyte preparation and cRNA injection
Ovaries from mature Xenopus laevis females were the gift of Prof. D. SatteUe, when resident 
at The Babraham Institute, Cambridge, and Professor T. Smart, Department of 
Pharmacology, The School of Pharmacy, University of London. The ovaries were washed 
and stored for up to 24 h before use in Standard Oocyte SaUne (SOS), which has the 
foUowing composition (mM): NaCl, 100; KCl, 2; CaCl2, 1.8; MgCl2, 1; HEPES, 5. The pH 
was adjusted to 7.6 by addition of NaOH, ION.
Healthy oocytes at stages V and VI of development were selected for experimentation. An 
incubation of up to 2 min in coUagenase type lA (Sigma, U.K.), 2 mg/ml in Ca '^^-free SOS, 
was used to ease removal of the foUicle layers that envelope the oocyte. The Ca^^-sensitive 
coUagenase was diluted in a version of SOS with CaCl2 omitted and clumps of oocytes were 
washed thoroughly in Ca^^-free SOS before and after coUagenase treatment. Detachment 
of the foUicle ceUs was completed manuaUy using fine forceps. cRNA encoding RDL^ ,^
1 pg/pi, was injected cytoplasmicaUy using a Nanoject pipette (Drummond, U.K.). Each 
oocyte received 50 ng of RNA except for those left uninjected for use in control 
experiments (see Figure 3.2).
AU oocytes were transferred to Petri dishes containing incubation medium. This consisted 
of SOS supplemented with antibiotics and an energy source as foUows: peniciUin 100 
units/ml, streptomycin 100 pg/ml, gentamycin 50 pg/ml, sodium pyruvate 2.5 mM, and 
horse serum 10 ml/1. In the 30 min foUowing injection, oocytes were kept at 4 °C to aUow
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recovery. The cells were then incubated at 16 °C and transferred to fresh incubation 
medium on a daily basis. Electrophysiological recording began when expression was 
sufficient, usually 18 h after injection. Batches o f cells showing consistent expression with 
large currents were moved to 4 °C to prolong their life. Such cells were viable for 4-8 days.
N uclear m icroinjection
cD NA cD NA
In vivo transcription 
and processing
In vitro 
transcription and 
capping
cRNA
C ytoplasm ic m icroinjection
Translation
Post-translational m odification 
Sorting, A ssem bly 
M em brane insertion
cRNAcRNA
G A BA  receptor
Figure 3.2 Xenopus oocyte oDNA and cRNA microinjection
Many foreign proteins are modified and targeted appropriately in Xenopus oocytes. The genetic material 
enabling their synthesis is introduced by microinjection o f either DNA or RNA into the nucleus or 
cytoplasm, respectively: Cytoplasmic injection was performed in the experiments described in Chapter 3, 
and nuclear injection in those in Chapter 4. Note that cRNA is a form of mRNA.
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3.3.2 Electrophyslology
Individual oocytes were secured in an 80 p,l perspex bath by a surrounding ring of stainless 
steel entomological pins. The pins were embedded into a layer of the polymer Sylgard, 
which lined the chamber. The bath was perfused continuously with SOS by a gravity-fed 
system, at a flow rate of 5 ml/min, which allowed administration of SOS and test drugs. 
The oocyte membrane potential was held at -60 mV and membrane currents were 
monitored by 2-electrode voltage-clamp, using 3 M KCl-fiUed electrodes (0.5-5 MQ) and 
an Oocyte Clamp OC-725C amplifier (Warner Instrument Corporation, U.S.A). Signals 
were displayed on a chart recorder. A schematic representation of the bath and circuit is 
shown in Figure 3.3.
GABA was dissolved in SOS to give a 0.1 M stock solution, made fresh each day, and a 
serial dilution performed to obtain test concentrations ranging from 1 mM to 10 nM. Test 
compounds (monoterpenoids and eugenol) were dissolved in SOS to 5 mM with the aid of 
a small amount of acetone or DMSO (dimethylsulphoxide), and then diluted with SOS. 
The concentration of organic solvent in the test solutions did not exceed 0.1 %. Solutions 
of 0.1 % acetone or DMSO had no effect on the current required to clamp injected oocyte 
membranes at -60 mV, nor did it affect responses to GABA. DMSO and acetone have 
been used as solvents for drugs in oocyte electrophysiology on previous occasions [113].
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Figure 3.3 Diagram of the disposition of the Xenopus oocyte and eiectrodes in the 
perspex recording chamber used in voitage-ciamp eiectrophysioiogy
The oocyte rests in a bath that is continually perfused with fresh saline. The voltage electrode, together 
with the bath or ‘reference’ electrode, monitors changes in the oocyte membrane potential resulting from 
intrinsic ion channel activity. The clamp-amplifier constantly compares the actual membrane potential 
(Vm) with the desired, or command, clamp potential (Vc) set by the researcher. The clamp-amplifier must 
increase Vm by a specific amount, the output voltage (Vo), to maintain Vc at all times. This is achieved 
by the injection o f  current (I) into the cell. The amount o f current injected is always exactly equal, but o f  
opposite polarity, to the net current flow through the channels. The current injected (in amps) is recorded 
and displayed by the clamp-amplifier. The change in amps injected over time can be displayed on a chart 
recorder as a trace.
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GABA was applied in doses of 15-30 s duration, separated by a 3-10 min SOS wash to 
avoid receptor desensitisation. Oocytes expressing RDL,^ were rejected if the responses to 
three identical GABA applications were not consistent. Terpenoids and eugenol were 
tested for activity on RDL^  ^GABARs by administering the compound alone at 100 pM for 
2 min, which allowed equilibration with any binding sites, and then co-administering with 
10 jxM GABA for 15 - 30 s. GABA, 10 pM, was close to a previously published EC50 for 
GABA [117], and therefore would elicit responses which were sensitive to either inhibitory 
or potentiating compounds. After each co-application, SOS was allowed to wash through 
for 10 min. This was followed by a further application of GABA to assess the reversibility 
of the terpenoid effect. Different terpenoids were tested on different oocytes, as the 
picrotoxane terpenoids were found to be incompletely reversible when tested in the same 
system [117]. Each terpenoid was screened on several RDLg^-expressing eggs (n = 3 or 
more from at least 2 batches). The effects of terpenoids on uninjected oocytes were also 
examined.
To further investigate the effects of GABA-potentiating compounds, a dose-response 
curve for GABA was generated from which the EC20 was estimated. GABA was applied to 
oocytes in increasing concentration until the maximum response was obtained. Data for 
each oocyte were normalised with respect to the maximum response, dose-response data 
for individual oocytes were then pooled, averaged and presented ± one standard error of 
the mean (± s.e.m.) of experiments on n cells. GraphPad Prism (GraphPad Software, U.K.) 
was used to fit the four-parameter logistic equation below, which describes a sigmoid curve 
of variable slope, to the averaged, normalised data:
=  /™+ (4„- U  /  (1 + 10
where Cp is the normalised current induced by a given concentration of agonist, [A];
and are the maximal and minimal normalised agonist responses, respectively; EC50 is 
the concentration of agonist predicted to elicit half the maximal response and n„ is the 
slope (HiU) coefficient.
Dose-response data for GABA-potentiation by monoterpenoids and eugenol at 
recombinant RDL^g insect receptors were collected by applying a set concentration of 
terpenoid for 2 min, followed by co-application of this concentration with E Q q GABA. 
This regime was repeated using increasing concentrations of test agent with a 10 min
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washout between each. Data were handled in the same manner as for the GABA dose- 
response curve above, except that each response was normalised to the ECjo GABA 
response for that cell. ECgo GABA was applied regularly throughout to ensure reversal of 
the potentiating effect during washout.
Source of materials
Terpenoids and eugenol were obtained from Sigma (U.K.). GABA was obtained from RBI 
(U.K.).
5.4 Results
3.4.1 Thymol potentiates the action of CABA at recombinant homomeric Drosophila 
melanogaster RDUdnsect CABA receptors
The GABA dose-response curve obtained from oocytes expressing RDL^cis shown in 
Figure 3.4. From this an ECgg value for GABA of 4 p,M was estimated for use in further 
experiments to investigate the potentiation by monoterpenoids. The ECspwas 8.5 [xM 
(95 % confidence interval: 7.1-10.0 pM), which was close to previously published EC50 
values for this receptor [24].
Thymol, IpM  - 100 [xM, potentiated the GABA response when co-applied for 15-30 s with 
EC20 GABA, following a 2 min pre-application with thymol alone (Figure 3.5). The 
potentiation was fully reversible: applications of GABA after a 10 min washout resulted in 
currents identical to the control response (Figure 3.5). Potentiation was dose-dependent 
with respect to thymol concentration, for example, 10 [xM thymol potentiated the response 
to EC20 GABA to a lesser degree (163 ± 22 %, n = 7) than 100 [xM thymol (715 ± 85 %, 
n = 6) (Figure 3.8). The degree of potentiation by thymol also appeared to be dependent 
upon GABA concentration: 100 p,M thymol increased the response evoked by 10 fxM 
GABA less than 2-fold, however the response to EC20 GABA (4 |xM) was potentiated over 
7-fold. Potentiation by concentrations of thymol greater than 100 pM could not be 
investigated as they caused instability of the clamped current and usually resulted in death 
of the oocyte. Concentrations of thymol of 100 fxM were without effect in uninjected 
oocytes (n = 3, from separate batches).
127
3.4.2 Thymol has direct agonist activity at heterologously expressed Drosophila 
melanogaster RDLac CABA receptors
A  direct effect of thymol was seen in RDL^j.-injected oocytes: Concentrations of 1-50 
thymol and below had a negligible effect, eliciting changes in the clamp potential of 15 nA 
or less. Thymol, 100 p,M, resulted in currents which were 57 ± 22 nA (n = 4) in amplitude 
at 2 min (Figure 3.5), and therefore were very small in comparison to the corresponding 
potentiated ECjo current, which was 47 pA on average from the same cells. The responses 
to thymol alone began immediately upon application but were very slow to gain amplitude 
and failed to plateau throughout the 2 min application time. This current was not the result 
of a change in electrochemical gradient across the cell, as the pH of the bathing solution 
was not affected by thymol.
3.4.5 Eugenol and carvacrol have similar activities to thymol at RdUc homomers
Co-application of eugenol, 10 pM — 1 mM, with ECjo GABA, after a 2 min pre-application 
with eugenol alone, also resulted in a dose-dependent potentiation of the GABA response 
(Figure 3.6). Eugenol, 100 p,M, increased the response to ECgo GABA 2-fold (231 ± 18  %, 
n = 4), whereas 1 mM eugenol gave a 17-fold potentiation (1713 ± 52 %, n = 3) (Figure 
3.8). Potentiation of GABA activity by eugenol was completely reversible: GABA 
applications after a 10 min washout generated responses that were identical to the controls 
(Figure 3.6).
In oocytes expressing RDL^c eugenol, 10p,M — 500 pM, applied alone had a negligible 
effect; at 500 p.M, currents were 16 nA or less. Eugenol, 1 mM, alone elicited currents of 
which the average was 42 ± 19 nA (n = 3) in amplitude, this was very small compared to 
the average 1 mM eugenol-potentiated ECgo GABA current in the same cells, which was 
17 pA. These responses were slow to gain amplitude and failed to plateau during the 2 min 
application time (Figure 3.6). The application of eugenol, ImM, to uninjected oocytes 
evoked no detectable response (n = 3).
Co-application of 0.1 — 100 p,M carvacrol with ECgg GABA, after a 2 min pre-application 
with carvacrol, also potentiated the ECgg GABA response (Figures 3.7 and 3.8). At 100 pM
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the response was 362 ± 49 % of control (n = 6). The GABA-potentiating activity of 
carvacrol was also completely reversible after a 10 min washout (Figure 3.7).
Applied alone, carvacrol 0.1 piM — 50 |xM had only negligible effects on the clamp current 
in RDLg^-expressing oocytes, 50 |iM carvacrol induced currents of less than 10 nA. At 
100 p-M, the average current was 26 ± 11 (n = 4) nA in amplitude in comparison to the 
average carvacrol-potentiated EC20 GABA current in the same cells, which was 24 pA. The 
agonist responses of carvacrol showed similar kinetics to those of thymol and eugenol 
(Figure 3.7). The application of 100 pM carvacrol to uninjected oocytes evoked no 
detectable response (currents <3nA, n=3).
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Figure 3.4 The GABA dose-response curve obtained from Xenopus oocytes expressing 
the Drosophila melanogaster GABA receptor subunit RDLac
Oocyte membranes were voltage clamped at -6 0  mV. Each point is shown ±  one s.e.m and is the mean o f  
4 - 1 1  observations. The EC50 on this curve is 8.5 fxM (estimated by GraphPad Prism), similar to a 
previously published EC50 for this receptor (see text). The EC20 was estimated from the curve by eye at 4 
irM.
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Figure 3.5 Effects of thymol at an Insect GABA receptor
In Xenopus oocytes expressing the Drosophila GABA receptor subunit RDLac voltage-clamped at 
-6 0  mV:
(a) thymol potentiates the EC20 GABA response
i. The response to EC20 GABA applied alone.
ii. EC20 GABA co-applied with 1 0 0  piM thymol after a 2  min thymol pre-application.
iii. The response to EC20 GABA after a 10 min washout.
(b) thymol, 100 piM, applied alone shows agonist activity
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Figure 3.6 The effects of eugenol on an Insect GABA receptor
Responses to eugenol recorded from Xenopus oocytes expressing RDLac homomeric GABA receptors, 
voltage-clamped at -6 0  mV:
(a) when co-applied with EC20 GABA
i. Control response to EC20 GABA.
ii. The response to EC20 GABA co-applied with 1 mM eugenol after a 2 min application o f  eugenol alone.
iii. The control GABA response after a 10 min washout period.
(b) when applied alone at 1 mM
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Figure 3.7 The effect of carvacrol on Insect RDLac homomeric GABA receptors
Application o f carvacrol to Xenopus oocytes expressing the Drosophila GABA receptor subunit RDLac, 
voltage clamped at -6 0  mV:
(a)
i. The response to GABA, EC20, applied alone.
ii. Carvacrol, 100 jiM, co-applied with EC20 GABA after a 2 min pre-incubation with 100 fxM carvacrol.
iii. GABA, EC20, after washout.
(b)
The effect o f  100 jxM carvacrol applied alone.
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Figure 3.8 Thymol, eugenol and carvacrol potentiate the GABA response of 
RDLac- containing Insect lonotropic GABA receptors
The Drosophila  GABA receptor subunit, RDLac was expressed in Xenopus oocytes, and the oocyte 
membranes held at -6 0  mV. Thymol, eugenol and carvacrol were co-applied with EC20 GABA. Currents 
are expressed as a percentage o f  the control response to GABA, shown here as 100 %. Data points are 
displayed ±  one s.e.m. Each point is the mean o f  n observations, n =  6-7 for thymol, n =  3-4 for eugenol, 
and 5-7 for carvacrol.
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3.5 Action of monoterpenoids on insect GABA receptors
3.5.1 A novel activity for monoterpenoids
The effects of certain monoterpenoids and other volatile natural products on the ionic 
activities of nerve and muscle cells of vertebrates have been investigated previously 
[35,146,195]. There is also evidence of equivalent effects in some invertebrate tissues 
[70,138], Certain monoterpenoids and eugenol have been shown to interact with 
heterologously expressed vertebrate neuronal receptor targets [176,285] but, thus far, there 
has been no evidence for their interaction with an equivalent invertebrate model. The 
results obtained in this investigation have identified a previously unknown target for 
volatile phenolic phytochemicals: the insect GABA receptor. Thymol, eugenol, and 
carvacrol aU enhance the action of GABA on heterologously expressed, homomeric insect 
GABA receptors, composed of the Drosophila melanogaster subunit RDL j^.- As thymol and 
carvacrol were shown to be amongst the most lethal of a selection of monoterpenoids 
towards human lice (P. humanus  ^see Chapter 2 of this thesis), and thymol, eugenol and 
carvacrol have aU been shown to be lethal towards some other species of insects [157,197], 
low molecular weight phenolic phytochemicals could represent a new class of GABAergic 
insecticidal molecules.
Resistance to many neuroactive insecticides is widespread and may involve, for example, 
alterations in binding site or a change in metabolic aspects relating to a particular chemical 
structure, such as increased detoxification [27,86]. Cross-resistance can occur not only 
between structurally similar molecules, but also between chemically unrelated molecules 
that have a common mechanism of action or pharmacokinetic property, for example, the 
insecticidal molecules picrotoxinin, fipronil and BIDN are all rendered less effective by the 
A302S mutation in RDL subunits [39,88,113,114]; although they are structurally diverse, all 
are GABAR antagonists. If the insect GABA receptor proves to be the mediator of 
monoterpenoid- or eugenol-induced lethality in insects, provided that these compounds do 
not depend on A302 of RDL for their potentiatory activity, insects with the A302S 
mutation would not be cross-resistant to them. So far, the binding sites for GABAR 
positive allosteric modulators appear to be distinct from those of GABAR antagonists, and, 
as the A302S mutation is thought to reside in the binding site, rather than the transduction 
domain, of this particular group of antagonists, cross-resistance is unlikely.
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Despite numerous reports of the insecticidal and insect behaviour-influencing nature of 
monoterpenoids and other volatile phytochemicals [101,135,196], there have been few 
attempts to relate these effects to insect molecular targets. This study provides the first 
evidence for the action of phenolic monoterpenoids and eugenol at a specific target in the 
insect nervous system, as it demonstrates their activity at a recombinant insect ionotropic 
receptor known to be representative of many native insect GABARs.
3.5.2 A putative role for CABA receptors In mediating the effects of monoterpenoids on 
Insects
The efficacy of the three volatile phytochemicals studied on RDL^  ^homomers, in order of 
decreasing potency, was: thymol > carvacrol > eugenol. In Chapter 2 of this thesis, thymol 
was also more potent than carvacrol at killing lice (the pediculicidal activity of eugenol has 
not yet been determined), suggesting there may be a correlation between the insecticidal 
activity of at least some monoterpenoids and the potency of insect RDI^^ GABAR 
modulation. This could be further evidence that these essential oil components exert their 
lethal activity via potentiation of insect GABARs, but more data in each assay system is 
required to confirm the correlation. However, it appears that not all monoterpenoids, even 
the most pediculicidal ones, have potentiatory activity at GABARs; preliminary 
observations suggest that terpinen-4-ol and linalool have no effect on RDL,,. homomers 
and that a-thujone produces a slight inhibition, as it does on GABAy  ^receptors [110]. It is 
not inconceivable that different monoterpenoids with similar insecticidal potencies may 
have very different mechanisms of action, and the present data suggests that even the 
relatively small structural variation that exists between monoterpenoids may result in 
different effects at the same target. Thus far, potentiation of GABAergic activity at insect 
GABA receptors appears to be common to the phenolic monoterpenoids, although 
citroneUol, citronellal and pinene were reported to potentiate responses of rat ionotropic 
GABA receptors expressed in Xenopus oocytes [285]; furthermore, the relative potency of 
the phenolic essential oil constituents as pediculicides and also their effects on louse 
physiology, including reduction of locomotory activity suggestive of a CNS depressant 
effect, indicates that potentiation of GABA may underlie their lethality towards P. humanus.
Lack of activity at RDL ,^. homomers may not necessarily reflect absence of activity at native 
insect GABARs, as such compounds may require the presence of more than one subunit 
type to act, analogous to the way that benzodiazepines require the presence of a  and y
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subunits to potentiate at mammalian GABARs, or they may act specifically on certain 
populations of GABA receptors. The reason for the species and developmental stage 
specificity described for insecticidal monoterpenoids [196] is as yet undetermined, it may 
reflect differences in GABA receptor populations, but other factors such as differences in 
bioavailability of the active moiety at the target site are equally likely.
Future studies could include the characterisation of the a-thujone inhibitory effect on 
RDL^g, and to investigate if the binding site is shared with thymol, eugenol and carvacrol; 
although they have similar physicochemical properties, it does not follow that their site of 
action on GABARs is the same. Even the two isomers of HCH, y (GABA-blocking) and 
Ô (GABA-potentiating), are believed to have different binding sites, as the A302S mutation 
reduces the potency of the former but not the latter in RDL,g homomers [23].
5.5.5 HOW does the activity of thymol, eugenol and carvacrol In potentiating GABAR- 
mediated currents compare with the actions of other Insecticides?
Several classes of insecticidal molecules have activity on the invertebrate nervous system: 
Some insecticides enhance neuronal activity by acting as agonists at receptors mediating 
excitatory stimuli. For example, pyrethroids maintain insect voltage-gated Na+-channels in 
the open state for extended periods [277], and the neonicotinoids, such as the 
nitroguanidine imidacloprid, are agonists at nAChRs [78]. The organophosphates result in 
neuronal stimulation by inhibiting the break-down of the excitatory transmitter ACh. 
Others insecticides enhance overall neuronal activity by blocking GABA-mediated 
inhibition in the nervous system [78]. Such convulsant antagonists with insecticidal activity 
include picrotoxin, cyclodienes, hexachlorocyclohexanes, BIDN and fipronil, all of which 
result in a net over-stimulation of the nervous system by decreasing the inhibitory input.
Unfortunately, cross-resistance to GABAergic insecticides is extensive, and not only affects 
structurally diverse molecules, but also affects ligands of more than one binding site: 
Radioligand binding and electrophysiological studies suggest that several convulsant 
antagonist insecticides, such as BIDN and dieldrin, interact with a common binding site yet 
fipronil and BIDN, and BIDN and picrotoxin do not share common binding locations 
[113,208]. Despite this, the potency of all of these compounds is reduced by the A302S 
mutation in Drosophila IW-encoded subunits and therefore the amino acid substitution is 
clearly not in an area responsible for transducing the effects of a single chemical class. Thus
136
the A302S mutation may either be within an area overlapped by the binding domains of 
several classes of antagonist, or it may affect common conformational changes induced or 
prevented by them. Monoterpenoids and eugenol are smaller than most antagonist 
compounds, and therefore probably have more discrete binding location(s). As the effects 
of potentiating compounds and blockers on channel activity are different it also follows 
that the conformational changes they influence, and the residues involved, are also distinct. 
This theory is supported by the differential effect of the A302S mutation on Ô- and y-HCH 
activity at RDL^  ^homomers.
The fact that the vast majority of insecticides act to increase insect neuronal activity may 
seem incompatible with the theory that the toxic actions of some mono terpenoids are 
dependent on their GABA-enhancing action, as this activity would lead to neuronal 
inhibition. However, a few other insect-lethal agents have been discovered which decrease 
neuronal activity, for example, the oxadiazines are insecticidal towards a variety of 
lepidopteran pests and act by blocking sodium dependent action-potentials [166]. A recent 
study on the dorsal unpaired median (DUM) neurones of P. americana revealed spontaneous 
action potential inhibition by DCJW (the active metabolite of the oxadiazine Indoxacarb) 
via block of both voltage-dependent sodium channels involved in the depolarisation phase 
of the action potential (those targeted by pyrethroids), and also so-called background Na"^  
channels involved in maintaining the resting and driving E„, towards the threshold for 
action potential generation [145].
The fact that oxadiazine-induced reduction of spontaneous action potential amplitude via 
voltage-dependent Na^-channel block proves lethal to insects supports the theory that 
phenolic monoterpenoids are insecticidal via GABA-potentiation, as decreased action 
potential amplitude is also a potential outcome of increased GABA activity.
5.5.4 Are other molecules which potentiate Insect CABA activity Insecticidal?
Many compounds, such as barbiturates, steroids and propofol, have aU been found to 
potentiate the effect of GABA at native insect receptors and at RDI^^ homomers. Unlike 
monoterpenoids and eugenol, which have been reported to be lethal towards certain 
species, these compounds are not generally considered insecticidal, Ô-HCH being the only 
exception. This observation does not preclude potentiation of GABA activity as an 
insecticidal mechanism; there are many determinants of insecticidal activity, such as
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cuticular penetration, tissue distribution and metabolism, not just potency at the site of 
action [78].
It is also possible that the maximum degree of enhancement produced by 
GABA-potentiating compounds at insect receptors may determine lethality. Table 3.1 lists 
the maximal potentiations generated by a variety of modulatory compounds at RDI^^ 
receptors; of the compounds tested in previous studies, Ô-HCH gives the largest maximal 
potentiation and it is also the only compound in the group with renowned insecticidal 
activity. Thymol shows a greater degree of potentiation than carvacrol over the range 
10’^  M to lO''^  M, and was also found to be more insecticidal towards lice in Chapter 2 of 
this thesis. Although eugenol has not been tested on lice, it was found to be insecticidal 
towards oak nut weevil, Mechoris ursulus [197]. It is difficult to compare the figures shown 
here for thymol, eugenol and carvacrol and other allosterically active agents, as percentage 
enhancements of EC20 concentrations are lower than those of EC^g doses (refer to [116] 
and also Chapter 4 of this thesis for illustrative dose-response curves). Furthermore, in 
contrast to the other modulatory compounds, it was not possible to obtain maximal 
enhancements for thymol, eugenol and carvacrol. However, as the maximum potentiation 
values for monoterpenoids and eugenol shown in Table 3.1 may be substantial 
underestimates of the true values, it may be worth investigating the link between maximal 
enhancement values and insecticidal activity.
Another important difference between thymol, eugenol, carvacrol, and the steroids, 
barbiturates, and propofol is that the second group of compounds aU have direct agonist 
activity at mammalian GABA^ receptors, but none tested so far have this property at 
RDL^c homomers. By contrast, thymol clearly has direct activity at both mammalian [176] 
and RDL^g receptors. As some authors believe that it may be the direct GABA receptor 
agonist effect of anaesthetics that is responsible for their activity, and overdoses of these 
compounds are lethal to humans, perhaps the equivalent activity in insects may also be 
responsible for the insecticidal effect.
It is interesting that a previous study of the actions of HCH isomers at GABA receptors 
did not relate their activity to GABAR block or potentiation per se, but instead found a 
correlation between insecticidal potency and the ability of the isomer to enhance receptor 
desensitisation [181]. Enhancing GABAR desensitisation would have the effect of 
rendering GABAergic neurotransmission unresponsive to endogenous GABA, allowing 
the nervous system to become overstimulated. The potential of volatile phenolic
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phytochemicals in influencing the rate of receptor desensitisation in the presence of GABA 
has not yet been tested, however, in this study, agonist responses induced by thymol did 
not desensitise over the 2 min application period. This may have been because only low 
concentrations on the agonist dose-response curve were tested, as only those responses to 
GABA above EC20 show marked desensitisation. However, non-desensitising agonist 
responses to EC^ oo thymol were reported in rat aip2y2 GABA^ receptors [176]. If receptor 
desensitisation proves to be a feature of monoterpenoid action it is likely to confuse studies 
of physiological responses in whole insects, as it is likely that evidence of both neuronal 
suppression and excitation would be observed prior to death.
Because of the multitude of determining factors, correlations between insecticidal potency 
and GABAergic activity made in this thesis and in other work must be treated purely as 
hypotheses. Further investigation is required to confirm the link between the GABA-ergic 
and insecticidal activities of volatile phytochemicals.
M aximal enhancem ent (% ) GABA cone" References
Eugenol 1713 EC20 Chapter 3
Thymol 715 EC20 Chapter 3
Carvacrol 362 EC20 Chapter 3
Ô-HCH 1000 ECio [24]
Propofol 880 ECjo [24]
Pentobarbitone 790 ECio [24]
5a-pregnan-3a-ol-20-one 180 ECio [24]
4 ’-chlordiazepam 180 ECio [116]
Control response to GABA = 100 %
Table 3.1 Allosteric modulation of RDL homomers
A comparison o f  the maximal degrees o f enhancement o f  GABA ECio and EC20 concentrations by various 
allosteric modulators on homomers composed o f  RDLac. Cone" = concentration.
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Summary and direction
In Chapter 3, the ability of the volatile phenolic essential oil constituents thymol, eugenol 
and carvacrol to enhance the actions of GABA at heterologously expressed RDL j^. 
homomers was demonstrated. These homomeric multi-subunit proteins are a 
representative model of a major type of insect GABA receptor, in that they reliably 
reproduce the pharmacology of many insect receptors studied in the native tissue.
In Chapter 4, the question of whether one of these compounds, thymol, has similar effects 
at a human ionotropic GABA receptor model wiU be addressed. If this proves to be the 
case, the fact that human GABA receptors have been more thoroughly studied than their 
insect counterparts, and have a wider range of associated pharmacological and molecular 
tools, means they wiU make a more useful vehicle than the RDL homomer for the Chapter 
4 study of the thymol binding site.
140
Chapter a 
Action of monoterpenoids on mammalian CABA receptors
4.1 Rationale for investigating monoterpenoid activity on mammalian 
CABA receptors
The purpose of the experiments described in this chapter was to investigate whether the 
positive modulation of GABA action by thymol on recombinant RDI^^-containing insect 
receptors was also apparent on vertebrate receptors and, if so, whether thymol was acting 
on a previously uncharacterised site of action on the GABA receptor. Selectivity for the 
invertebrate receptor would be toxicologically advantageous if thymol were to be 
developed as an insecticide. Conversely, activity at both insect GABARs and mammalian 
GABAy^Rs would allow further investigation of the site of action, as the multiple subunits 
available and more potent positive modulatory ligands make the GABAy^R a more useful 
tool for this purpose than the insect GABAR.
Previous literature has concluded that potentiating compounds, such as barbiturates, 
steroids, and benzodiazepines, act at GABA receptors via an allosteric site, unrelated to 
either the agonist or convulsant antagonist binding sites [241]. In this Chapter, tests were 
devised to screen for the interaction of thymol with one of the various allosteric modulator 
binding sites.
Interactions of ligands with particular sites on neuronal receptors can be analysed in 
binding studies [see for example 192,193], or by electrophysiology. Electrophysiological 
experiments utilising recombinant receptors of known subunit composition are the most 
informative: By changing the subunit combination of heteromeric receptors, the subunit 
dependency of ligands such as the benzodiazepines and loreclezole can be identified; 
alternatively, by keeping the same subunit combination, the effects of combinations of 
ligands can be observed to investigate if they compete for the same binding site; another 
approach is to generate mutant subunits, often using either chimaeric or point-mutated 
gene sequences, to assess the dependency of ligand action on certain sections of the protein 
or individual amino acids. The latter experiment can be problematic, for example, a major
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drawback is that not all mutant proteins express as well as wild-type subunits. A common 
approach is to observe differential efficacy of a compound on receptors varying in one 
subunit type, identify the residues in which the two subunit types differ, and systematically 
mutate runs of these residues in the sensitive subunit to residues in the insensitive subunit, 
until sensitivity is abolished (or vice versa); then the number of residues mutated are 
reduced until the minimum structural requirement(s) is identified. This allows the 
researcher to narrow down potential areas for site-directed mutagenesis.
4.2 Methods for expression of recombinant human CABA receptors
4.2.1 oocyte preparation and cDNA injection
Ovaries from mature Xenopus laevis females (Blades, U.K.) were provided by Ms Sally 
Thompson and Ms Lola Wheat at Merck, Sharp and Dohme, Terling’s Park, U.K. The 
ovaries were immersed in Modified Barth’s Solution (MBS) of the following constitution 
(mM): NaCl, 88; KCl, 1; NaHCOj, 2.4; HEPES, 10; MgSO^.THzO, 0.82; Ca(N0 3 )2.4H2 0 , 
0.33; CaCl2.2H2 0 , 0.91; pH 7.5 by addition of 10 N and/or 1 N NaOH. The ovary tissue 
was divided into groups of 100-200 oocytes using fine forceps and transferred to a 
hypertonic isolation medium composed of (mM): NaCl, 108; KCl, 2; EDTA, 1.2; HEPES, 
10; pH 7.9 with NaOH. In this medium the oocytes shrank away from the surrounding 
follicular membranes, facilitating manual membrane detachment with forceps. Residual 
follicular cells were removed by incubating the oocytes in coUagenase type lA (Sigma, 
U.K.), 0.5 mg/ml in MBS, for 6 min.
Each cell nucleus was injected with 20 nl of GABA subunit cDNA mixture using a manual 
oocyte injection pipette (Drummond, U.K.). After injection, cells were transferred to 
individual compartments of a multiweU plate, each of which contained 2 ml of incubation 
medium. The incubation medium in this case was MBS supplemented with gentamycin,
50 mg/1; penicillin, 10,000 U/1; streptomycin, 10 mg/1; and sodium pyruvate, 2.5 mM. 
Oocytes were maintained at 19 °C initially, but were transferred to 4 °C if necessary to 
keep expression levels in check; over-expression can lead to perturbations in subunit 
stoichiometry away from the 2a2|3lY ratio desired.
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CABA subunit CDNAS
Human cDNAs, encoding a l ,  a 6, P3, (31 and y2s GABA receptor subunits, were supplied 
by The Molecular Biology Department, Merck, Sharp and Dohme, Terling’s Park, U.K.
The subunit cDNAs were injected in combinations of three, in the ratios 1:1:1 or 1:0.1:1 
(a, (3, Y, respectively), the concentration of total cDNA being 20 ng/ml in injection buffer 
comprising of (mM): NaCl, 88; KCl, 1; HEPES, 15; pH 7 with NaOH.
4.2.2 Eiectrophysioiogy
Recordings were obtained from cells as soon as sufficient expression was detected, usually 
18-24 h after injection. Cells were only used if maximal responses of 100 nA or more could 
be elicited by applications of 3 mM GABA (EC^ og). Oocytes were secured inside a ring of 
stainless steel entomological pins embedded into Sylgard, which lined the bottom of a 
400 pi perspex bath. Fresh MBS was continually perfused through the chamber by a gravity 
fed system at 4 ml/min. AU drugs were applied dissolved in MBS, although stock solutions 
of hydrophobic compounds were prepared in DMSO or acetone for further dilution in 
saline. Membrane currents were measured by two-electrode voltage-clamp, with the 
membrane held at -60 mV, using 2 M KCl-fiUed electrodes with 1 % agar in 2 M KCl at the 
tip. Electrode resistance was maintained at 0.5-5 MQ. Signals were amplified using a 
GeneClamp 500 (Axon Instruments, U.S.A.) and recorded on two outputs in tandem: 
electronically using ‘Oocyte’ for the Digitimer Digistore™ System (Digitimer Ltd., U.K.) 
and on chart paper with a Thermal Arraycorder WR 8500 series (Graphtec, U.K.).
Each ceU was first chaUenged with 3 mM GABA to obtain the maximal response, then 
GABA dose-response curves or isolated ECjgS were obtained prior to the assessment of 
thymol action in the same cell. By applying increasing GABA or thymol concentrations, 
dose-response data were generated. In order to minimise desensitisation and run-down 
effects, oocytes were chaUenged with drugs 5 min after a maximal GABA response, and 3-7 
min after other appUcations, depending on the drug and concentration applied. Only 
oocytes yielding stable responses were selected for experimental work. Uninjected oocytes 
did not respond to GABA. Curves were fitted to the dose-response data, both for 
individual ceUs and also to the mean data points, using the non-Hnear regression equation 
in GraphPad Prism described in Section 3.3.2. Results are presented as the mean ± one 
s.e.m. EC50 values given in the text are mean values calculated from several EC50 values,
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each of which was estimated from the dose-response data obtained from an individual cell. 
For the graphical presentation of data, all dose-response results were averaged before a 
single regression line was fitted.
Chemicals
Acetone, 99.8 %, was obtained from BDH; DMSO, 99.99 %, from Fisher Scientific; 3- 
HMC from Tocris and propofol (2,6-düsopropylphenol) from Aldrich. GABA, 
pentobarbital, 5a-pregnane-3a, 20a-diol, 5a-pregnan-3a-ol-20-one (allopregnanolone) 
and thymol were aU supplied by Sigma (U.K.). Flumazenil (Rol51788) was synthesised by 
K. Moore at The Chemistry Department, Merck, Sharp and Dohme, Terling’s Park, U.K.
4.3 Results
4.3.1 Potentiation of CABA action by thymol
Thymol, 1 p-M - 100 pM, applied in conjunction with ECgo GABA produced a dose- 
dependent potentiation of the GABA response in oocytes injected with oil |33y2s cDNAs 
(Figure 4.1 (a) and (b) and Figure 4.2). Above 100 pM, potentiation decreased with 
increasing thymol concentration (Figure 4.1 (c)). The maximal potentiation achieved was 
416 ± 72 %, at 100 pM thymol (n = 5).
4.3.2 Intrinsic activity of thymol
Cells expressing al|33Y2s did not respond to 1 pM-50 pM thymol, when applied alone (any 
changes in clamping current were less than 9 nA in amplitude). Thymol at 100 pM and 
above generated responses, although these were extremely small in comparison to the 
100 pM thymol-potentiated GABA current (Figure 4.1 (b) and (c): Responses to 100 pM 
thymol measured an average of 9 nA (n = 7), in the same cells the mean potentiated 
GABA current, measured from the baseline, was 878 nA. Dose-response curves showing 
the agonist action of thymol were not examined because the concentrations of acetone 
required to solubilise 300 pM thymol and above have increasing non-specific effects on the 
current required to clamp the cell.
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4.3.5 Effect O f  thymol on the CABA dose-response curve
Thymol enhances the response to concentrations of GABA below ECiqo, the largest effects 
being seen over the range ECg - EC50 (Figure 4,3). The amplitudes of currents induced by 
3 p,M and 100 (xM GABA were 7.6 ±1.7 % (n = 5) and 89.0 ± 4.8 % (n = 5) of the 
maximum, respectively. In the presence of 50 p,M thymol, these responses were 
potentiated to 45.0 ± 5.2 % (n = 5) and 98.6 ± 3.0 % (n = 5) of the maximum GABA 
response, respectively. The GABA dose-response curve, (calculated by non-linear 
regression analysis of the mean data points from 5 cells) was shifted to the left by 50 [xM 
thymol and the mean EC50 for GABA (the average of the EC50S from five individual dose- 
response curves) was significantly reduced from 15 ± 3 p.M to 4 ± 1 jxM, as demonstrated 
by a paired t-test (p = 0.0044) at the p = 0.05 level. The HiU slope was also reduced 
significandy (shown by a paired t-test at the p = 0.05 level, with a p value of 0.0076) from 
1.35 ± 0.14 to 1.04 ± 0.16. However, 50 [xM thymol had Uttle effect on the maximum 
GABA response (Figure 4.2).
4.5.4 Effect O f  different subunit compositions on thymol potentiation
Over the range 1 p.M-100 [xM, thymol potentiated the EC20 GABA response mediated by 
alj3ly2s and a6|33y2s vertebrate GABA receptors in a dose-dependent manner. The 
thymol dose-response curves obtained for al|3ly2s, a6|33y2s and al^3y2s receptors were 
almost identical: over the range of concentrations tested, GABA activity at aU of these 
three subunit combinations was potentiated equaUy by thymol (Figures 4.4 and 4.5).
4.5.5 Effect O f  the benzodiazepine non-competltlve CABA antagonist 
flumazenil, on thymol potentiation
Application of 50 p-M thymol, ECgg GABA and 1 |xM flumazenil to (%l(33y2s expressing 
oocytes foUowing pre-applications of flumazenil (30 s) and thymol plus flumazenil (40 s) 
resulted in a mean increase of the ECgo GABA response to 276.3 ± 6.6 % (n = 4 ) (Figure 
4.6 (a) and (c) ). Co-application of thymol and GABA, foUowing a 40 s pre-incubation with 
thymol, potentiated the GABA response to 346.5 ± 34.7 % (n = 4) (Figure 4.6 (b) ). These 
two sets of data were obtained from different oocytes, so an unpaired t-test was performed
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to examine the flumazenil effect. The mean of the data for thymol potentiation in the 
presence of 1 pM flumazenil was found not to be significantly different from that in its 
absence at the p = 0.05 level (p was 0.0936), suggesting thymol is not acting via the 
benzodiazepine site
4.3.6 Effect O f  3-hyclroxymethyl-p-carbollne (3-HMC) on thymol potentiation
In cells expressing a l  P3y2s, a slight decrease in the EC20 GABA response was apparent in 
the presence of 100 jxM 3-HMC, the amplitude being 83.7 ± 3 % (n = 3) of control 
(Figure 4.7). The oocytes were then challenged with 50 piM thymol and EC20 GABA in 
combination, which resulted in potentiation of the control GABA response to 
320.3 ± 60 % (n = 3). Application of 50 [xM thymol, EC20 GABA and 100 pM 3-HMC 
together, following pre-applications of thymol and 3-HMC, resulted in an augmentation of 
the EC20 GABA response to 308 ± 64 % (n = 3). The difference between the normalised, 
thymol-potentiated EC20 GABA response data in the presence and absence of 3-HMC was 
shown to be non-significant at the p = 0.05 level (p = 0.1264) in a paired t-test.
4.3.7 Effect O f  the pregnane steroid 5a-pregnane-3a, 20a-dioi on thymol 
potentiation
Co-application of the pregnane steroid 5a-pregnane-3a, 20a-diol, 3 p-M, with ECgq GABA 
increased the al(33'y2s GABA response to 164 ± 26 % (n = 4) of control (Figure 4.8). The 
mean potentiation of the EC20 GABA response by 50 pM thymol in these cells was 360 + 
37 % (n = 4) of control. Application of thymol, GABA and 5a-pregnane-3a, 20a-diol, 
following pre-applications of 5a-pregnane-3a, 20a-diol alone (40 s) then thymol plus 5a- 
pregnane-3a, 20a-diol (40 s) enhanced the control response to 395 ± 39 % (n = 4). A 
paired t-test demonstrated that EC20 GABA potentiation by 50 pM thymol was 
significantly larger than that of 3pM 5a-pregnane-3a, 20a-diol at the p = 0.05 level (p was 
0.0256). A further paired t-test demonstrated that 3pM 5a-pregnane-3a, 20a-diol served 
to significantly augment the response to co-applied thymol and GABA at the p = 0.05 level 
(p was 0.0287).
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4.3.8 Effect Of the barbiturate pentobarbital on thymol potentiation
Pentobarbital elicited inward currents in oocytes expressing a l  P3y2s (Figure 4.9). Repeated 
doses of 300 jiM pentobarbital were applied until consistent responses were obtained, the 
mean of which was 558 ±315 nA (n = 4). Thymol, 50 p,M, was then applied for 40 s prior 
to co-application of thymol with 300 p,M pentobarbital. The response to pentobarbital was 
potentiated by 50 [xM thymol to 996 ± 567 % (n = 4). A paired, one-tailed t-test of the 
results, expressed as a percentage of the pentobarbital current, showed the potentiation to 
be significant at the p = 0.05 level (p was 0.0263).
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4.3.9 Effect Of the general anaesthetic propofol on thymol potentiation
Oocytes expressing a l  |33y2s responded to applications of 60 |xM propofol with inward 
currents (Figures 4.10 and 4.11). Propofol was applied until consistent responses, with a 
mean of 1236 ± 87 nA (n = 4) were obtained. Thymol, 50 p,M, was applied for 40 s prior 
to co-application with 60 p,M propofol. The response to propofol was enhanced in the 
presence of thymol to 1464 ± 111 % (n = 4). A paired, one-tailed t-test of the results, when 
expressed as a percentage of the propofol current, showed the difference in means to be 
significant at the p = 0.05 level (p was 0.0043).
As the potentiation achieved here was marginal, further tests were carried out: Firstly,
300 nM 5a-pregnan-3a-ol-20-one (allopregnanolone) was applied for 40 s followed by co­
application of 300 nM aUopregnanlonone and 60 p-M propofol. Allopregnanolone alone 
generated a small current, 8.9 % (n = 1) of the value of the mean control propofol 
response, and potentiated the current produced by 60 pM propofol to 151 % (n = 1). The 
purpose of applying allopregnanolone, a GABA-potentiating steroid, was to investigate the 
degree to which the 60 pM propofol response could be potentiated by another positive 
modulator, known to act at a different site from propofol, and compare it with thymol 
potentiation of the 60 pM propofol response in the same cell. Potentiation of the 60 pM 
propofol response by thymol in this cell was 124 % of control (n = 1).
In the same cell, a subsequent test compared thymol-induced potentiation of the propofol 
and GABA responses, to assess if the potentiation of GABA was greater. The response to 
60 pM propofol was found to approximate that of GABA EQo in this ceU and therefore 
the 50 pM thymol-induced potentiation of GABA EQgwas assayed; it was found to be 197 
% of control (n = 1).
148
(a)
GABA 8 nM
Thymol 5 nM
GABA 8 jiM
60 !
(b)
G ABA 9 nM
Thymol 100 nM 
GABA 9 nM
60s
(C )
Thymol 500 (xM 
GABA 8 (iM
GABA 8 jiM
60 s
Figure 4.1 Thymol-Induced potentiation of submaximal GABA responses, recorded from 
heterologously expressed human GABAa receptors
Recordings obtained from Xenopus oocytes expressing a ip 3y2s GABA receptor subunits, voltage- 
clamped at -6 0  mV.
In (a), (b) and (c), traces demonstrating potentiation are shown adjacent to EC20 GABA control responses 
recorded from the same cell.
(a) Lower test concentrations o f  thymol, such as 5 fxM, had a smaller potentiating effect on the GABA  
response than (b) higher concentrations. Thymol, 100 p.M, induced a 416 ±  72 % (n = 5) increase in the 
control GABA current, and also showed agonist activity when applied alone.
(c) Above 100 |xM, increasing thymol concentrations led to a decrease in the amplitude o f  the potentiated 
current and an increase in the agonist activity o f thymol.
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Figure 4.2 Dose-dependent potentiation of the response to ECgo GABA by thymol in 
Xenopus oocytes expressing human aip3y2s GABA* receptors
The oocyte membrane potential was clamped at -6 0  mV and potentiated currents recorded. Data are 
shown as the mean o f  4-6 observations ± one s.e.m.
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Figure 4.3 Effects of thymol on the GABA dose-response relationship of a human GABAa 
receptor
(a) and (b): the degree o f  potentiation o f  the aipSyZs GABA response by 50 pM thymol is [GABA]- 
dependent, and is greater when applied with lower test [GABA]. (c): Thymol, 50 |xM caused a significant 
leftwards shift o f  the GABA dose-response curve (at the p=0.05 level). Data were normalised by 
expression as a percentage o f  the maximal GABA response. Data are shown as the mean o f  
5 observations ± one s.e.m.
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(a) aipSyZs
200 nA
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60 !
Thymol 100 nM
GABA 9 nM
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Thym ol 100 (xM 
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(c) a6p3v2s
GABA 1 [iM
u
200 nA
6 0 s
Thym ol 100 (xM 
G A B A 1 nM
Figure 4.4 The effects of thymol on the GABA responses of three different 
heteroiogousiy-expressed vertebrate GABAa receptors were not significantly different
Thymol potentiates GABA at: (a) a l  P3y2s receptors (shown previously in Figure 4.1).
(b) a ip iy l s  receptors
(c) a6p3y2s receptors
The above are shown alongside the control current elicited by EC20 GABA, obtained in the same cell.
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Figure 4.5 The potentiating effect of thymoi at heteroiogousiy expressed vertebrate 
GABAa receptors with different subunit combinations
Thymol, 1 piM-100 jxM, potentiated the EC# GABA response mediated by human ionotropic GABA  
receptors with the subunit combinations a ip iy 2 s;  a6p3y2s; a ip 3y2s; there was no difference between 
subunit combinations with respect to the degree o f potentiation induced by a given concentration o f  
thymol within this range. Data points are shown as the mean o f  3-6 observations ±  one s.e.m.
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Figure 4.6 Flumazenil does not affect the GABA-potentiating activity of thymoi at 
heteroiogousiy-expressed human aip3y2s GABAa receptors
(a) Enhancement o f  EC20 GABA by co-application o f thymol and flumazenil. This increase in GABA  
receptor activity was not significantly different from that elicited by thymol alone (b).
(c) Data from 4 oocytes, shown ±  one s.e.m.
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Figure 4.7 The co-application of 3-hydroxymethyi-p-carboiine (3-HMC) with thymoi does 
not affect thymoi enhancement of the ECgo GABA response in Xenopus oocytes 
expressing human a l p3y2s GABA receptors
(a) Sequential recordings from a single oocyte.
(b) Collated data from several oocytes showing the mean o f  3 results, ± one s.e.m.
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Figure 4.8 The steroid 5a-pregnane-3a, 20a-diol (5a-pregnanediol) has no significant 
effect on the thymol enhancement of the human a1p3y2s GABA receptor-mediated 
response to GABA
(a) Traces recorded sequentially from a single oocyte.
(b) Mean data (n =  4) shown ± one s.e.m.
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Pentobarbital 300 piM
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Figure 4.9 Potentiation of the human a1p3y2s GABAa receptor response to 300 pM
pentobarbital by 50 pM thymoi
Receptors were expressed in Xenopus oocytes and currents recorded with the voltage clamped at -6 0  mV.
Thymol potentiates the response to pentobarbital at human otipSyls GABAa receptor:
(a) Data from a single oocyte.
Q)) Mean data from 4 experiments, shown ± one s.e.m.
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Figure 4.10 Thymol-Induced potentiation of the human a l p3y2s GABAa receptor response
to propofol
(a) The current amplitude elicited by propofol showed a small (for thymol) but significant increment in 
the presence o f  thymol. For comparison, (b) potentiation o f  the propofol response by allopregnanolone 
and (c) the response to EC30 GABA, which is o f  the same relative amplitude as that o f  60 |iM propofol, 
and its enhancement by thymol are also shown. All recordings are from the same cell.
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Figure 4.11 Enhancement of the response to 60 pM propofol by 50 pM thymol at a human 
GABAa receptor
Human aip3Y2s GABAa receptors were expressed m. Xenopus oocytes and the oocyte membranes 
voltage-clamped at -6 0  mV. Data points represent the mean response from 4 oocytes, shown ±  one s.e.m
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4.4 Monoterpenoid interaction with recombinant mammaiian GABA 
receptors
4.4.1 Thymol Is a positive modulator of human C A B A a  receptors and also has 
direct agonist activity
In Chapter 3, the potentiating effects of the phenolics thymol, eugenol and carvacrol on a 
heteroiogousiy expressed insect GABAR were demonstrated. The results presented here 
show that thymol also potentiates the actions of GABA at a recombinant human GABA^  ^
receptor. Modulation of the human aip3y2s receptor was dose-dependent over a similar 
concentration range as that seen for potentiation of RDL,^ homomers, although it appears 
that thymol is less potent on the mammalian than the insect model; a given concentration 
of thymol produced a lower potentiation at the GABA^ receptor than at the insect receptor 
(See Figures 3.8 and 4.2). A small but definite effect of thymol applied alone was seen at 
both mammalian and insect recombinant receptors when high concentrations were tested. 
This was likely to have been the result of direct agonist activity of thymol at GABA^  ^
receptors, as uninjected eggs did not produce responses to thymol at equivalent 
concentrations; furthermore, direct agonist activity of thymol has recently been described 
at rat a l  (32y2 receptors expressed in HEK cells (the potentiatory effect was not 
investigated) [176]. In the invertebrate receptor assay, potentiating effects of concentrations 
of thymol above 100 |xM thymol could not be tested as they caused instability of 
membrane currents in expressing cells, whereas in this, vertebrate equivalent the solubility 
of thymol and the decrease in potentiation levels at concentrations above 100 [xM were the 
limiting factors.
Given that thymol is able to potentiate GABA activity at the a l  P3y2s GABARs as well as 
at RDLg  ^homomers, it could be postulated that other volatile phytochemicals, especially 
eugenol and carvacrol, may also have this activity. Recently, it was found that eugenol, 
citronellol, pinene and citronellal all potentiated GABA responses in Xenopus oocytes 
injected with whole rat brain mRNA [285]. Although the subunit composition of the 
receptors formed was not determined, the findings of the aforementioned study suggest 
that the potentiation of GABA action at vertebrate ionotropic GABA receptors, by plant 
derived monoterpenoids and other similar compounds, is not restricted to those structures 
with a phenolic functional group.
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Structure-activity studies of monoterpenoids on both insect and vertebrate GABA 
receptors may reveal that some are actually highly specific for insect receptors, thereby 
indicating potentially selective agents for development as insecticides. In this study, instead 
of examining the structure-activity relationships, the binding site and molecular 
requirements for the interaction of monoterpenoids with GABARs were examined; the 
variety of pharmacological and molecular tools available for the GABA^R made its use 
preferable over RDL,,. homomers. Binding site information is important in the study of 
insecticidal activity, as it allows the researcher to determine if the site of action is shared by 
any other previously known ligands of the receptor. By grouping ligands in such a way, the 
potential for cross-resistance within and between groups can be studied. Furthermore, even 
if some compounds in an identified binding site class are not useful clinically or 
agriculturally, they could stiU be used as tools to study molecular interactions at that site, via 
competition or radio-ligand binding studies for evaluation of related structures. Knowledge 
of both the optimal pharmacophore and the nature and shape of the binding site allows the 
drug-receptor interaction to be modelled and this is important in rational drug design.
4,4.2 Effect Of thymol on the CABA dose-response curve
The significant leftwards shift of the GABA dose-response curve obtained from 
al|33Y2s-expressing oocytes demonstrates that thymol can increase the efficacy of 
submaximal concentrations of GABA, but does not greatly affect the maximum response. 
This suggests that thymol is specifically facilitating the manner in which GABA binds to or 
activates the receptor, but cannot increase the current flow above the maximum possible 
achieved by GABA alone. The Hill coefficient of the GABA dose-response curve was also 
decreased in the presence of thymol, suggesting a reduction in the number of GABA 
molecules required to activate the channel; unliganded GABARs require two or more 
GABA molecules for channel activation, whereas the thymol-modulated receptor may only 
require one. In these respects, the action of thymol on GABA^ receptors is similar to that 
of the insecticide Ô-HCH on RDL^  ^homomers but not to that of Ô-HCH on GABA^Rs; 
on RDLgg homomers, Ô-HCH shifts the dose-response curve to the left, decreasing nH 
without affecting the maximal response [116]; on GABA^Rs, however, Ô-HCH shifts the 
dose-response curve to the left but also depresses the amplitude of the maximal response 
[272].
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4.4.5 Effect O f  changing subunit composition on thymol action
Changing the subunit combination of the receptor is useful as a first step towards 
elucidating modulator binding sites, as it is a relatively quick method of identifying portions 
of the protein, in the form of specific subunits or subunit interfaces, important for 
mediating the effects of a ligand. Neither changing the a l  subunit to a6 nor changing the 
P3 subunit to p i had any effects on the potency or maximal potentiation of thymol on 
GABA;^ receptors. Substituting a l  to a6 renders receptors otherwise sensitive to the 
majority of benzodiazepines unresponsive to the majority of this class of compound, with 
the exception of certain benzodiazepine site ligands, such as the partial inverse agonist Ro 
15-4513 [265]. This substitution was used previously in an attempt to characterise a novel 
positive aUosteric modulator of GABA^ receptors: the activity of 
(+)-ROD188 was compared on benzodiazepine-sensitive (rat aip2y2) and 
benzodiazepine-insensitive combinations of subunits (rat al|32, rat a6|32Y2). In fact, this 
compound was most active at receptors containing the a6 isoform in axP2y2 , where x = 
1,2,3,5,6. Thymol had no particular selectivity for a l  or a6, suggesting that it does not act 
via the benzodiazepine binding site, nor the (+)-ROD188 site [248].
Loreclezole potentiates the actions of GABA at both RDL^  ^a.nd GABA^ receptors, the 
determinants o f potency at the loreclezole site on GABA^ receptors being shared by the 
positive modulatory actions of etomidate and DMCM [107,242]. As there are no 
competitive inhibitors of loreclezole available, the most readily available way in which to 
test if a compound shares a site on the receptor with loreclezole is to investigate if it, like 
loreclezole, has reduced potency on (31-containing receptors in comparison to (33- 
containing receptors; the activity of thymol was not affected by this change in recombinant 
a l  (3xy2s GABA^Rs (where x = 1 or 3). This study shows that, unlike loreclezole, thymol 
potentiates the GABA response at a ip iy 2  or al(33y2 receptors with no difference in EC50 
or efficacy, suggesting that thymol does not interact via the loreclezole binding site.
4.4.4 Benzodiazepine and p-carbollne binding sites
Further evidence that thymol does not interact with the benzodiazepine binding site was 
provided by competition studies using the ligands flumazenil and 3-HMC. Certain 
benzodiazepines, such as the aUosteric enhancer fiunitrazepam, are active on many native
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insect receptors and also GABA^ receptors but do not have activity at RDL homomers 
[116,219]. It has been suggested that the activity of these benzodiazepines on insect 
receptors depends on the presence of more than one subunit type, as it does in vertebrates 
[119]. Other benzodiazepines, such as 4’-chlorodiazepam, do potentiate agonist activity at 
RDL homomers [116]. However, it is relatively difficult to perform competition studies 
between two compounds that both potentiate GABA responses, and antagonists are 
preferred for this purpose: for this reason, the known potent GABA^ receptor antagonist 
flumazenil and inverse agonist 3-HMC were chosen for study,
Flumazenil (Rol5-1788), at 1 pM, was used in a previous functional study to investigate the 
interaction of the positively modulating (3-carboline ZK 91085 with the rat recombinant 
alp2y2 GABA^ receptor: potentiation by 0.1 mM and 0.7 mM ZK 91085 was reduced by 
70 % and 51 % respectively in the presence of flumazenil [116], indicating an action at the 
benzodiazepine binding site. However, 1 pM flumazenil had no effect on the activity of 
(+)-ROD188, which therefore does not compete with benzodiazepine binding [248].
Not all |3-carbolines interact exclusively via the benzodiazepine/j3-carboline binding site, 
for example, one o f the best characterised P-carbolines, DMCM, acts as an inverse agonist 
via this site but, at high concentrations, positively modulates via the loreclezole site. So far, 
there is no evidence that 3-HMC displays the latter property at GABA receptors and 
therefore is more useful in competition studies; it blocks GABA action at the cockroach Df 
motor neuron, and, although it does not have inverse agonist activity at RDL homomers, it 
was reported to competitively antagonise the potentiating effects of 4’-chlorodiazepam at 
this receptor [116].
Both flumazenil and 3-HMC have high binding affinities to GABA^ receptors. Therefore, 
assuming that the affinity of thymol is not particularly high, a substantial reduction in 
thymol activity associated with its displacement from the receptor would be expected if 
thymol acted via the benzodiazepine/P-carboline binding site. In this case, neither 
compound had a significant effect on the activity of thymol, suggesting that there is no 
competition for binding site between thymol and compounds of these classes.
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4.4.5 Interaction with the steroid binding site
Functional competition studies where both agents potentiate the effects of the agonist are 
the most difficult to interpret; it is not possible to predict exactly how the potentiating 
activities of two different compounds, whether acting at the same binding site or not, will 
be integrated by the receptor in terms of overall conformational changes and subsequent 
effect on the response. Previous literature [248] used the rationale that an interaction 
between compounds would manifest as a potentiation by the dual combination less than 
the (theoretical) additive effect of the two compounds applied separately. The fact that 5a- 
pregnanediol potentiation of the GABA response was much lower than that of thymol 
suggests that a functional interaction might result in a combined enhancement lower even 
than that produced by thymol alone.
When applied together the combined enhancement by thymol and propofol was actually 
higher than that produced by thymol alone. An unpaired t-test revealed that there was no 
significant difference between the expected combined potentiatory actions of thymol and 
5a-pregnanediol, calculated by summation of the individual percentage potentiations, and 
the actual potentiation, allowing the conclusion that the effects of thymol and 5a- 
pregnanediol are entirely additive. This result suggests that thymol does not act via the 
steroid binding site.
4.4.6 Interaction with a barbiturate site of action
Barbiturates potentiate the effects of GABA at GABA^ receptors, and also have a direct 
agonist effect [199]. As competition studies between two potentiating compounds can be 
liable to ambiguities in their outcome, it could prove more conclusive to study the ability of 
thymol to potentiate the agonist effect of pentobarbital; if thymol can potentiate this 
activity it is possible that thymol binds to a site aUosteric to the barbiturate agonist binding 
site; if thymol cannot enhance barbiturate agonist action, or shows only marginal 
potentiation, it is Ukely that thymol binds via the same site. The pentobarbital response was 
potentiated significantly by thymol (see Figure 4.9), suggesting a distinct mode of action. 
Response amplitudes to pentobarbital as an agonist are often highly variable, consistent 
with the results obtained in this study. For example, in the study investigating (+)-ROD188 
action at the pentobarbital agonist site, the mean potentiated pentobarbital current was
164
given with an s.e.m of ± 37 %, responses to other drugs in this paper typically had s.e.m.s 
of between ± 5 and ± 12 % (from 7 examples chosen at random). Furthermore, although 
this paper claims that (+)-ROD188 potentiates the pentobarbital current, it does not state 
if the potentiation was significant or not [248].
4.4.7 Interaction with propofol
Thymol-induced potentiation of the direct agonist effect of propofol, which also acts as a 
positive aUosteric modulator at GABARs, was also examined. Although the ampUtude of 
the propofol current was found to be significantly greater in the presence of thymol, the 
degree of propofol potentiation by thymol appeared rather low in comparison to thymol- 
induced potentiation of ECjo GABA responses. PreUminary tests were then carried out on 
a single oocyte to see of it could be determined whether the thymol-potentiated propofol 
current was in fact reduced, on account of an interaction between the compounds: 5a- 
pregnan-3a-ol-20-one (aUopregnanolone) was used to assess the degree by which the 
propofol response could be potentiated by another positive modulator; furthermore, to 
compare potentiation of a functionaUy equivalent dose of GABA, thymol enhancement of 
EC30 GABA (equivalent to 60 p,M propofol in terms of the fraction of the maximal GABA 
response produced) was assessed. It was found that the thymol potentiation of the 
propofol response, the aUopregnanolone potentiation of the propofol response and the 
thymol potentiation of the EC30 GABA response were aU similar in terms of the percentage 
increase in current above control, this provides further evidence that potentiation of the 
direct effect of propofol by thymol is not inhibited by competition with propofol, and 
therefore thymol does not act via the propofol agonist site.
4.4.8 The site of action of thymol on CABA receptors, as determined 
by functional competition studies
The evidence reported here suggests that thymol does not share sites of action with many 
of the most widely investigated aUosteric modulators of GABA^ activity, these being 
benzodiazepines, (3-carboUnes, barbiturates, propofol, loreclezole and steroids. It is stiU 
contentious as to whether the barbiturates and propofol act as agonists and positive 
modulators via the same or distinct sites: a range of point mutations on GABAR subunits 
influence both the agonist and modulator activities of pentobarbitone and/or propofol
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[9,200] leading some authors to conclude that the sites for both activities are identical, 
however, such mutations could possibly be affecting aspects of transduction, rather than 
binding [25]. The simplest conclusion is that thymol has a mode of action different from 
that of pentobarbital and propofol as GABAR agonists, and possibly also as modulators.
It should be considered that, without binding data, there is a chance that an inhibition by 
one ligand on the potentiatory activity of another may be the result of an aUosteric action, 
and not competition. Furthermore, differences in activity at different subunits may reflect 
differential transduction rather than differential binding. In this study, the lack of positive 
results in aU experiments suggests that neither the binding site nor transduction domains 
were affected in any of the test conditions.
To assess sites of interaction on the receptor, binding studies have historicaUy been more 
commonly employed as a first line method of studying ligand-receptor interactions than 
functional competition studies. For reasons outlined in the previous paragraph and below, 
binding data make a useful accompaniment to functional studies. Obtaining data on 
binding kinetics prior to functional studies can predict the appropriate concentrations of 
competing agents to use in functional studies. To ensure sufficient displacement of the 
compound of interest occurs to see an effect on the response, certain types of compounds 
are not amenable to binding assays; for example, a-endosulphan, a GABAR antagonist, 
readily partitions into membranes and this precludes determination of affinity [72]. 
Monoterpenoids are also known to partition into membranes and therefore binding studies 
may be similarly problematic. However, a recent study has successfully dealt with 
differential displacement of the radioligands pH]muscimol and pH]MK801 (NMDA 
receptor antagonist) from mouse cortical membranes by linalool [37], and a-thujone was 
shown to displace pH]EBOB binding [110]. Perhaps further studies should therefore 
attempt to confirm that the reason for the lack of competitive effects between thymol and 
other GABAergic agents is not because the affinity of thymol for its site is too great to 
allow even partial displacement by the other ligands to occur.
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4.4.9 Further possible mechanisms of thymol action
In this study, thymol has tentatively been termed a positive aUosteric modulator of GABA 
receptors, however, as yet no putative aUosteric site for thymol has been identified. One 
review of aUosteric receptors describes aUosteric modulation as the interaction of a 
molecule with “sites of action on receptors or carrier molecules that are different and 
distant from signal substance or substrate binding sites” [100]. Another, more inclusive 
definition states that an aUosteric interaction between receptor Ugands occurs, not by 
“classical mutual exclusion,” but via “specific,” “topographicaUy and stereochemicaUy 
distinct sites” [64]. It is therefore interesting to note that (+)-ROD188 was described in a 
recent pubUcation as a positive aUosteric modulator of the GABAR, simply by the virtue 
that it stimulated GABA induced currents at GABARs in a concentration dependent 
fashion and induced negUgible currents by itself (ampUtude not given), despite the fact that 
no high affinity binding sites were demonstrated; a weak interaction with the 
benzodiazepine site was found but was clearly not the site through which potentiation was 
mediated. SUght selectivity was shown for a6  containing receptors, but this does not 
necessarily reflect binding preferences [248]. To confirm the interaction of compounds, 
such as (+)-ROD188 or thymol, with GABARs as aUosteric, first a “specific” site for 
interaction on the receptor should be described. Otherwise, there may be the possibiUty 
that there is an intermediary site of action; for example, thymol could be activating ceUular 
components of oocytes that interact with GABA receptors. Alternatively, thymol could be 
affecting properties of the Upid bilayer, thereby indirectly altering the conformation of the 
multimeric receptor.
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Does thymol affect CABAaRs by Interaction with the llpId bllayer?
The previous study addressing thymol action at heteroiogousiy expressed GABARs [176] 
compared its activity with propofol, an intravenous anaesthetic compound, however, 
perhaps a comparison between thymoi and volatile anaesthetic agents would also be useful. 
Many compounds which have similar properties to thymol, being volatile and lipophilic in 
nature, share common anaesthetic effects in humans [136]. Anaesthetics in fact encompass 
a wide variety of non-volatile, volatile and gaseous substances including trichloroethanol, 
barbiturates, steroids, xenon, propofol and isoflurane [9]. Anaesthetics generally have low 
affinity for multiple binding sites, and have been reported to affect many aspects of cell 
function, therefore possessing “non-specific” modes of action (although it should be noted 
that steroids are perhaps an exception, being particularly potent and selective for 
GABA^Rs at concentrations relevant to anaesthesia). However, these compounds generally 
affect ion channels at therapeutic concentrations, and other cellular processes at levels 
higher than those producing anaesthesia [170]. For many years anaesthetics were believed 
to act by disordering the lipid bilayer, and recently certain observations have added weight 
to this argument, for example, detergents and free fatty acids can affect receptor channel 
function by changing bilayer properties [137], and theories of how this disordering effect 
might affect the gating of intrinsic ion channels have been put forward [136].
Monoterpenoids have been studied for their membrane disordering properties in 
mitochondria with positive results, the most potent, and also the most lipophilic of these 
was methyl-limonate, which uncoupled 50 % of oxidative phosphorylation at 200 pM and 
inhibited 50 % of inner membrane electron transfer at 1 mM [18]. These concentrations are 
at the upper end of the concentration range of the terpenoids tested on oocytes in Chapter 
3, and mitochondrial uncoupling or disruption of PM integrity could provide the reason 
why carvacrol was particularly liable to induce rapid loss of membrane potential in oocytes 
at concentrations higher than 100 pM. Thymol, eugenol and carvacrol did not affect lipid 
bilayer integrity at the concentrations required for potentiation, as the leak currents in 
uninjected oocytes were negligible (less than 10 nA for 100 p,M thymol and 1 mM eugenol) 
when these compounds were applied alone, confirming that the plasma membrane was 
intact. Furthermore, if the oocyte mitochondria had been affected at these concentrations, 
depolarisation of the plasma membrane would have occurred when thymol, eugenol or 
carvacrol were applied alone to uninjected oocytes, as the membrane potential of a cell is 
highly dependent on the supply of ATP from mitochondrial activity to power active ion 
transport across the membrane.
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Actions of monoterpenoids as membrane-perforating and membrane-stabilising agents 
have been documented; for example, carvacrol enhances the transmembrane penetration of 
other drugs [142]. However, regarding the effect of membrane disordering on receptors, it 
is contentious as to whether the degree of fluidisation caused by general anaesthetics (at 
relevant concentrations) is significant or not [136,170] Considering the mounting evidence 
for the action of many of these compounds at discrete sites on the ligand-gated ion 
channels themselves, especially in the case of GABA^ receptors, the possibility that they 
affect channel gating indirectly, via the plasma membrane, now seems unlikely. For 
example, gaseous anaesthetics are active at a distinct set of ion channels from volatile 
anaesthetics [275,276], and it is unlikely that perturbations of the lipid bilayer differentially 
affect different channels.
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Intracellular constituents
The widespread actions of anaesthetics led to the question of whether they were acting on 
a unifying intracellular component. This was disproven in the case of GABA s^^ Rs, as 
potentiation of GABA^R activity by anaesthetics also occurs in membranes separated from 
all intracellular constituents [151]. Nevertheless, it is interesting that both thymol and 
eugenol appear to affect processes which influence intracellular Ca^  ^levels ([Ca^^J, as Ca^  ^
controls a range of cellular activities, such as secretion, neurotransmitter release, muscle 
contraction and Ca^  ^sensitive enzyme activity; enzymes regulated by Ca^ "^  include kinases 
and phosphatases that affect ligand-gated ion channel activity [204]. The Ca^ "^  
concentration gradients across the cell membrane and the membranes of internal stores are 
steep, and therefore the activation of processes which lead to Ca^  ^entry or release have 
profound effects on [Ca^^j. Even if [Ca^^jOr Ca^^-regulated processes do not underlie 
thymol/eugenol induced potentiation of GABARs, it could be that the effects of thymol 
and eugenol on [Ca^^j contribute to the physiological activities observed in response to 
these terpenoids.
Thymol is potent at releasing Ca^  ^from internal stores in both nerve and muscle 
[138,140,195] and, interestingly, calcium release from the sarcoplasmic reticulum (SR) is a 
property shared by the anaesthetics chloroform and halothane [204]. However, the actual 
consequences of thymol-induced calcium release appears to vary between preparations: 
thymol is reported to be one of the most potent stimulators of Ca^  ^induced Ca^  ^release 
from SR, which leads to raised cellular [Ca^^; and, consequentially, muscular contraction 
[109]. However, in retinal rod photoreceptors, thymol-induced increases in [Ca '^ j^ were 
only transient, leading to speculation that, in this case, Ca^ "^  release activated a Ca^ "^  
transporter which then lowered the [Ca^^j to below the original level [140]. Release of Ca^ "^  
from intracellular stores also occurs in invertebrates, as demonstrated by monitoring Fura-2 
fluorescence in snail (H. pomatiâ) neurones [138].
Although there is some evidence that eugenol may release Ca^  ^ from intracellular stores 
[174], this probably only occurs at high concentrations (3-12 mM), which induce 
contractures of toad skeletal muscle; lower concentrations (0.1-2.5 mM) of eugenol blocked 
- induced contracture [146]. This effect of eugenol at low concentrations may have been 
due to eugenol blockade of Ca^  ^channels, and this was also the likely reason for the 
negative inotropic effect of eugenol in guinea pig heart muscle [227]. In some nerve 
preparations, such as H. pomatia neurones, eugenol also blocks Ca^ "^  currents. However,
170
eugenol probably has different effects on distinct mechanisms of calcium entry and exit 
from the cell, as in rat dorsal root ganglion (DRG) neurons, 1 mM eugenol activated a Ca^  ^
current [188] and eugenol-mediated vasodilatation of rabbit aorta appeared to be via 
inhibition of both uptake and extrusion mechanisms for Ca^  ^ [185].
Although the information regarding the effects of thymol and eugenol on Ca^ "^  currents 
and [Ca ’^^ i regulation in nerve and muscle cells is still rather sketchy, the possibility that 
thymol, eugenol and other monoterpenoids may be raising oocyte internal Ca^  ^levels, 
which then activates a Ca^^-dependent, GABAR-modulating mechanism should not be 
ruled out at this stage. Another interesting aspect of this research is that, so far, it appears 
that the primary Ca^'^-related effect of thymol is intracellular Ca^^-store release, whereas 
eugenol clearly affects Ca^ "^  channels and/or uptake mechanisms, and this could underlie 
the differential utility of these compounds as anaesthetics. A tentative hypothesis would be 
that eugenol relaxes muscles directly via blockade of calcium channels; and that central 
nervous system depression could be effectively achieved via a combination of reduced 
excitatory neurotransmitter release from nerve terminals, due to reduction of Ca^  ^entry 
and subsequent fusion of vesicles containing neurotransmitter to the presynaptic 
membranes [204], the concomitant decrease in GABA release could be compensated for by 
potentiation of GABA activity at the receptor level. However, it is not fully known how the 
anaesthetic state it achieved by any particular compound, so this model is entirely 
speculative.
Single or multiple monoterpenoid binding sites on cabars?
Aside from affecting the lipid bilayer or intracellular components, there are other putative 
explanations for the reason why many volatile, lipophilic compounds act on so many 
regulatory proteins [25], for example, it has been suggested that small volatile compounds 
do not have a binding site per se (consistent with the lock and key theory ligand-receptor 
interaction) but interact opportunistically with multiple sites on receptors [136]. Yet the 
plausibility of this theory is reduced in light of the findings that two specific point 
mutations confer ethanol and enflurane sensitivity to GABA pi receptors [169]. Even if 
this mutation was in a transduction domain rather than a binding domain it seems unlikely 
that multiple small binding sites across the receptor would converge on the same two 
amino acids, especially as propofol sensitivity was not conferred. Furthermore, residues in 
the N-terminal domain influence ethanol inhibition of nAChRs [170], providing evidence 
than ethanol binds to a specific, extracellular area on these receptors; therefore ethanol
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action is probably not via the lipid bilayer nor activation of an intracellular component.
Often, the volatile anaesthetics are referred to as a group in terms of GABA potentiatory 
activity. However, it appears that not all volatile anaesthetics depend on the same portions 
of the protein for activity [96], Furthermore it appears that volatile convulsants and volatile 
anaesthetics share different sites of action on GABARs [127], This leads us to suspect that 
there also may not be a single “monoterpenoid binding site” on GABARs but perhaps 
different sites for different structures: there is evidence for a-thujone binding to the 
convulsant site [110] but, if thymol were to share this property, it would be unusual for a 
positive aUosteric modulator. Evidence that at least some monoterpenoid binding sites may 
be shared by several structures comes from the observation that [3H]-menthol binding to 
guinea-pig lung is displaced by eugenol and camphor (and also capsaicin) [274], There may 
be multiple sites mediating the effect of one structure in the manner proposed for many 
anaesthetics, where sites mediating potentiatory activities are probably separate from those 
through which a direct agonist effect occurs [176]; dual potentiatory activity and (less 
potent) agonist activity is another characteristic of thymol that is shared by anaesthetics.
The putative thymol binding site on GABA^Rs could be investigated further by observing 
the activities of other monoterpenoids at these receptors: if another monoterpenoid could 
be found which competitively inhibited the potentiation of thymol, but had no activity 
itself, analogous to the activity of flumazenil with respect to other benzodiazepines, this 
may provide additional evidence that binding was to specific sites and not just 
“opportunisticaUy” at random hydrophobic pockets. Even if a specific binding site on 
GABA receptors is discovered, this does not preclude the discovery of monoterpenoid 
action at other neuronal receptors; there are many other GABAergic compounds with 
multiple targets: PTX blocks several ion channels, such as vertebrate glycine-gated- 
channels [155], invertebrate L-glutamate-gated chloride channels (L-GluRs) [210], and acts 
at some nAChRs [169]; BIDN and fipronil also block L-GluRs [210,282]; general 
anaesthetics affect the functions of many transmitter-gated ion channels such as excitatory 
ionotropic glutamate, nicotinic acetylcholine and 5-HT) receptors, inhibitory strychnine- 
sensitive glycine receptors and GABA^Rs, modulation can be positive or negative or absent 
depending on the agent and the receptor [112], Volatile anaesthetics induce neuronal 
inhibition via blockade of excitatory pathways as well as via stimulation of inhibitory ones 
[92], Propofol also acts to suppress L-type Ca^  ^channels in the heart and sensory motor 
neurones of the spinal cord [99]; Ca^  ^channel blockade, especially in heart muscle, appears 
to be a property shared by eugenol. The variety of different target sites or mechanisms of
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action of anaesthetics are thought to underlie the different elements of the anaesthetic state 
[90]. Thymol and eugenol also have multiple bioactivities but clearly further work is 
required to establish the precise targets behind the majority of these effects.
Thymol appears not to act as an anaesthetic agent in contrast to eugenol and although this 
could be due to their relative activities at other targets, there is a possibility that differential 
effects at GABAy^Rs might be the cause. Future studies could perhaps compare the 
potentiatory and direct effects of thymol and eugenol at various GABAy^R subunit 
combinations to test this theory.
4.4.10 Implications with respect to use of thymol and related 
compounds as Insecticides
The likelihood that the results of the experiments carried out in this Chapter are also 
applicable to the interaction of thymol with insect GABA receptors is high, although of 
course this requires confirmation. Despite the fact that aUosteric modulator and convulsant 
antagonist binding sites differ between GABA^ and insect receptors in terms of binding 
affinities and pharmacology at each individual site, the spectrum of compounds which 
occupy the distinct, discrete binding sites, is the same for both type of receptor. As thymol 
has similar activities at insect and human GABAy  ^type GABARs, it is Ukely to occupy 
equivalent binding sites on the two receptor types and therefore probably would be shown 
not to interact with insect GABAR benzodiazepine, loreclezole, steroid, barbiturate or 
propofol binding sites in equivalent studies.
If thymol, carvacrol and eugenol do represent examples from a group of insecticidal 
compounds that have a novel mode of action on GABA receptors, as these results suggest, 
they could represent a new avenue in pesticide, or even therapeutic, research; further 
investigations into the binding site and synthetic optimisation to improve GABAergic 
activity, pedicuUcidal activity, physicochemical or pharmacokinetic properties would 
probably yield chemicals with improved potential. Selectivity for the insect receptor may 
also be improved by chemical modification, however, data of GABAergic activity of other 
insecticides suggests that this is not necessarily a prerequisite for the success of the 
compound as an insecticide, as both Undane and dieldrin, for example, also act on 
mammaUan GABA receptors [180]. These organochlorines have occasionaUy caused acute 
poisoning in mammals experiencing food shortage, as the breakdown of fatty tissue where
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they accumulate leads to their sudden release into the body. However, the reason for their 
withdrawal as agricultural insecticides was not because of insufficient selectivity but due to 
their extreme stability and consequent environmental persistence [78].
Summary and direction
In addition to its actions at an insect GABA receptor, thymol has been shown to potentiate 
the agonist activity of GABA at heteroiogousiy expressed human GABA receptors. So far, 
it appears that thymol does not share a binding site with any of the following major classes 
of aUosteric modulator; benzodiazepines, |3-carboUnes, barbiturates, propofol, steroids, 
loreclezole. Although this could mean that thymol binds to a completely different, and 
previously unexplored, GABA receptor site, the possibiUty that thymol may be acting on a 
unifying ceUular component should not be entirely ruled out. Further experiments, perhaps 
utiUsing kinase inhibitors, Ca^  ^imaging and different membranous expression systems may 
help to reject the latter hypothesis, whilst radio-Ugand binding studies may lend support to 
the theory of a direct interaction at the receptor level.
Whether or not the efficacy of thymol in potentiating the action of GABA at 
heteroiogousiy expressed GABA receptors is, in any way, related to its insecticidal potency 
on human Uce and their eggs remains to be confirmed.
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Conclusions and further development of this work
The incidence of head lice is increasing in the developed world, and is still highly prevalent 
in the undeveloped world. The main reason for the increase in frequency in the West is 
likely to be the continued propagation of insecticide resistant lice. Although physical 
intervention methods have been proposed, they are unlikely to be completely successful; as 
part of the adaptation to the parasitic state involves the ability to withstand all manner of 
grooming procedures, making the combing out of lice and eggs too time-consuming to be 
effectively implemented. Therefore unless new chemical treatments are introduced the 
problem is likely to continue escalating, and the normally innocuous condition of 
pediculosis capitis could, again, become a threat to health in this country.
The currently recommended chemical intervention methods are based on active ingredients 
from chemical classes with broad-spectrum insecticidal activity, and in vitro research 
suggests that, even in the absence of resistance, all have incomplete ovicidal activity. 
Although formulation can help, to ensure that all eggs are killed the recommended 
treatment regime is a 12 h application, repeated after 7 days in case any lice or eggs 
survived the first treatment. If head louse remedies were more ovicidal, the patient would 
not need to be exposed to the insecticide for such a length of time.
Essential oils and their constituent monoterpenoids have frequently been discussed for the 
purpose of head louse control, and several previous lines of evidence suggest their utility. 
However, a rational approach to in vitro work is necessary. For example, even if synergy 
between essential oil components is possible, there is little point screening random 
combinations of oils before the efficacy of individual oils is assessed. Similarly, it is 
important to assess the pediculicidal efficacy of different structural types of individual 
essential oil components, as their contribution to the activities of whole oils can then be 
determined in the future. The question of whether whole oils or constituents might provide 
a superior basis for a product could then be answered independently.
In order to minimise exposure to the patient and to the louse, thereby reducing the 
likelihood of adverse effects and resistance, respectively, the duration of insecticide 
application should be as short as possible. A treatment time of less than 3 h would provide 
convenience and reduce patient-insecticide contact time, it also would be important in the 
case of volatile oils, as the concentration on the scalp after application is likely to decrease
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significantly with time, and this may increase the rate of resistance.
In this study, the relative short-term toxicides of various monoterpenoids and nerolidol, a 
sesquiterpenoid, were screened on lice and eggs. These results showed that the most 
effective pediculicidal monoterpenoids were monocyclic, and contained a single O-atom. 
O f the compounds selected, (+)-terpinen-4-ol had the highest activity, supporting the 
many incidences of anecdotal evidence for the efficacy of tea tree oil, which contains 
terpinen-4-ol as a major constituent, against head lice.
However, the ovicidal testing carried out so far suggests that although the ranking for 
activity on lice and eggs shows some similarities, for example, the higher potency of thymol 
over menthol and carvacrol, it also reveals important differences: nerolidol was more 
ovicidal than thymol, whereas it was ineffective in the pediculicidal study. Lice eggs are 
considered to be more difficult to kill than adults, and the fact that nerolidol appears to 
have specific ovicidal activity may indicate its potential for use in an anti-louse product. 
Although the recommended pediculicides currently contain only one active component, 
most likely due to licensing restrictions, it may be relatively easy to obtain a licence for a 
formulation with two distinct ‘ovicidal’ and ‘pediculicidal’ terpenoids, or whole essential 
oils, due to hallowed usage of the latter.
Future studies could investigate if the rapid killing times achieved in vitro might also be 
possible in the field by conducting clinical trials. Further in vitro work might also compare 
the efficacies of monoterpenoids with the currently available pesticides. In the case of 
personal parasite control, relative toxicity (insect vs. human) is more important than 
absolute insect toxicity.
Given the apparent selectivity of monoterpenoids towards certain insects, it is doubtful 
that a more suitable model could be found to screen for activity against head lice than the 
Orlando strain clothing louse. Although the house dust mite, in preliminary tests, appeared 
to show the same relative sensitivity to essential oils as the clothing louse, the same 
application methods cannot easily be applied to both species, as the dust mite is so small, 
and far more mobile; therefore, as the efficacy of an insecticide is notoriously not only 
dependent on the species but also the route of exposure, the house dust mite appears to be 
an unsuitable model. If the clothing louse is completely unavailable, other closely related 
lice of mammals, or larger mite species, could be considered instead.
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The mechanisms of action of pediculicidal monoterpenoids should be investigated to 
determine the relative likelihood of toxic effects towards humans. Knowledge of the 
binding site and its structure-activity relationships would also facilitate the development of 
more selective or more effective agents. Previous reports suggesting a neurophysiological 
mode of action for monoterpenoids were supported by observational studies on Uce and 
eggs in this thesis. To investigate this activity further, monoterpenoids were tested on an in 
vitro model of an insect GABA receptor, the Drosophila RDL^  ^homomer, expressed in 
Xenopus oocytes. Orthologues of this receptor have been found in a wide variety of insects 
and therefore also probably occur in lice, although this has not been explored so far. 
Confirmation of the existence of RDL in lice could be achieved by antibody staining of 
nervous tissue.
The homomeric RDL,,. insect GABA receptor was identified as a novel target for 
monoterpenoids and eugenol, a structurally similar phenylpropanoid. Although preliminary 
observations suggested that the most effective pediculicidal monoterpenoid, terpinen-4-ol, 
was inactive at this receptor, thymol, eugenol and carvacrol all potentiated the actions of 
GABA by substantial degrees, and also showed agonist activity at higher concentrations. 
Potentiation of GABA receptor responses is a property shared by the insecticidal 
compound Ô-HCH, and modulation of neuronal inhibition may be a mechanism by which 
monoterpenoids cause either death, knock-down or both.
Thymol also potentiated responses to GABA at (xipSyZs human GABA^ receptors. 
Although this could mean that its use as an insecticide could result in cases of toxicity due 
to insufficient selectivity, activity at the same target site in insects and mammals does not 
preclude the success of an insecticide. The site of action of thymol on the (%ip3y2s 
receptor was investigated and, so far, functional studies have failed to find any interaction 
with benzodiazepine/|3-carboline, barbiturate, propofol, steroid or loreclezole sites of 
action. Competitive binding studies between thymol and other radiolabelled GABA 
receptor ligands may yield further data to support these observations.
Furthermore, in light of the recently discovered activity of the monoterpenoid a-thujone at 
the convulsant antagonist binding site on vertebrate GABARs, it would be interesting to 
investigate the effects of co-application of thymol with picrotoxin, BIDN or fipronil, or to 
observe if displacement of [^H]EBOB binding could be achieved with thymol. The activity 
of thymol at the A302S RDL^  ^homomeric receptor might also be examined. Although 
other positive allosteric modulators appear to act at sites distinct from the convulsant
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binding site, the likelihood that thymol may bind there should be tested. The possibility of 
thymol acting indirecdy via activation of an intracellular constituent could be addressed by 
electrophysiology on isolated membranes as described in [151].
Without an identified binding site or receptor mutant, it is not possible to convincingly 
demonstrate that activity at the GABA receptor is required for the pediculicidal activity of 
thymol. As the evidence so far suggests that there is no chemical compound to which 
insects cannot become resistant, a strategy for confirming GABAR involvement might be 
to select for thymol resistant strains of lice in the laboratory. DNA sequences from wild- 
type lice, mutant lice and Drosophila could then be compared in order to identify if the 
mutant genes encoded GABA receptor subunits.
Lethal effects o f monoterpenoids on lice: the next stages o f experimental 
developm ent
Although neuronal targets like the GABAR have been identified as causing the rapid 
symptoms of insecticide poisoning or ‘knock-down,’ it has been suggested that insects can 
recover from certain types of neuronal paralysis [94], and a lack of correlation between 
knock-down and mortality has been demonstrated in some cases [91]. It seems that 
mortality and disturbances in motor neuron activity are not as tightly linked as many 
insecticidal studies assume.
Interestingly, recent evidence suggests that insecticide action at neuronal receptors that 
control neurosecretion may be more important in determining death [61] than at those 
receptors affecting co-ordination and locomotion; the former is also considered 
irreversible. In one study, desert locusts from which the diuretic hormone producing corpora 
cardiaca had been removed, failed to undergo pyrethroid-induced water-loss, unlike the 
intact animals [97]. In this thesis, some monoterpenoids, especially cineole, induced a 
profound shrivelling effect in lice, however, these lice did not cease movement throughout 
the course of the experiment, leading them to be classified as alive. Although a paralysing 
effect on Uce is beneficial, as writhing Uce can be felt by the patient, the paralysis must be 
irreversible. Interestingly, a recent study identified anti-RDL staining in the corpora cardiaca, 
suggesting the subunit might function in the control of neurosecretion [221]; however, 
further proof would be required for the involvement of the GABAergic effect of 
monoterpenoids in water-loss, especiaUy as antibody staining to RDI^^ is fairly widespread 
in insect nervous systems.
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This thesis has provided the first evidence of monoterpenoid and eugenol interaction at a 
specific, isolated, insect neuronal receptor target site: the insect GABA receptor. This may 
have implications not only with respect to monoterpenoid toxicity, but also the wide 
variety of other ecological effects they elicit in insects. Equally importantly, it provides 
evidence that combinations of monoterpenoids, such as those found in essential oils, may 
prove to be more effective at eradicating infestations of pediculosis capitis than a single 
entity applied alone; future formulations may not only include distinct ovicidal and 
pediculicidal actives, but also perhaps those with effects on different physiological systems, 
with the aim of maximising toxicity and minimising treatment failure and resistance.
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